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Caffeine is the most widely consumed socially acceptable drug in the world and is commonly used 
for its ergogenic properties with demonstrated performance enhancing effects in endurance, power 
and strength based activities. Despite a wealth of evidence concluding a caffeine induced 
performance benefit, the direct effects of the drug on peripheral physiological processes have not 
been fully examined. Early works showed high dose caffeine has direct force potentiating effect on 
skeletal muscle, a notion that has only recently been confirmed by James et al. (2005) to also occur 
at a maximal human physiological concentration (70µM). The present research, using mouse muscle 
as a model for mammalian muscle in general, provides an in-depth assessment of the direct effect of 
physiological concentrations of caffeine on isolated skeletal muscle performance. This research 
uniquely: quantifies the dose response relationship; assesses the effects of caffeine on maximal and 
sub maximal muscle power output and fatigue; looks at the relationship between muscles with 
different fiber type compositions. As high concentrations of caffeine and taurine are a constituent of 
many energy drinks, the suggested interaction of these ingredients to further potentiate muscle 
mechanical performance was also assessed. The study further examines how mammalian muscle 
mechanical properties change over an age range of development to aged, and how this differs 
between muscles with predominantly different anatomical locations and functions. In light of this 
the age related direct effect of physiological concentrations of caffeine was assessed in order to 
examine whether the ergogenic benefit changed with age. The present results demonstrate a direct 
muscle performance enhancing effect of physiological concentrations of caffeine that is likely to 
promote greater benefit on long duration endurance based activities. Furthermore, the present 
study demonstrates that there is no direct effect of physiological concentrations of taurine and no 
further performance enhancing benefit when combined with caffeine. Finally this research uniquely 
highlights the muscle specific age related changes in mechanical performance and further indicates 
that the direct effect of caffeine changes with age. 
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1.1. General Introduction & Thesis Outline 
Caffeine is the most commonly consumed socially acceptable drug in the world, a constitute of 
common drinks such tea, coffee, sodas and energy drinks, it is consumed largely for its stimulant and 
ergogenic effects (Graham, 2001). It is estimated that approximately 80% of the world's population 
consumes a caffeinated product every day, and that 90% of adults in North America consume 
caffeine on a daily basis (Ogawa & Ueki, 2007; Heckman et al. 2010).The performance enhancing 
properties of caffeine have been evidenced over a broad range of endurance and high-intensity 
based exercise activities (Graham, 2001; Davis & Green, 2009, Astorino & Roberson, 2010).  On the 
basis of this evidence, caffeine has become a lucrative marketable ingredient and is the key 
component of many energy drinks (Reissig et al. 2009). In the U.S. alone from 2002 to 2006, the 
average annual growth rate in energy drink sales was 55% with a 2006-estimated market value of 
$5.4 billion (Reissig et al. 2009).Despite a large body of research, the ergogenic effect of caffeine is 
still a widely investigated and current research area as scientists strive to improve our understanding 
of the effects and actions of this drug. The recent boom in the energy drinks market, and the 
removal of caffeine from the World Anti-Doping Agency’s (WADA) prohibited list, has produced an 
era in which caffeine abuse is readily acceptable within sporting circles and therefore it is important 
to develop our understanding of its effects.Chester and Wojeck (2008) concluded that the use of 
caffeine amongst British athletes was more widespread and accepted in competitive sport 
particularly at the elite level following the WADA 2004 change in stance. 
Once ingested caffeine is rapidly absorbed into the blood and its hydrophobic nature allows free 
passage across all biological membranes resulting in distribution to all tissues of the body (Magkos & 
Kavouras, 2005). The potential central and peripheral action of caffeine has been discussed in recent 
reviews, however the specific magnitude of response in each physiological system cannot be 
quantified separately via human studies due to the potential of caffeine to act on many major 
 2 
physiological systems simultaneously and the ethical restrictions imposed on human testing 
(Graham, 2001; Magkos & Kavouras, 2005).The primary aim of the present thesis is to provide an in-
depth evaluation of the direct effect of caffeine, at concentrations that are physiologically relevant 
to humans (70µM maximum), on isolated skeletal muscle performance. i.e. the aim is to determine 
whether physiological concentrations of caffeine can enhance muscle performance independently of 
the central effects of caffeine. Early work on isolated skeletal muscle suggested that high, millimolar, 
concentrations of caffeine (that would be toxic for human consumption: Fredholm et al. 1999) elicit 
a direct potentiation of contractile force by enhancing the process of excitation contraction coupling 
(Luttgau & Oetliker, 1967; Huddart, 1968; Weber & Herz,1968; Endo et al. 1970; Allen et al. 1989; 
Allen & Westerblad, 1995). More recently James et al. (2005) was the first to conclude a direct effect 
of 70µM caffeine (the maximum likely human physiological caffeine concentration) to promote 
force-potentiating effects in mammalian muscle, using isolated mouse extensor digitorum longus 
(EDL; relatively fast muscle). The work by James et al. (2005) provides the foundation for the present 
body of research where a more detailed evaluation of the effects of physiologically relevant 
concentrations of caffeine is gathered.  
In the thesis the mechanical properties of isolated skeletal muscle are gathered using a number of 
methods, however like James et al. (2005), the present research implements the work loop 
technique where skeletal muscle is assessed during cyclical length changes that are a closer 
approximation of in vivo muscle function than previous techniques(Josephson, 1985; James et al. 
1996). Based on the theme of evaluating the response of isolated muscle to physiologically relevant 
concentrations of caffeine, the thesis is composed of 5 research studies answering a number of 
unique research questions: 
1. The Effect of Physiological Concentrations of Caffeine on the Power Output of Maximally 
and Sub Maximally Stimulated Mouse EDL (Fast) and Soleus (Slow) Muscle  
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The aim of the initial study is to examine the effects of 70µM caffeine (human physiological 
maximum) on isolated mouse muscle with predominantly different muscle fiber types (i.e. fast vs. 
slow). Furthermore the study also looks to assess if the magnitude of the caffeine effect is increased 
if the muscle is stimulated at a sub maximal intensity with the hypothesis that caffeine would 
stimulate a greater SR Ca2+ release at a lower stimulation intensity. Finally this study aims to quantify 
the dose dependant effect of a range of physiologically relevant doses of caffeine. 
2. Does a Physiological Concentration of Caffeine (70µM) Affect Endurance In Maximally or 
Sub Maximally Stimulated Mouse Soleus (Relatively Slow) Muscle? 
James et al. (2005) reported that fatigue resistance in maximally stimulated mouse EDL muscle 
(relatively fast twitch) was not significantly affected when treated with caffeine. The second study is 
the natural progression aiming to assess the effects of 70µM caffeine on the fatigue resistance of 
relatively slow muscle. Furthermore this study also aims to assess if the effect of caffeine is altered 
when the muscle is stimulated at a sub maximal intensity. The aetiology of fatigue will be different 
between muscles with different predominant phenotype and when activated at maximal vs. sub 
maximal intensity. Therefore the potential link between aetiology of skeletal muscle fatigue and the 
ergogenic effect of caffeine can be established. 
3. Does a Physiological Concentration of Taurine Increase Acute Muscle Power Output, Time 
to Fatigue, and Recovery in Mouse Soleus (Slow) Muscle With or Without the Presence of 
Caffeine? 
In conjunction with caffeine, taurine is a further constituent of energy drinks that is included in large 
concentrations. Despite this the acute effect of taurine on performance has received very little 
attention. The present study aims to assess the potential direct effects of physiologically relevant 
concentrations of taurine on isolated skeletal muscle performance and to further investigate the 
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suggested hypothesis that taurine may act to increase the ergogenic effects of caffeine (Geib et al. 
1994; Steele et al. 1990). 
4. Do Skeletal Muscles with diverse Functions Age at Different Rates? The Effect of Ageing on 
Isolated Locomotory (EDL) and Respiratory (diaphragm) Skeletal Muscle Performance   
The vast quantity of research publications that assess the ergogenic properties of caffeine on 
performance are conducted on subjects that are within an age range corresponding to their 
physiological prime. The effect of caffeine to promote performance-enhancing effects in children 
and the elderly is a sparse research area, and subsequently, a key area of interest that this thesis 
looks to address. 
This study aims to: firstly provide detail of changes in skeletal muscle mechanics over a mammalian 
life span; secondly investigate if the ageing and development of muscles vary between muscles with 
differing function and composition (i.e. EDL muscle, a relatively fast twitch locomotory muscle under 
voluntary neural activation Versus diaphragm, a core muscle of mixed fiber type used to power 
respiration and primarily under involuntary neural activation);Understanding the age related 
changes in skeletal muscle’s performance could provide an interesting insight into the physiology of 
ageing, not previously assessed using the work loop technique. Determining the potential muscle 
specific effects of ageing that occur overtime could aid in improving future exercise regimes to 
enhance the quality of life in elderly citizens. 
5. Does the Ergogenic Benefit of Caffeine Change with Age? The Effect of Physiological 
Concentrations of Caffeine on the Power Output of Maximally Stimulated Mouse EDL and 
Diaphragm Muscle  
The final study in this thesis aims to address the earlier question as to the effects of caffeine on 
isolated muscle over an age range spanning from development to elderly. The increase in muscle 
function during development and the later decline in aged muscle are related to a number of 
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interacting mechanisms that may affect the direct ergogenic properties of caffeine at the skeletal 
muscle level with primary consideration to changes in excitation contraction coupling and 
predominant muscle fiber type (Luff & Atwood, 1971; Navarro et al. 2001). With the direct effects of 
caffeine relating to excitation contraction coupling, a potential age related change in calcium 
handling would significantly modify the ergogenic benefit.  As the development and ageing of 
skeletal muscle is likely to be related to compositional and functional properties, study five will 
assess the effects of caffeine on EDL and diaphragm muscle. Furthermore this study is the first to 















1.2. In vitro Testing Methods for the Assessment of Isolated Skeletal Muscle Performance 
In vitro testing is a procedure that takes place in a controlled environment on a non-living organism. 
The example used in the present research is the isolation of a muscle tendon unit via dissection and 
testing of the muscle properties, thus allowing exclusive examination of muscle performance (if the 
preparation is clamped at the tendons). In skeletal muscle testing, it is important that these control 
conditions correspond to the in vivo (real life) environment of the muscle(James et al. 2005).The in 
vitro method provides greater benefit in deducing biological mechanisms of action as isolation of a 
muscle in this way eradicates other possible contributors to performance. Such investigations into 
acute and chronic (fatigue) muscle performance, including studies by Askew et al. (1997), James et 
al. (2004), James et al. (2005), and Vassilakos et al. (2009), have implemented this technique in 
order to achieve these benefits allowing inferences to be made regarding skeletal muscle 
mechanisms. Krebs solution containing a supramaximal concentration of glucose manages 
limitations in muscle metabolism. Oxygen delivery as a variable is minimised, as the surrounding 
fluid is superfused with oxygen at a constant rate. The muscle is directly stimulated causing muscle 
contraction, therefore eradicating the effects of central stimulation; further to this the stimulation 
pattern given to the muscle is identical over time ensuring that any change in muscle force output is 
due to a change in the muscle mechanism of action. The environmental temperature can be 
maintained at a constant for all the preparations eradicating the effect of hypothermia and 
thermoregulation requirements. Rarely in vivo will a muscle produce a true maximal force due to 
central inhibition as a method to prevent damage (Macintosh, 2006). Therefore a maximal 
stimulation will produce a true maximal force output that may only be achievable in vivo in time of 
fight or flight. Furthermore it can be assured that during drug treatment trials, all muscle 
preparations are receiving the same dose throughout the duration of the experimental protocol as 
direct treatment eradicates difference in digestion that will occur in human consumption. 
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It is possible to test skeletal muscle properties in vivo using living organisms (Fulco et al. 1994), 
however there is greater difficulty in controlling confounding variables particularly in human based 
studies due to vast individual differences in genetics and lifestyle. The overriding downfall of in vivo 
testing is being unable to determine a clear division between central and peripheral factors 
contributing to performance.  
Isometric, isotonic and isovelocity tests are common in vitro methods conducted to examine 
mammalian skeletal muscle properties. The work loop (WL) technique, originally explored in depth 
by Josephson (1995), has been more recently employed to provide a closer estimation of in vivo 
performance (James et al. 2004; 2005). A combination of such methods allows a profile of the 
contractile properties to be developed with these mechanical measurements providing information 
regarding the interaction of cross bridges (Fitts, 1994).  
Simulating in vivo Performance for in vitro Testing 
Temperature is a key variable that must be considered when testing muscle using any in vitro 
methods as this can have the greatest effect on the muscle’s ability to perform work. This is widely 
established and discussed in a review by Marsh (1994), who concluded an increased activation and 
relaxation rate resulting in a power enhancement in different species of frog with increased 
temperature. For greater validity of results a physiologically relevant temperature must be used 
which is not the case in many early studies where low temperatures were used in order to keep the 
muscle alive for longer (Luttgau & Oetliker 1968). 
To provide greater replication of muscle function in vivo, simulation of in vivo activation and length 
change cycles must be considered. These in vivo variables can be determined via electromyography 
to measure muscle activation, high speed video analysis or cine and sonomicrometery to determine 




The generation of muscle force relates to the number of actinomyosin cross bridges in force 
generating states (Rome, 2002). Isometric testing holds the muscle at a constant length throughout 
electrical stimulation allowing examination of the muscle’s ability to produce maximum force whilst 
static. Commonly isometric twitch and tetanus experiments are conducted on the muscle. A twitch 
response represents the smallest contractile response that can be elicited (Figure 1.2.1.). The delay 
between the stimulation and response (Figure 1.2.1.) of the muscle is known as the 
electromechanical delay (latency period) and denotes the time required for depolarisation of the t-
tubles, release of calcium into the intracellular space and the initiation of the cross bridge cycle 
(Cavanagh & Komi, 1979). Twitch magnitude and duration are greatly affected by the speed of Ca2+ 
release, Ca2+ affinity with tropnonin, and the speed of cross bridge cycling (Jones, 2004). The speed 
of these biochemical reactions is determined greatly by muscle fiber type and temperature 
(Macintosh, 2006).  
A tetanus response occurs when the muscle is subjected to a number of subsequent electrical 
stimuli (Figure 1.2.1.), each occurring before the muscle is relaxed (Macintosh, 2006). In this case the 
muscle fibers are stimulated before relaxation of the twitch can occur, therefore the next 
contraction will produce greater force as the level of intracellular Ca2+ is elevated. This combination 
of twitches is known as summation (Macintosh, 2006). Elevating stimulation frequency will promote 
sustained force generation. An unfused tetanus displays partial relaxation between stimuli whereas 
contraction is sustained in a fused tetanus. The peak force achieved depends on the frequency and 
number of stimuli and consequently the concentration of Ca2+ release and the number of myosin 
cross bridges that can form. Prior to the final stimulus the muscle force remains high (Figure 1.2.1.), 
this is due to the high level of intracellular Ca2+, and subsequent relaxation is dependent on the 
speed that Ca2+ can be removed from the sarcoplasm (Jones, 2004). 
 
 9 
Figure 1.2.1 -Typical twitch and tetanus responses. Isometric tension in response to a single and a 
series of muscle action potentials. The dashed lines show the expected response if only the first 
action potential of a series occurred (Matthews, 2003) 
In both twitch and tetanus methods maximal performance will occur at an optimal muscle length, so 
a number of tests should be conducted changing the length of the muscle and examining the 
responses. From this a force length curve (Figure 1.2.1.) can be developed highlighting this most 
favourable length where optimal thick and thin filament overlap occurs resulting in maximal cross 
bridging (Rome, 2002). The force length relationship was first established using length clamp 
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Figure 1.2.2.The force length relationship and single sarcomere myofilament interaction during 
shortening and lengthening (Matthews, 2003) 
Largely isometric studies are useful for controlled investigation of a muscles maximal contractile 
force. James and Navas (2008) investigated the effect of temperature (15, 25 and 35oC) on muscle 
performance in toads. The results indicated no significant change in maximal tetanic force 
production with increased temperature however a significant increase in the rates of force 
generation and relaxation.   
A limitation to isometric testing is its lack of validity to real muscles that produce power during 
human movement in vivo. It is rare for muscle to be acting completely isometrically and usually 
shortening is required for the muscle to perform work (Rome, 2002). During in vivo locomotion 
dynamic activation is required and thus the muscle will often go through a large range of motion 
This item has been removed due to third party copyright. The unabridged version of the thesis can be viewed at the Lanchester 
library, Coventry University.
 11 
resulting in altered muscle length. James et al. (1996) concluded that isometric testing vastly 
underestimated the in vivo rate of force activation and relaxation and is limited by not considering 
the passive properties of muscle. A muscle cannot shorten indefinitely and it will eventually have to 
re-lengthen. Therefore there will be a time in vivo where the muscle will be producing negative work 
(Josephson, 1993). 
Isotonic Testing 
Isotonic testing involves maintaining the muscle at a constant force and usually involves usage of 
Hill's (1938) equation to determine the force-velocity relationship of a muscle: 
(F+a)(V+b)=(F0+a)b 
Where: F is the tension (or load) in the muscle, V is velocity of contraction, F0 is the maximum 
isometric tension (or load) generated in the muscle, a is coefficient of shortening heat, b =  a. V0/F0, 
V0 is the maximum velocity, when F = 0 
 
Shortening velocity is one of the most predominant features in distinguishing between muscle fiber 
types. Important dynamic properties of active muscle can be evaluated by exploring the relationship 
between the muscle force output and velocity of shortening (Fig 1.2.3). The most important aspects 
of the force velocity relationship are the curvature of the line and the muscle’s maximum shortening 
velocity (Vmax; Barclay & Litchtwark, 2007). The hyperbolic force velocity curve denotes that the 
velocity of muscle contraction is inversely proportional to the load. During isotonic testing the 
muscle will shorten against a constant load and the shortening velocity of the muscle is plotted 
against resistive force. The theory behind the force velocity relationship relates to the sliding 
filament hypothesis and lack of time for cross bridges to form as shortening velocity increases. 
Further to this increasing shortening velocity will result in a decreased calcium sensitivity of the 
muscle (Hofmann & Moss, 1992). The force velocity relationship highlights a point of maximal power 
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output (PO) as a product of muscle force multiplied by velocity. This optimal level will rarely arise in 
vivo due to the varying shortening velocities and force production of the cyclical movement 
occurring (James et al. 1996). Josephson (1993) stated the importance of force velocity curves in the 
measurement of instantaneous power output but that force-velocity studies lacked the capability to 
provide information regarding sustainable PO.  
When considering dynamic muscle power force production and shortening velocity will change, this 
is not considered in this method. James et al. (1996) concluded, from their study examining 
isometric and isotonic muscle properties as determinants of WL output in rabbit latissimus dorsi, 
that isotonic testing vastly overestimated muscle PO. The force velocity curve implies that a muscle 
can shorten indefinitely, as negative work is not considered PO calculated from this technique is 
approximately double that derived from the WL technique. In order for the power output predicted 
from force velocity data to be maintained through repetitive cyclical length changes, James et al. 
(1996) suggested that several unrealistic conditions would have to apply. The muscle must activate 
and relax instantaneously and muscle force and shortening velocity must remain at an optimal 
throughout shortening. As previously highlighted this is not an attainable feat during in vivo action as 
variation in muscle length and activation will alter the force produced. In conjunction with this 
shortening velocity will also change particularly when the muscle is coming to the end of shortening. 
The muscle should be fully relaxed throughout lengthening as lengthening against a resistance will 




















Isovelocity testing involves shortening the muscle at a constant speed and has been used as a 
second method of attaining force-velocity relationships and a predictor of PO. Commonly this form 
of testing is achieved using the step-and-release protocol whereby isovelocity releases are 
immediately preceded by a step length change (Barclay, 1996). The muscle is initially stimulated to 
produce an isometric tetanus, however once peak force has been achieved a muscle length change 
occurs causing the muscle force to decrease. The muscle is then shortened from this new length at 
an estimated velocity that enables the muscle to maintain its new level of force. Animals have 
different fiber types, thus a different V/Vmax and throughout movement will operate over a range of 
V/Vmax (Rome, 2002).Measurement of shortening velocity again represents a single muscle 
This item has been removed due to third party copyright. The unabridged version of the thesis 
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characteristic and although valuable it is not a true simulation of dynamic muscle contracture in vivo 
as muscle-shortening velocity will alter throughout a movement.  
The ‘iso’ tests have the benefit of determining the intrinsic relationships between three basic muscle 
characteristics, force, length and velocity. Graphical representation from the data gained provides 
visual representation of the occurrences in active muscle. By using ‘iso’ methods much of the 
original theory behind how muscles operate during movement has been gained, as well as the 
underlying mechanisms. Although some muscles operate under these conditions, particularly 
isometrically contracting stabilising muscles, dynamic contraction integrates all of these factors and 
thus in this instance the limitations should be considered. Initially ‘iso’ testing ignores the passive 
properties of the muscle (James et al. 1996), a muscle is unable to shorten indefinitely and at some 
stage must return to its original length. Therefore the muscle must undertake negative work and 
requires energy to re-extend. Furthermore, muscle force, length, and velocity are dynamic factors 
throughout human movement and the interaction of these properties should be considered 
(Josephson, 1985). In addition these methods of testing do not accurately consider the time needed 
for muscle activation and relaxation, which further extends the limitations when relating the results 
to in vivo performance.   
The Work Loop Technique 
The current research primarily implements the work loop technique due to its greater validity in 
relation to muscle performance for in vivo. Previously outlined in vitro testing methods are poor 
estimates of true muscle function in vivo testing (James et al. 1996). Muscles work in antagonist 
pairs and go through cyclical length changes to produce a frequent movement necessary for 
locomotion (e.g. walking and running; Josephson, 1985). This practice is able to establish how much 
work and power is available from a muscle undergoing a cyclical length change. 
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The work loop technique was initially developed by Machin and Pringle (1959) as a method of 
investigating the mechanics of asynchronous flight muscle. Josephson (1985) proposed the 
advantages of the WL method over other in vitro techniques as being the first to consider the 
multiple factors that determine muscle performance; for example activation events, shortening 
dependant deactivation and pre-stretch effects. 
Commonly sinusoidal length changes are used as estimates of muscle function during repetitive 
locomotory movements. Although it has been established that in vivo muscles will go through much 
more complex length change cycles this movement pattern has been considered a good, easy to 
implement, generalisation. The WL technique simulates the activity of the muscle by emulating this 
length change pattern and stimulating the muscle to contract. The muscle is subjected to the 
electrical stimuli at a selected time within the length change cycle; stimulation can be in the form of 
a single stimulus or a burst of stimuli. The area of the work loop represents the net work output per 
cycle; this is formed by plotting muscle stress (force ÷ cross-sectional area) against strain (length 
change ÷ initial length) over a full cycle (Van Leeuwen, 1992). The network generated is the 
difference between the energy required to stretch the muscle and the work produced during 
subsequent shortening (Josephson, 1985; Figure 1.2.4).  
The major advantage of the WL technique is that it is the only in vitro technique that considers both 
the active and passive properties of the muscle (Josephson, 1985). For example a flexor muscle 
developing force during joint flexion and then relaxing to offer a small resistance to elongation 
during subsequent extension would produce a positive net energy output per cycle as the muscle 
has performed positive work on the moving joint (Figure 1.2.4; A). If however the muscle were 
inactive during flexion of the joint and active during extension to resist elongation net energy output 
would be negative, as the limb is required to perform work on the muscle. A muscle could be 
inactive throughout the whole of the length change cycle, producing passive net negative work 
(Figure 1.2.4; B). However positive work loops still have a passive element as the muscle cannot 
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shorten indefinitely and must be re-extended during each cycle involving a small amount of negative 
work. To minimise negative work the muscle must be relaxed during this elongation (James et al. 
1996). However not all muscles may produce net positive work in vivo e.g. those acting eccentrically 
for braking and joint stabilisation are active whilst lengthening and consequently produce a net 
negative WL. 
Figure 1.2.4 – A: Construction of a net positive active work loop, B: Construction of a passive work 
loop (adapted from Josephson, 1985) 
Passive negative work is largely due to the connective tissue arrangement within the muscle, thus 
energy is required to stretch the muscle to overcome passive resistance to lengthening. In larger 
muscles the amount of connective tissue will be greater thus greater energy requirement will be 
need for elongation. The direction of the loop distinguishes between net positive and net negative 
work loops. Anticlockwise loops represent net positive work output by the muscle whilst net 
negative clockwise loops depict energy absorption or negative work. Average PO (J s-1) can be 
This item has been removed due to third party copyright. The unabridged version of the thesis can be viewed at 
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calculated by multiplying net work output per cycle (Joules) by cycle frequency (s-1) (Josephson, 
1993).  
The WL technique has become a common in vitro method for examining the effects of muscular 
fatigue. Changes in the WL shape provide visual indication of a change in the muscle properties and 
its ability to produce positive work. Askew et al. (1997) used mouse soleus to investigate the effects 
of attainable cycle frequency on the development of fatigue using repeated WL cycles. During 
fatigue a reduction in force, a slowing in deactivation and changes in the force velocity properties of 
the muscle were reported. These mechanical changes were indicated by alterations in the shape of 
the work loops and also by highlighting an increase in negative work and a decrease in positive 
(Figure 1.2.5). Further to this greater cycle frequencies demonstrated a decreased ability to maintain 
muscle PO, however a midrange cycle frequency produced the highest absolute PO. 
The initial and most obvious point to note in relation to WL shape during fatigue development is a 
reduction in the area of the WL thus indicating a reduction in muscle work (Figure 1.2.5). This 
reduction in work consists of a decrease in both the peak force attained and the force maintained 
during shortening. As fatigue develops it takes longer for this peak force to occur indicating a 
decreased activation rate. In conjunction with this, and evident to a greater degree, is prolonged 
relaxation apparent from the increased duration in the time required for the muscle to reach its 
baseline force (Vassilakos et al. 2009). Therefore, as fatigue develops the muscle is still active at the 
end of shortening thus requiring greater energy to elongate the muscle indicated by an increased 
force during lengthening, resulting a decrease in net positive work. As fatigue progresses a figure of 
eight WL will develop with the right hand side portion of the loop consisting of the positive work and 
the left hand side portion negative as a greater proportion of the length change cycle is conducted 
during active lengthening (James et al. 2004). Further fatigue then results in a full negative work 
loop as the muscle will undergo the same length change cycle with greater force produced during 
lengthening than during shortening. 
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Figure 1.2.5 – Effects of fatigue on work loop shape in mouse soleus (Askew et al. 1997) 
Parameters that will affect the PO from a muscle include, the cycle frequency implemented, the 
strain (length change) imposed on the muscle, the trajectory of this strain, and the electrical 
stimulation phase and pattern (Josephson, 1993). Askew and Marsh (1997) reported that increasing 
the proportion of the cycle spent shortening will result in increased muscle power output over a 
range of cycle frequencies. In rare cases such as cardiac and some insect wing muscle, muscles will 
operate via a twitch contraction per cycle (Josephson, 1985), thus a single stimulus would be 
appropriate for estimating in vivo net work output. However, most mammalian muscle will operate 
under conditions requiring a burst of stimulation per cycle. The optimal stimulus phase to maximise 
PO is where activation begins towards the end of the lengthening half cycle to allow time for 
activation prior to shortening and faster force increase. Increasing muscle strain will maximise the 
duration in which electrical stimuli can be applied but will result in a complementary increase in 
energy required to elongate the muscle back to its resting length. As a consequence increasing strain 
will result in a greater net work up to an optimal, after which a decline will occur (Josephson, 1993).  
In vitro muscle testing is subject to a vast number of parameters that can greatly affect mechanical 
performance. The primary factors include the environmental conditions and the maintenance of 
This item has been removed due to third party copyright. The unabridged version of the thesis can be viewed at the Lanchester 
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these conditions overtime. It is possible to conduct such experiments on fiber bundles or single 
fibers but the present study uses whole muscle in order to account for not only changes in 
contractile properties but also the interaction of all other properties of the skeletal muscle. 
Subsequently, using a whole muscle allows better simulation of in vivo performance, however larger 
preparations have increased risk of the development of an anoxic core (Barclay, 2005). In light of this 
the present research will use relatively small mouse muscle allowing greater diffusion of oxygen to 
the muscle core and thus limiting the previously described effect. 
Muscle Mechanics and Function in vivo 
The primary function of skeletal muscle is to provide the work and power that causes movement. 
Not all muscle in the body works in a predictable manner and the integrated muscle tendon unit 
should be considered. The type of movement and the intensity of the activity strongly dictates the 
muscle specific function, i.e. it is possible to perform an isometric contraction by pushing against a 
wall however muscle function will vary greatly over dynamic cyclical contractions such as those used 
for locomotion. Although many muscles produce work under cyclical contraction (hence the 
importance of the work loop technique), co-activation of muscles has largely been seen as a way to 
provide stability around a joint or to perform precise slow movements, and in some instances result 
in eccentric contraction (Marsh, 1999). Muscles that are active during lengthening absorb energy 
and reduce economy. In some instances, such as the findings of Full and Stokes (1998) and 
unpublished work by Buhanan and Marsh (cited Marsh, 1999), muscles have been shown to absorb 
more work than they produce. In light of this, how well does in vitro testing of muscle mechanical 
properties relate to in vivo muscle contraction?  
Usage of the work loop technique to optimise sinusoidal length change waveforms to mimic cyclical 
contractions has provided much information regarding muscle function (Josephson, 1993). In some 
instances, such as fish swimming and insect flight, sinusoidal length changes provide an accurate 
representation of in vivo muscle length change cycles (Coughlin et al. 1996; Chan & Dickinson, 1996). 
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Despite sinusoidal length trajectories being used regularly in research employing the work loop 
method (Altringham & Young, 1991; Askew et al. 1997; James et al. 1996; 1996, 2004; 2005; 
Vassilakos et al. 2009), this should be deemed an approximation of in vivo cyclical muscle activities 
(Dickinson et al. 2000). Further in vitro research suggests that other cyclical shapes cause a 
significant enhancement in muscle performance. Greater muscle power output has been shown 
using a non-symetrical ‘sawtooth’-shaped cycle whereby the shortening phase is longer than re-
lengthening allowing a longer stimulation duration and a more complete activation of the muscle, a 
more rapid rise in force due to an increased stretch velocity and an increase in the optimal strain 
amplitude (Askew & Marsh, 1997; Marsh, 1999). Askew and Marsh (1997) reported 5-10% higher 
power in mouse soleus and EDL using ‘sawtooth’ waveforms compared to sinusoidal work loops. 
Despite a greater power, ‘sawtooth’ length trajectories would still be deemed a very basic 
generalisation as in vivo the pattern of fiber stimulation and length change waveforms are likely to 
be manipulated throughout movement (Wakeling & Rozitis, 2005). 
During level running of turkeys ankle extensor muscle length change was small in and tendon energy 
storage and recovery provided more than 60% of the total work of the muscle tendon unit (Roberts 
et al. 1996). It is considered that when forces are high during ground contact some muscles work 
almost isometrically to provide tension and allow effective storage of elastic energy (Marsh, 1999). 
Biewener et al. (1998) reported similar findings to that of Roberts et al. (1996) in steady speed 
hopping in wallabies, thus further suggesting the view that the tendon elastic saving of energy is an 
important mechanism to enable animals to locomote at higher speeds without large increase in 
metabolic energy expenditure. 
Mouse EDL and soleus muscle were not chosen for use in the present body of research because they 
are likely to function under sinusoidal or ‘sawtooth’ length change trajectories in vivo; rather they 
were selected because they are two commonly examined mammalian muscles that are either 
predominantly fast or slow twitch. As with previous research the present thesis will use sinusoidal 
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length trajectories as an easy to understand simplification of the length change waveforms used in 
real life locomotion (Dickinson et al. 2000). Length change trajectories are likely to be muscle 
specific and implementation of a sinusoidal length change waveform provides a convenient and 


















1.3. Skeletal Muscle Fatigue 
Skeletal muscle fatigue is one of the greatest limiting factors to sporting performance and is defined 
as a reduction in force generating capacity that results from prolonged activity (Fitts, 1994). A failure 
in the process of excitation contraction coupling will contribute to this reversible phenomenon 
occurring during prolonged and intense activity. The overall effect of fatigue is a consequence of 
central and peripheral physiological actions that reduce the muscle’s functional capacity. 
The aetiology of muscle fatigue is complex and is still not fully understood; however it is universally 
recognised that a single factor will not be the sole contributor, but that fatigue will result from a 
multitude of interacting effects. Combinations of acidosis, CNS and metabolic factors will contribute 
to a reduction in the ability of the muscle to maintain power output and repetitive cyclical 
movements (Allen et al. 2008).  
Central Fatigue 
Fatigue of the Central Nervous System (CNS) is an area that has caused great debate with conflicting 
literature presented regarding this phenomenon. The initial occurrence in the process of muscle 
activation is an efferent impulse sent through the nervous system resulting in an action potential in 
the target muscle. A disruption in this efferent impulse may contribute to fatigue by affecting motor 
unit activation.  
Evidence that condemns the CNS theory of fatigue stems from what is now deemed a classic study 
by Merton (1954). Merton (1954) attempted to determine whether a decrease in CNS drive or 
intensity was responsible for a reduction in the capacity of a muscle to produce force. In order to 
accomplish this Merton (1954) superimposed a large electrical stimulation onto a maximal voluntary 
contraction of a fatigued muscle with the theory that if CNS effects were responsible for reduced 
muscle force production, then an added external stimulation would increase the force. Results failed 
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to demonstrate any increase in muscle force, consequently it was concluded that CNS deficiencies 
were not responsible for muscle fatigue. 
In contrast to this it has been established that prolonged exercise can disrupt the cerebral cortex 
(Enoka, 2008). It is believed that in addition to impairing output to the active muscles, disruption of 
the cerebral cortex will also impede one’s ability to accurately perform cognitive tasks. One of the 
mechanisms believed to contribute to this disruption is a disturbance in the balance of 
neurotransmitters; however it is unclear how severe these effects are. More established areas to 
consider are the effects of elevated core body temperature and hypoglycaemia that can occur 
during prolonged exercise. Hyperthermia has been shown to decrease the ability of the cerebral 
cortex to produce the required efferent motor activity (Todd et al. 2005). Hypoglycaemia could also 
have an effect, as the cerebral cortex requires glucose as a fuel for energy regeneration (Enoka, 
2008). A further idea is that efferent impulses are unable to cross the synapses of adjacent nerve 
cells due to a decrease in acetylcholine, thus the signal is not passed on as it fails to cross the 
synaptic cleft. It is believed that failed transmission of impulses may also occur at the neuromuscular 
junction such that an action potential in the muscle cannot be initialised (Gardiner, 2001).  
A further theory relates to the exercise induced accumulation of serotonin, a neurotransmitter 
associated with effects on arousal, sleepiness, lethargy and mood (Davis et al. 2000). Glycogen 
depletion results in increasing amounts of amino acids released from the working muscles. An 
example of this is Tryptophan, which primarily travels in the blood bound to albumin; a small free 
concentration is able to cross the blood brain barrier promoting the synthesis of serotonin. Further 
to this as greater FFA's are released from adipose tissue, this competes for albumin resulting in a 
greater free concentration of tryptophan thus greater synthesis of serotonin (Davis et al. 2000). 
EMG studies are a popular technique that has been employed to measure the electrical activity of 
skeletal muscle. Lepres et al. (2001) investigated the effects of prolonged cycling (>5 hours) on 
neuromuscular fatigue and reported significant reductions in EMG activity in the vastus lateralis 
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muscle. Lepres et al. (2001) concluded a decreased neural drive in the latter stages of exercise. 
Vandewalle et al. (1991) also demonstrated the occurrence of central fatigue after reporting 
decreased EMG activity in subjects using an adapted Wingate test. Kay et al. (2001) investigated 
neuromuscular changes during fatigue by implementing EMG during 6 high intensity 1-minute cycle 
sprints. Results gained by Kay et al. (2001) demonstrated that power output and IEMG decreased 
progressively during sprints 2-5, however both power and IEMG increased during the final sprint. In 
this instance fatigue was attributed to a combination of changes in neuromuscular recruitment and 
central or peripheral control systems. 
Cellular Mechanisms of Fatigue – Skeletal muscle  
Muscle fatigue can be subdivided into two categories, low (LFF) and high frequency fatigue (HFF). 
HFF is that induced by intense activity, characterised by a rapid reduction in force that swiftly 
recovers, attributed to readily reversible ionic imbalances affecting muscle excitation (Favero, 1999). 
LFF is characterised as force reduction due to activities at lower stimulation frequencies, here 
recovery is prolonged. LFF is attributed to a wider variety of mechanisms including mitochondrial 
and metabolic disruptions (Favero, 1999). The intensity of the activity greatly influences the 
aetiology of fatigue, however further considerations regarding variables such as fiber type 
distribution and training state of an individual must be noted. 
In vitro methods have provided evidence for mechanical changes in the muscle and have allowed 
physiological conclusions to be drawn with regards to fatigue mechanisms. Askew et al. (1997) used 
mouse soleus muscle to investigate the effects of attainable cycle frequency on the development of 
fatigue using repeated work loop cycles. Fatigue caused a reduction in force, a slowing in 
deactivation and changes in the force velocity properties of the muscle, as indicated by a change in 
the shape of the work loops including an increase in negative work and a decrease in positive work 
(Figure 1.2.3). The force generated at the muscles’ peak length and the maintenance of force 
through shortening rapidly decreased. Fatigued muscle also failed to completely relax by the end of 
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shortening which in turn increased the work required for muscle lengthening(Figure 1.2.3: Evident 
from work loop 20 at 2hz and 40 at 6Hz). Askew et al. (1997) also demonstrated that greater cycle 
frequencies caused a decreased ability to maintain muscle power output. 
The importance of intracellular Ca2+ has already been explained; limiting the free Ca2+ concentration 
would result in decreased force production (Berchtold et al. 2000). At the onset a fatigue there is a 
reduction in myofibrillar Ca2+sensitivity, meaning a reduction in the affinity for tropinin-C binding 
and consequently a reduced number of free actin binding sites for cross bridging (Allen et al. 1995). 
Fatigue also causes impaired Ca2+ release from the SR, thus reducing the effectiveness of the Ca2+ 
induced Ca2+ release mechanism (Allen et al. 1995). It has been established that the increased 
acidosis and accumulation of Pi associated with fatigue will reduce the sensitivity of myofibrils to 
Ca2+ (Godt & Nosek, 1988).  
Acidosis 
During prolonged high intensity exercise anaerobic glycolysis will become the primary method of 
ATP regeneration.  A by-product of this form of metabolism is lactic acid and if production outweighs 
removal accumulation will occur (Powers & Howley, 2006). For many years it was believed that 
fatigue was associated with an accumulation of lactate, however it has now been established that 
the formation of H+ ions associated with lactic acid production is not a large mediator in the onset of 
fatigue (Cairns, 2006).During anaerobic glycolysis H+ is generated, such that in a high intensity bout 
of exercise the rate will be substantial and as an overall effect the tissue buffering system will be 
overcome. A net consequence of H+ accumulation is a decrease in pH resulting in acidosis. Muscle pH 
at rest is maintained at 7.05; however, following intense activity this may drop as low as 6.5 (Allen et 
al. 2008). The fastest fiber type (IIb) will be more greatly utilized in high intensity activity thus this 
will be the site of greatest pH decline. The most widely established theory is that H+ ions will 
compete with Ca2+for binding sites on troponin-C, thus inhibiting binding of myosin heads and hence 
force production (Crains, 2006). Blanchard and Solaro (1984) reported a decrease in myofibrillar 
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troponin-C affinity for Ca2+ as pH was reduced, a conclusion further echoed by Palmer & Kentish 
(1994). A flux of H+ has also been shown to inhibit the rate of cross bridge transition from weakly 
bound to a strongly bound state (Fitts, 2004). This reduction in strongly bound cross bridges will 
massively reduce the maximal force capacity of the muscle. High levels of H+ are also believed to 
inhibit the SR calcium release channel and furthermore reduce the affinity of Ca2+ binding to the SR 
pump affecting relaxation (Allen et al. 2008). With Ca2+ not being removed as quickly from the 
intramuscular space, a larger concentration of free Ca2+ will occur resulting in greater isometric force 
production in early fatigue (Allen et al. 2008). High concentrations of free Ca2+ may inhibit the 
function of the t-tubules, with accumulation in this region blocking transmission of the action 
potential into the axial core of the fiber (Fitts, 1994). 
Long-term high concentrations of Ca2+ within the muscle cytoplasm will cause an accumulation in 
surrounding organelles or movement of Ca2+ out of the cell. The result is a decline in free Ca2+ 
concentration in the muscle cytoplasm and ultimately that available for release from the SR. 
Lannergren et al. (2001) reported a marked increase in mitochondrial Ca2+ concentration in Xenopus 
fibers following repetitive tetanic contractions. However, the rate of Ca2+ extraction from the cell is 
believed to be very slow (Allen et al. 2008).  
A change in muscle pH will decrease the activity of enzymes essential in energy regeneration and 
impairment of the myofilament proteins. The net result would be impairment of cross bridging 
activity, decreased Ca2+ activation of troponin and impaired function of myosin ATPase (Cairns, 
2006). However a low pH could have beneficial effects on membrane conductance, it is believed that 
lowering the pH will reduce the Cl- conductance of the t-tubular membrane allowing action 
potentials to propagate more readily (Allen et al. 2008). 
A decreasing muscle pH is historically the most popular candidate for producing fatigue as it affects 
multiple sites. However, it has been established that pH can only explain a portion of the fatigue 
effect as the initial rapid stage that can be observed in recovery occurs when muscle pH is still 
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declining (Fitts, 1994). In recent years the relationship between lactic acid and fatigue has been 
reviewed by Cairns (2006). Correlation type studies provided the early evidence showing a 
relationship between H+ accumulation and declining force. However in more recent studies using 
physiologically relevant experimental temperatures this negative effect is not shown at such an 
extent and in some cases acidosis has been shown to enhance performance (Fitts & Holloszy, 1976; 
Nielsen et al. 2001). The Cairns (2006) review reported that acidosis can have a protective effect 
against K+ induced fatigue, however controversy exists about the mechanism. 
However much the lactic acid hypothesis is scrutinised it is clear that acidosis plays a part in inducing 
fatigue during intense exercise bouts. Studies using H+ buffering agents such as Sodium Bicarbonate 
have demonstrated that reduced acidosis will enhance exercise performance thus providing 
evidence for the acidosis theory. Lindh et al. (2008) reported that Sodium Bicarbonate ingestion 
improved mean200m freestyle swimming time by 1.5 seconds in elite male competitors. Sodium 
Bicarbonate studies in vivo produce mixed results. This subsequently highlights the need to examine 
the effects of sodium bicarbonate directly on skeletal muscle. 
Inorganic Phosphate 
A single molecule of ATP is hydrolysed during the cycling of each actin-myosin cross bridge. The 
splitting of the ATP molecule, via myosin ATPase, produces ADP and inorganic phosphate (Pi; Powers 
& Howley, 2006). Pi will also arise from ionic pumps in the muscle that work against a concentration 
gradient and thus require energy (i.e. Na+-K+ ATPase and Ca2+ ATPase). If ATP is metabolised at a 
greater rate than regeneration a resulting increase in free concentrations of ADP and Pi will occur in 
the muscle cytoplasm. In contrast to the buffering system in place to deal with high H+ 
concentration, the regulation of Pi within the muscle is dependent on its transport into the 
mitochondria.  
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Pi at rest is maintained at 1-5 mM, however during intense activity this can increase to 30-40mM 
(Allen & Westerblad, 2001). In a number of studies a clear reduction in myofibrillar Ca2+ sensitivity 
due to elevated levels of Pi has been demonstrated (Allen et al. 1995). Elevated sarcoplasmic Pi 
concentration will promote fatigue by directly affecting the cross-bridge function, resulting in a 
decreased force during early fatigue. The release of Pi from the transition of cross bridges from a 
weakly bound to a strongly bound state suggests that Pi inhibits this process (Westerblad et al. 
2002). Westerblad et al. (2002) further reported the inhibitory effect of Pi on the SR Ca2+pump.  
Allen et al. (2008) stated that the mechanism results in a 10% decrease in maximal force at 
physiological temperature. It is also believed that accumulation of Pi will result in failure of Ca2+ 
release from the SR during fatigue and is the main contributor to an early fall in force during intense 
exercise.  
The SR concentration of free Ca2+ is approximately 1mM, but the total concentration is much greater 
as it includes Ca2+ bound to binding proteins such as calsequestrin (Somlyo et al. 1981). Precipitation 
of calcium phosphate may occur as it is reported that Pi is capable of entering the SR via anion 
channels (Westerblad et al. 2002). Once the solubility product of Pi exceeds the 6mM threshold it 
binds to calcium producing CaPi and precipitation will slowly occur. CaPi precipitation causes a 
decrease in free SR Ca2+ concentration and that bound to calsequestrin therefore limiting its release 
into the intracellular space (Allen & Westerblad, 2001).  
The value of Pi as a mechanism of fatigue can be viewed in a study by Dashlstedt et al. (2000) that 
genetically modified mice by inactivating creatine kinase, which prevents a rise in Pi due to inhibition 
of the catabolism of phosphocreatine. Here the early rise in force, increased sarcoplasmic 
concentration of Ca2+ and increased Ca2+ transient time are abolished leading to the conclusion that 




The membrane hypothesis of fatigue involves disturbances in excitation contraction coupling, 
altering sarcolemmal or t-tubular excitability (Fitts, 1994). Skeletal muscles’ resting membrane 
potential is most reliant on potassium, such that any alteration in concentration gradient or 
conductance across the sarcolemma will vastly affect membrane potential. 
A combination of the previously described ionic reactions to fatigue will result in an increased 
muscle osmolality. As well as impeding physical contraction of the muscle, increased osmolality will 
also account for up to a 50% increase in K+ concentration depending on exercise intensity (Lindinger, 
1995). During high intensity exercise a rapid force loss is accompanied by a slowing of action 
potential waveform, attributed to the accumulation of K+ in the extracellular spaces of the muscle. 
This potassium theory generally dictates that a K+ efflux, in conjunction with inhibition of the Na+-K+ 
pump or its capacity to regulate a K+ efflux and a Na+ influx, will result in cell depolarisation of the 
resting membrane potential (Lindinger, 1995). Changing the membrane potential will vastly limit the 
rate of firing action potentials and ultimately depressed t-tubular charge will result in inhibition of 
the SR Ca2+ release channel. The t-tubules in the interior of the muscle may depolarize enough to 
block action potentials, thus resulting in inactivation of the myofibrils (Fitts, 1994). These 
mechanisms can be viewed as a muscle safety instrument that protects the cell against Ca2+ 
accumulation and ATP depletion, preventing damage to the cell by avoiding catastrophic alterations 
in its homeostasis. The effect of fatigue on K+ has also been established during prolonged activity 
with LFF being associated with a continued net loss of K+ from the activated muscle (Lindinger, 
1995). 
Glycogen 
During prolonged activity aerobic metabolism forms the basis of energy production; incidentally Pi 
and H+ remain relatively low (Powers & Howley, 2006). The mechanisms of fatigue here are not 
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clearly understood however depletion of muscle glycogen and low blood glucose concentration are 
key determinants. Muscle recruitment for endurance-based activities largely involves type I and IIa 
muscle fibers, as these provide the greatest resistance to fatigue (Powers & Howley, 2006). A 
relationship between glycogen concentration and SR membranes in skeletal muscle has been 
established. It has been proposed that this association causes glycogen to regulate Ca2+ efflux from 
sequestration into the SR (Favero, 1999). Once the supply of glycogen is utilised beta-oxidation 
becomes the primary method of energy regeneration. Mobilising FFA’s requires a greater quantity of 
oxygen to yield the same amount of ATP; here exercise intensity will decrease as the oxygen supply 
is limited. 
Hypoglycaemia has also been shown to contribute to failure of the CNS; the store of glucose in 
neuronal tissue is limited and is therefore largely reliant on glucose from the bloodstream. Nybo 
(2003) investigated the effect of ingestion of carbohydrates during prolonged exercise and its effect 
on CNS activation of skeletal muscle. The study concluded that exercise-induced hypoglycaemia 
attenuates CNS activation during sustained muscle contraction. 
Environmental Conditions 
A well-established phenomenon is that prolonged exercise capacity will be greatly reduced in high 
environmental temperatures (Todd et al. 2005). The physiological stress caused by the environment 
will result in dehydration, thus a loss in plasma volume and a decreased venous return. Greater skin 
blood flow compromises muscle blood flow and therefore reduces substrate and oxygen delivery, as 
well as inhibition of by-product removal (Gonzalez et al. 1999). 
A number of studies have demonstrated that a decreased ambient partial pressure of O2, such as 
that at high altitudes, will significantly decrease time to fatigue (Fulco et al. 1994). A decrease in 
PO2, and subsequent reduction in blood O2 and its delivery to the working muscles, will severely 
reduce the rate of ATP regeneration; therefore exercise cannot be maintained. 
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Modality of exercise and the environment will have the greatest influence on the mechanism of 
fatigue. Biochemical changes affecting the release and affinity of Ca2+ resulting in a loss of muscle 
activation is a primary mechanism of fatigue. These alterations can affect the pathway of excitation 
contraction coupling from stimulation to filament interaction. This review can be deemed brief in 
light of what is a complex series of events. Other areas should be considered such as a link between 
a rising level of free radicals and control and/or modification of Ca2+ regulation has been established 
(Favero, 1999). However it is clear that a number of contributing factors will result in muscle fatigue 
depending on an individual’s level of fitness, exercise intensity and environmental stressors. A 
primary way to enhance one’s ability to offset fatigue is through a specific training regime or via the 














1.4. Caffeine as an Ergogenic Aid 
The effects of caffeine as a powerful ergogenic aid have been examined for its effects both on the 
central nervous system (CNS) and directly on skeletal muscle (Graham, 2001). In vivo and in vitro 
studies have found enhancements in endurance exercise performance, power and fatigue recovery, 
accredited primarily to the effects on the CNS (Kalmar & Cafarelli, 2004). Until 2004 caffeine was 
recognised as a banned substance by the World Anti-Doping Agency (WADA). Urinary levels 
exceeding 12 µg.ml-1 post competition were deemed illegal and consequently led to athletes being 
disqualified (Spriet & Howlett, 2000). Presently caffeine is still not included on WADA’s prohibited 
list (Word Anti-Doping Agency, 2012) despite its documented popularity as a performance enhancer 
as a aiding training and in competition. It is essential to critically examine some of the key research 
surrounding the ergogenic properties of caffeine in order to assess the quality of the experiments 
conducted and their relevance to human performance.  There are a number of potential modes of 
action for caffeine, however this report will provide greater focus on the direct skeletal muscle 
response due to the context of this investigation. 
Caffeine Digestion and Concentration in Blood  
Caffeine (common name for 1,3,7-trimethylxanthine; Fig 1.4.1) is present in the diet of most 
individuals, but is not an essential nutrient, nor beneficial to promoting health (Magkos & Kavouras, 
2005). Subsequently, prior to 2004 ingestion of caffeine as a means for improving performance was 
deemed as drug abuse. 
Following digestion caffeine is readily absorbed into the blood stream and can be measured for up 
to 5 hours post ingestion. Peak plasma concentration will occur between 30-60 minutes following 
ingestion (Lorist & Tops, 2003). Caffeine is hydrophobic in nature allowing it to pass freely across all 
biological membranes, thus it can be distributed through all tissues of the body (Magkos & Kavouras, 
2005). Caffeine is also able to diffuse from the cerebral circulation across the blood brain barrier 
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Figure 1.4.1. – The Chemical Structure of Caffeine 
Caffeine is processed in the liver forming the three metabolites paraxanthine, theophylline, and 
theobromine (Goldstein et al. 2010). Caffeine and its metabolites are excreted through the kidneys 
and caffeine has a half-life of 2.5-10 hours in humans for a caffeine dosage below 10 mg.kg-1. 
Elimination from the blood is dependent on the quantity consumed and the rate it is absorbed and 
metabolised (Magkos & Kavouras, 2005). As caffeine is able to cross all membranes it makes it 
increasingly difficult to determine where the greatest physiological effect occurs and it is misleading 





Caffeine in Sport 
Caffeine is a readily available, socially acceptable drug therefore high levels of consumption occur 
regularly within day-to-day life and the sporting world (Graham, 2001). Without a current limitation 
on the level of consumption within sport, a growing number of athletes are exploiting this method 
as a way of achieving a legal performance enhancement. 
With the benefits of this ergogenic aid demonstrated within the scientific literature, the present 
marketing of caffeine as a performance enhancer has become a common occurrence with many 
sporting foods, drinks, tablets, gums and gels claiming to significantly improve performance (Davis & 
Green, 2009). Lucozade, the popular sports drink company, support the performance benefits of 
caffeine via their marketing of a caffeine boost drink that they claim has been proven to “enhance 
consistent work rate or running speed” (Lucozade, 2010). Also Red Bull energy drink claims to 
"increase performance, stimulate metabolism, and increase concentration and reaction speed (Red 
Bull, 2010). This represents a fraction of the high caffeine concentration products available on the 
market, all boasting similar claims. 
Caffeine and Exercise Performance 
Graham (2001) reviewed a multitude of studies investigating the influence of caffeine in a number of 
diverse exercise modes and intensities. In light of these findings it is possible to conclude 
performance enhancements occur in endurance (activity lasting greater than 30 minutes), power 
and strength activities, although conflicting verification does exist within these categories.  
Table 1.4.1 represents a sample of the literature representing the effect of caffeine supplementation 
on endurance-based activities. Consistent with the reviews by Graham (2001), Davis & Green (2009) 
and Goldstein et al. (2010), the majority of evidence is in favour of an increased performance in the 
caffeine treated trials. In contrast Table 1.4.2 represents a sample of the literature regarding high 
intensity and muscular strength activities. Here the conflicting evidence suggests that a caffeine-
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induced enhancement of performance is not as consistent and at least some of the diversity in these 
findings may be explained by the variety in testing methods. The majority of this evidence 
concerning human based studies results in an increased complexity in understanding the underlying 
locality of caffeine’s greatest effect as in such whole body research a number of physiological 
systems are interacting to produce a change performance.  
Bruce et al. (2000) represents a typical human based approach to the investigation of caffeine as a 
performance enhancer. This randomised, double blind, cross over study considered 2000m rowing 
performance in competitive athletes. 8 subjects conducted 3 trials after ingestion of a placebo, 6 or 
9 mg.kg-1 body mass of caffeine treatment 1 hour prior to participation in the exercise protocol. The 
low dose caffeine trial resulted in a significant 1.3% improvement in time to complete the 2000m, 
whilst the high dosage resulted in a significant 1% improvement. SD of ± 0.9% highlights a varied 
individual effect to the treatment, which is a common theme throughout such studies. An average 
mean power output increase of 2.7% was reported in comparison to the placebo trial. Again 
common in the vast amount of literature no significant differences occurred in HR, VO2 or RER. 
Urinary samples following testing rose to 6.2 ± 3.6 mg.l-1 for the low dosage and 14.5 ± 7.0 mg.l-1 in 
the high dosage. The subjects received identical dosages of caffeine, yet there was a large SD in 
urinary samples following ingestion. With relevance to WADA’s pre 2004 stand on caffeine 
competitors would be deemed cheating if urinary threshold exceed the 12 mg.ml-1. However in 
some cases urinary sample may be lower for the same dosage of caffeine, as expressed in this study, 
thus revealing a problem in predicting how much caffeine will result in illegal urinary levels. 
Individuals will differ in caffeine uptake, rate of caffeine metabolism and excretion; this therefore 
will affect how much caffeine is required at an individual level to promote an enhancement in 




Author Subjects Caffeine Dose Protocol Performance 
Enhanced 
Comments 
Long Duration Endurance Activity 
Norager et al. 
(2005) 
15 men and 15 women > 70 
years – divided into group A 
(placebo trial then caffeine 
trial) and B (caffeine then 
placebo) 
6 mg.kg-1 60 mins prior to 
exercise 
Cycle ergometer with an increasing 
load of 25 W every second minute 
until 65% of the expected maximal 
heart rate was reached. The load 
remained at this level, and the time 
until exhaustion was recorded. 
YES Endurance significantly increased by 14% in group 
A and by 32%in group B 
Graham et al. 
(1998) 
9 actively endurance 
training males aged 27.8 
4.5 mg.kg-1 caffeine total 
volume of liquid 7.15 ml/kg 1 
hour prior – caffeine in water, 
decaffeinated coffee with 
caffeine capsule or regular 
coffee  
Ran at 85% of maximal oxygen 
consumption until voluntary 
exhaustion 
YES Endurance was only increased in the caffeine 
capsule trial (7.5-10 minutes). Increase in adrenalin 
in all 3 trials but no significant difference between 
trials. No treatment effects on blood glucose 
Kovacs et al. 
(1998) 
15 healthy and well-trained 
male subjects (triathletes 
and cyclists) 23.3 ± 
0.9 yr 
Drinking 14 ml/kg 
BW with 7% carbohydrate-
electrolyte solution with 150, 
225,and 320 mg/l caffeine 
Cycle ergometer - perform a set 
amount of work (equal to 1 h 
cycling) as quickly as possible. (90 
rpm at 70%) 
YES Completed the time trial significantly faster and 
with a significantly higher mean work output after 
ingestion of CES-225 and CES-320 
Conway et al. 
(2003) 
9 well trained cyclists and 
triathletes 25.5 ± 5 
 
Compared effect of single and 
divided dose caffeine. Single 
caffeine dose 6 mg.kg-1  60 mins 
prior to exercise and placebo 45 
into exercise divided caffeine 
dose 3 mg.kg-1  60 mins prior to 
exercise and 3 mg.kg-1  45 mins 
into exercise 
Cycled for 90 min at 68% maximal 
oxygen uptake followed by a self-
paced time trial (work equivalent 
to 80% of max oxygen uptake 
workload over 30 mins) 
 
Probable Tendency shown for faster time trial performance 
in the caffeine trials (P=0.08) caffeine and placebo 
24.2 mins and divided caffeine trial 23.4 mins 
compared to 28.3 mins in the placebo trial. Study 






15 males and 6 females  
subjects  
32 ± 7 yrs (mean±SD) 
 
13 caffeine users and 8 
caffeine non users 
 
5 mg.kg-1 caffeine 1,3 or 6 hours 
prior to testing   
Cycling to exhaustion at 80% 
VO2max 
 
YES Non-users, exercise times 1, 3 and 6 hours after 
caffeine 32.7 ± 8.4, 32.1 ± 8.6 and 31.7 ± 12.0 min, 
each significantly greater than the corresponding 
placebo values 24.2 ± 6.4, 25.8 ± 9.0 and 23.2 ± 7.1 
min. Caffeine users, exercise times 1, 3 and 6 were 
27.4 ± 7.2, 28.1 ± 7.8 and 24.5 ± 7.6 min, 
respectively. Exercise times 1 and 3 hours were 
significantly greater than the respective placebo 
trials of 23.3 ± 6.5, 23.2 ± 7.1 and 23.5 ±5.7 min. 
Cohen et al. 
(2006) 
5 men 2 women (23-51 
years old) 
0.5 or 9 mg.kg-160 mins prior to 
exercise 
 
Maximal effort 21-km road races in 
hot humid conditions 
 
NO No effect of caffeine on race time, no change in the 





7 well trained competitive 
runners 
 
9mg/kg 1 hour prior 
 
2 trials running and 2 trials cycling 
to exhaustion at 85% VO2max 
  
YES Endurance time increased during running from 
49.2 ±7.2 mins to 71± 11 mins and cycling 39.2± 
6.5 mins to 59.3 ±9.9 mins.Adrenalinwas increased 
prior to and during exercise. No effect on RER or 
plasma FFA 
Sustained High Intensity Activity 
O'Rourke et 
al. (2006) 
The well-trained group 15 
participants (age 32.2 ± 8.8 
yrs) at least five years club-
level competition 
experience. Recreational 
runners 15 participants (age 
29.0 ± 5.7 y), history of 
playing team-sports 
5mg.kg-1 60 mins prior to 
exercise 
5km time trial on running track YES Caffeine trial significantly improved running time 
by 1.1% in well-trained and 1% in recreational 




8 male distance runners 3mg.kg-1 60 mins prior  to 
exercise 
8km time trial on running track YES Caffeine trial resulted in a statistically significant 
23.8s (1.2%) improvement in 8km running time, 
elevated blood lactate following the first 3 mins, 
higher heart rate, and a decreased RPE despite 
faster running speed 
Bruce et al. 
(2000) 
8 well trained male rowers 
 
6 or 9 mg.kg-1 45 mins prior  to 
exercise 
2000-m time trial rowing 
ergometer 
 
YES Low dose resulted in a 1.3% improvement in time 
to complete 200m, higher dose resulted in a 1% 
improvement. Blood lactate 22% higher & blood 
glucose 13% higher in caffeine trials. 50% increase 
in resting plasma FFA in low dose 100% increase in 
higher dose 
Jackman et al. 
(1996) 
3 women 11 men (aged 
23.5±2) who participated in 
recreational endurance 
actives 
6mg.kg-1 60 mins prior  to 
exercise 
Cycle ergometer - 2mins at PO 
requiring Vo2max/ 6 min rest/ 
repeated exercise/ 6 min rest/ 
repeated exercise until voluntary 
exhaustion 
YES Significant increase in endurance in caffeine trial 
when compared to placebo (4.12 + 0.36 and 4.93 + 
0.60 min) Higher plasma adrenalin in the caffeine 
trial, no difference in muscle glycogen or blood 
lactate 
Wiles et al. 
(1992) 




3 g of caffeinated coffee60 mins 
prior to exercise 
 
1500m running performance 
 
YES Mean time to complete decreased by 4.2 seconds 
in caffeine trial, the speed of the final min 
increased by 0.6 kmph 
 
Table 1.4.1. - Example of literature showing how different amounts of caffeine supplementation, administration, and exercise protocols affect performance 
in endurance and sustained high intensity activity. 
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High Intensity Anaerobic Activity 
Carr et al. 
(2008) 
10 male team sport players 
(aged 25±5) 
6 mg.kg-1 60 
mins prior 
5 sets of 6x20m sprints; sets 1, 3, and 5 had 
departure time of 25s, sets 2 and 4 60s. 
YES All sprints significantly faster in caffeine trial 
Schneiker et 
al. (2006) 
10 male amateur level team 
sport athletes 
6 mg.kg-1 60 
mins prior 
2 x 36 min cycling integrated with 18 x 4s sprints 
with 2 min recover 
YES Caffeine trial resulted in 8.5% improvement in total work in 
the first half and 7.6% greater in the second half. Sprint 
mean peak power increased by 7% in the first half and 6.6% 
in the second (P<0.005 in both cases) 
Collomp et 
al. (2001) 
6 healthy volunteers - non-
specifically trained 
 
5 mg.kg-1 60 
mins prior  
Wingate test 
 
NO No significant change in anaerobic capacity, power and 
ability to maintain power. Significant increase in 
catecholamine and blood lactate 
Stuart et al. 
(2005) 
9 male rugby players 
 
6 mg.kg-1 70 
mins prior 
Specific rugby union test consisting of 7 circuits in 
2 x 40 min half’s with 10 min rest break. 
Measured sprint time (20 & 30m) drive power & 
accuracy of passing  
YES Sprint speeds improved, 0.5% through 2.9%; first-drive 
power, 5.0%; second-drive power, -1.2%; and passing 
accuracy, 9.6% (±6.1%). Attributed to reduction in fatigue 
and elevated arousal and concentration 
Greer et al. 
(1998) 
9 physically active males 
(aged 29.1±2.7) 
(Not accustomed to high 
intensity exercise) 
6 mg.kg-1 60 
mins prior 
30 second Wingate tests with four minute 
recovery 
NO No effect on power output (peak or average) performance 
declined in trial 3 and 4. Elevated adrenalin was 
demonstrated but this effect had ceased prior to testing. 
Muscle Strength and Fatigue of Muscle Strength 
Norager et 
al. (2005) 
15 men and 15 women > 70 
years – divided into group A 
(placebo then caffeine) and B 
(caffeine then placebo) 
6 mg.kg 60 
mins prior 
The maximal voluntary isometric arm flexion 
strength was measured in the dominant arm 
using a strain gauge mounted on a dynamometer 
chair 




22 resistance trained men  6 mg.kg 60 
mins prior 
1 rep max barbell bench press and leg press - 
followed by reps to failure at 60% 1 rep max 
NO No significant difference found in maximal muscle strength 
nor time to fatigue 
Beck et al. 
(2008) 
37 resistance trained men 
divided into caffeine (n=17) 
and placebo groups (n=20) 
6 mg.kg 60 
mins prior 
1 rep max, muscle endurance (total volume of 
weight lifted at 80% 1 rep max) for free weight 
bench press and leg press 
YES Significant increase in bench press 1 rep max in caffeine 
group no significance in any other parameters measured 
 
 




Investigation of the literature in this area has highlighted many limitations to the previous human based 
studies conducted and thus explains some of the variability in results and conclusions gained. As caffeine 
can be found in abundance in the energy dense western diet it is difficult to fully control subject’s blood 
plasma caffeine content prior to conducting the exercise protocol and in early studies this factor was not 
considered. Bruce et al. (2000) attempted to manage this variable by insisting on nutritional control of the 
participants. Restrictions were placed on caffeine 72 hours prior to testing and nutritional intake dictated 
24 hours before each trial. It is widely considered that caffeine is an addictive stimulant (Fredholm et al. 
1999), thus can the food diaries provided be satisfactory proof that cessation of caffeine ingestion 
occurred during the 72 hours before the trials? Also the problem of caffeine withdrawal from habitual 
consumers should be considered. Juliano and Griffiths (2004) reported some of the primary symptoms of 
caffeine withdrawal to be headache, fatigue, decreased energy/alertness, drowsiness and muscle 
pain/stiffness among others. Symptoms occur within 12-24 hours post withdrawal reaching peak intensity 
between 20-51 hours. The overall duration of the symptoms last for 2-9 days. Habitual users may display 
further non-respondent effects to caffeine consumption compared to subjects that are no habitual 
consumers. 
Optimal prescription of caffeine use in relation to timing and dosage is a factor to be considered when 
examining human studies. It is not uncommon for subjects to be given an absolute dose of caffeine 
treatment rather than a dosage as a proportion of their body mass. Therefore in such studies blood 
caffeine concentration is not consistent throughout subjects resulting in misleading results due to a large 
variability in dosage causing variability in response. Caffeine is rapidly absorbed and is usually consumed 
an hour before the exercise protocol. In relation to this Graham (2001) reported that it was rare to find 
instances where plasma concentrations had been measured in subjects prior to execution of the exercise 
protocol thus discrepancy between participants was not distinguished. Ample evidence has been 
collected in human and animal studies highlighting that some tissues are able to adapt to long-term 
caffeine exposure resulting in a reduction of its effect.  Thus posing the question could caffeine provide 
greater benefit in some athletes who have not been exposed? Evidence for this is apparent throughout 
 40 
the literature; a prime example being a study conducted by Bell and Mcleellan (2002). Bell and Mcleellan 
(2002) divided their subject pool into users (consumption > 300 mg/d) and non-users (consumption < 50 
mg/d) and concluded that the treatment led to increased time to exhaustion in both groups, however the 
effect lasted approximately 3 hours longer in the non-users. 
A variation in the subject pool between studies is also evident. Commonly differences in age, sex and 
performance level exist with some studies using elite athletes (table 1.4.1; table 1.4.2.). This variability 
could go some way to explaining the variation in results and individual response level. 
Some of these limitations outlined in human research are addressed in the animal model, all muscle 
preparations receive the same direct dosage of caffeine, and thus variation in digestion is eradicated. 
Furthermore, mice don’t have a diet high in caffeine so potential habituation effects are also eliminated. 
Adverse Effects of Caffeine Consumption 
Further to the previously discussed effects of caffeine withdrawal, prolonged consumption of high dosage 
of caffeine can have adverse physiological effects on performance and health. A review by Smith et al. 
(2002) explored how high doses of caffeine can lead to increased anxiety in some individuals and 
impairment in fine motor control. Further to this Smith et al. (2002) displayed evidence for the common 
theory that caffeine will decrease one’s ability to sleep. However, it was further suggested that humans 
are good at regulating their caffeine consumption and will not consume high doses at night. 
Caffeine has also been recognised as having a diuretic action, Maughan and Griffin (2003) reviewed 
caffeine ingestion and fluid balance and concluded that caffeine-containing beverages result in excess 
fluid loss resulting in a poor hydration status. Large, acute doses of at least 250mg resulted in short term 
stimulation of urine output. The result of this is a decrease in plasma volume and electrolyte balance, 
which may decrease time to fatigue in prolonged exercise. 
There is also evidence showing that caffeine will accelerate bone mineral density (BMD) loss. Harris and 
Dawson-Hughes (1994) concluded that daily consumption of high doses caffeine accelerated BMD loss 
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from the spine and total body in healthy postmenopausal women with calcium intakes below the 
recommended daily intake. Similar results were further confirmed by Rapuri et al. (2001). Controversial 
are the effects of high dose caffeine consumption on risk of coronary heart disease; the most recent 
literature has shown that caffeine does not increase the risk of Coronary Heart Disease (CHD) and death 
(Kawachi et al. 1994; Kleemola et al. 2000; Lopez-garcia et al. 2006). 
Caffeine Mechanisms of Action - CNS 
A review by Lorist and Tops (2003) explored the behavioural and performance response to caffeine 
ingestion and demonstrated an increase in response to stimuli, an elevated state of arousal and a 
decreased rate of perceived exertion with support from EEG data. In much of the literature caffeine is 
considered a psycho stimulant along with amphetamines and cocaine, as it results in similar behavioural 
responses. The most widely established behavioural effects of caffeine are on motor activation and 
arousal (Fredholm et al. 1999). 
The most extensive evidence suggests that caffeine functions as an adenosine receptor antagonist 
(George, 2000). Due to the similar molecular structure as adenosine, caffeine will bind to adenosine 
receptors thus inhibiting the binding of adenosine and its functions (Kalmar & Cafarelli, 2004). 
Caffeine will act on the four cloned receptors to a varying extent however it is believed that at A1 
receptors highly expressed in the brain and A2a receptors of large concentration in the striatum the 
effect is greatest (Ferre, 2008).  
A1 receptors are responsible for reducing neuron firing and result in vasodilatation of blood vessels 
allowing increased oxygen consumption during sleep. A decrease in muscle activity is achieved via a 
decrease in cAMP formation and inhibiting the function of voltage dependant calcium channels 
cumulatively important in the transfer of neural impulses (Fredholm et al. 1999). Reducing neuron 
firing will result in a lower peak force and slower time to activation, as the rate of Ca2+ efflux from 
the SR thus the intracellular concentration will be lower.  
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A2a receptors are believed to play a key role in promoting a sleep like state; failure of this process 
via caffeine ingestion will result in an arousal enhancing effect (Ferre, 2008). Activation of A2a 
receptors leads to decreased affinity of dopamine binding to D2 receptors. The binding of 
adenosine to A2a receptors has been shown to promote the release of GABA, the primary inhibitory 
neurotransmitter. However, the binding of dopamine to D2 receptors promoted via caffeine has 
been shown to block the release of GABA. It has been established that a substantial increase in the 
concentration of caffeine increases the turnover of several neurotransmitters notably dopamine. 
Inhibition of adenosine receptors via caffeine will result in an increased transmission via dopamine 
at D2 receptors (Fredholm et al. 1999).  
As a further consequence of caffeine treatment, the pituitary gland senses the increase in neuron 
firing and responds by releasing adrenalin, a caffeine-induced, increased plasma adrenalin level was 
concluded in studies by Jackman et al. (1996) and Graham et al. (1998). The net result of increased 
adrenalin is an increased heart rate, blood pressure and vasoconstriction of the blood vessels and 
arteries, and increased glycogenolysis. Adrenalin is also believed to promote enhanced oxidation of 
free-fatty acids thus promoting glycogen sparing, contributing to increased endurance performance 
(Davis & Green, 2009) however this occurrence was not concluded by Graham et al. (1998). Spriet 
et al. (1992) took muscle biopsies from subjects cycling at 80% VO2max to exhaustion and 
concluded decreased glycogenolysis by approximately 55% during the first 15 minutes of exercise 
following caffeine treatment. An increase in FFA’s was also concluded throughout much of the 
literature (e.g. Essig et al. 1980: Bruce et al; 2000). Rush & Spriet (2001) further supported the 
mechanism of glycogen sparing concluding that caffeine at levels of moderate human consumption 
can inhibit and reduce the sensitivity of glycogen phosphoralase, therefore reducing the rate of 
glycogenolysis. Chesley et al. (1998) reported that muscle glycogen decreased by 28% following 
caffeine ingestion in half of the subject population, and was unaffected in the other half. However,  
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Chesley et al. (1998) further reported that caffeine significantly increased resting FFA concentration 
and adrenalin concentration twofold during exercise in all subjects. This, therefore, shows an 
increase in FFA via the mechanism induced by caffeine supplementation may not necessarily result 
in glycogen sparing. As with many of the mechanisms in this area, contradicting literature is also 
evident here. Graham (2001) questions the glycogen sparing theory as the manner promoting 
increased endurance capacity. Well documented is the fact that caffeine will elevate circulating 
catecholamines, conversely the increased mobilization of FFA’s as a knock on effect has not been 
verified. More recent articles reviewed concluded that a decrease in Respiratory Exchange Ratio 
(RER), where a reduced value represents a greater fat metabolism for energy production, has not 
been demonstrated during prolonged activity (Graham et al. 2008; Turley et al. 2008; Ivy et al. 
2009). A further confounding theory is a reported increase in blood lactate following the 
consumption of caffeine (Graham et al. 1998; Bell & Mclellan, 2002) that contradicts the glycogen-
sparing hypothesis with carbohydrates being essential in this form of metabolism. 
Caffeine Mechanisms of Action – The Effects of High Concentrations of Caffeine on Skeletal 
Muscle 
The importance of in vitro studies centre on the isolation of a muscle tendon unit allowing its properties 
to be compared in caffeine and non-caffeine trials. As previously outlined, in human studies it is difficult 
to isolate factors that result in direct muscle performance improvement from muscle performance 
improvement resulting from central mechanisms.  However an isolated muscle is externally stimulated 
and its metabolism controlled, thus it is possible to exclusively examine the skeletal muscle reaction to a 
caffeine dose. The direct treatment of muscle with caffeine eliminates individual differences in 
metabolism that occur between humans and ensures that all muscle preparations are subject to the same 
dose over identical periods. Additionally the animals from which these preparations are taken do not have 
a diet high in caffeine eliminating this variable that is difficult to control in human investigations. 
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Much of the evidence of the direct effects of caffeine as an ergogenic aid on muscle derive from the early 
in vitro studies such as Luttgau & Oetliker (1967) who tested millimolar caffeine treatment 
(supraphysiological for humans) on isolated semitendinosus and iliofibularis muscle in Swiss mountain 
frogs. The study concluded significant increases in twitch force following treatment with 6-10 mM 
caffeine and an increased sensitivity to caffeine following a drop in temperature from 20oC to 1-3oC.At 
high concentrations caffeine has even been shown to produce contracture without stimulation (Huddart, 
1968). 
The primary mechanism by which caffeine can promote greater force output in skeletal muscle is believed 
to be via interference with excitation contraction coupling (Davis & Green, 2009). It has been established 
that the specific mechanism of action lies with alteration in the intramuscular ion handling, primarily 
concerning the increased concentration of Ca2+ within the intracellular space (Magkos & Kavouras, 2005). 
The role of Ca2+ in promoting muscle activation has already been explained, however it is believed by 
increasing the intracellular concentration promotion of faster muscle activation and therefore a greater 
power output will occur. One of the earliest studies that investigated this theory was Weber & Herz 
(1968). They isolated SR from frogs and monitored Ca2+ release to varying caffeine concentrations. 
Caffeine caused an immediate release of Ca2+ in 11 of 12 preparations. It was established that a shift in 
the voltage dependant Ca2+ release mechanism to a more negative membrane potential resulted in this 
phenomenon. This mechanism was later confirmed by Endo et al. (1970) using skinned muscle 
preparations with SR left intact.  
Allen et al. (1989) demonstrated that a 10mM caffeine treatment promoted an enhanced opening of the 
RyR2 channels of the SR resulting in a greater Ca2+ influx into the intracellular space. A later study by Allen 
& Westerblad (1995) provided additional evidence demonstrating that a caffeine treatment led to a 
decrease in the sensitivity of the SR Ca2+ pump and an increased SR Ca2+ permeability. Consequently the 
rate of Ca2+ efflux from the intracellular space will be significantly slower during caffeine treatment, 
resulting in a greater intracellular Ca2+ concentration at rest and during activation (Allen & Westerblad, 
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1995). Magkos and Kavouras (2005) further suggested that if Ca2+ is released from SR at a quicker rate 
then this will result in a quicker response of the Ca2+ induced Ca2+response mechanism. Allen and 
Westerbald (1995) also recognised that caffeine caused an increase in myofibrillar Ca2+ sensitivity. 
The overall effect of caffeine is a modified Ca2+ transient time resulting in an increase in basal and 
activated intracellular levels of Ca2+ in conjunction with an elevation in the plateau phase (Fryer & 
Neering, 1989). A combination of these factors will result in a decrease in the muscle’s ability to restore 
the intracellular concentration back to pre-treatment resting levels thus making it harder for the cessation 
of muscle activation. Allen & Westerblad (1995) demonstrated a decreased rate of muscle relaxation in 
mouse flexor brevis muscle. Along with an increased Ca2+concentration due to caffeine treatment, the 
intracellular caffeine concentration would have to fall further to achieve relaxation due to an increased 
Ca2+ sensitivity. Another possibility is that as a result of this increased sensitivity, it may take longer for 
Ca2+ to dissociate from troponin. Therefore it is likely that a decreased rate of muscle deactivation may be 
due to alterations in muscle Ca2+ transient time. During locomotion a decrease in time to relaxation may 
prove to be disadvantageous, as an active muscle undergoing lengthening will result in elevated passive 
force. 
A further proposed mechanism as to how caffeine could modify excitation contraction coupling lies with 
increased stimulation of Na+/K+-ATPase activity (Davis & Green, 2009). The ability of a cell to maintain 
plasma K+ homeostasis is essential in the maintenance of cell membrane potential. If this can occur more 
readily with greater efflux of Na+ and influx of K+ action potentials will be able to propagate at a faster 
rate. Therefore Ca2+ can be released at a faster rate in response to an oncoming stimulus. 
Many in vitro studies have found that caffeine treatment elicits acute one off enhancement of force (e.g. 
Huddart 1968; Fryer & Neering, 1989; Allen & Westerblad, 1995; Germinario et al. 2004; James et al. 
2004; James et al. 2005), however this benefit has not been shown to transfer to prolonging muscle 
power output with studies by Germinario et al. (2004), Reading et al. (2004), James et al. (2005) all 
concluding against an increase in time to fatigue. Germinario et al. (2004) concluded that caffeine 
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significantly reduced time to fatigue at maximal and sub maximal activation levels in mouse EDL and 
soleus muscle.  
Effect of Physiological Doses of Caffeine in vitro 
Graham (2001) provided an in-depth review of caffeine and exercise in relation to metabolism, endurance 
and performance effects along with possible underlying mechanisms. The initial significant point to be 
noted is that caffeine within human physiological concentrations is usually below 70 µmol/l with common 
blood plasma levels being 20 – 50 µmol/l. However, most in vitro investigations have used non-
physiological caffeine concentrations of between 500 – 5000 µmol/l. Such studies have no physiological 
relevance to humans as blood caffeine levels exceeding 70µM are toxic, with levels exceeding 1mM often 
fatal (Fredholm et al. 1999). This lack of human relevance in relation to the caffeine concentration used 
suggests that conclusions drawn from such experiments to be of little value in relation to investigation of 
the drug as an ergogenic aid in humans 
Many of the initial in vitro studies are also limited due to the physical environment that the preparations 
were tested in. James et al. (2004; 2005) were the first to mimic the physiologically relevant conditions of 
human muscle and used a caffeine dosage that was attainable in blood plasma. James et al. (2005) used 
mouse EDL (relatively fast muscle) to assess the effects of micromolar caffeine concentration on force 
production and power output in non-fatigued muscle over short or prolonged cyclical activity. Further to 
this the effect of caffeine on recovery from fatigue was also investigated. It is the methods used that 
provide the James et al. (2004; 2005) studies with their greatest validity. During testing the muscle was 
maintained in Krebs-solution at a temperature of 35oC. The Krebs solution contains glucose as well as 
micromolar concentration of a number of other substances at a pH of 7.60 (reduced to pH 7.4-7.5 during 
the experiment as it is bubbled with 95% O2, 5% CO2) allowing simulation of the blood plasma that 
surrounds mammalian muscle in vivo. Principally, this solution was maintained at a temperature of 35oC 
comparable to physiological temperature. Caffeine treatments of 70µM were added to the Krebs solution, 
representing a maximum level of caffeine relevant to blood plasma in vivo (Fredholm et al. 1999), making 
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this work conducted by James et al. (2005) unique for mammalian muscle. The work loop technique was 
implemented as a practice to incorporate the dynamic conditions of length, force and velocity that 
simulate the cyclical length changes that can occur in skeletal muscle in vivo. James et al. (2005) 
concluded that small but significant increases (2%) in mean net muscle power output occurred after 
caffeine treatment, attributed to increased force production during shortening. Further to this a marked 
performance difference between preparations was present. As demonstrated in the human research 
(Table 1.4.1 and 1.4.2), response to the caffeine treatment should therefore be viewed on an individual 
level highlighting a division of responders and non-responders.  The caffeine induced potentiation of 
maximal power was not maintained throughout fatigue tests, thus 70µM caffeine treatments had no 
significant effect on delaying the onset of fatigue or enhancing recovery from fatigue. Further to this no 
enhancement in the recovery from fatigue with 70µM caffeine treatment was reported by James et al. 
(2004). 
It has clearly been demonstrated that caffeine is an ergogenic aid. The 2% direct increase in muscle power 
output established by James et al. (2005) in vitro could cause measurable improvement in sporting 
performance, especially in sprint events where tenths of a second separate athletes. Constant throughout 
the in vivo and in vitro literature is a division of subjects into responders and non-responders (e.g. James, 
2005; Skinner et al. 2009), such that for responder’s high level caffeine consumption could provide an 
advantageous effect. In conjunction with this direct effect, caffeine could also cause CNS improvements 
and debatable beneficial substrate metabolism to further increase performance (Graham, 2001). Caffeine 
has always had a firmly established role as a stimulant increasing awareness and reaction time thus 
further cementing its function as a performance enhancer (Yacoubi et al. 2000). 
Caffeine Concentration in the Present Research 
As with previous research, the present work will use 70µM caffeine concentration to represent the 
human maximum physiologically attainable caffeine concentration in blood plasma (James et al. 2004; 
2005; Rosser et al. 2009). Caffeine is almost completely (99%) absorbed from the gastrointestinal tract 
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and its hydrophobic nature allows free passage across all biological membranes allowing distribution to all 
bodily tissues (Magkos & Kavouras, 2005; Fredholm et al. 1999). However, the distribution of caffeine to 
these tissues is unlikely to be equal in magnitude across all tissues. Berg and Werner (1971) examined the 
tissue distribution of caffeine and its metabolites in a number of tissues from mice. The results initially 
indicate that the tissue concentration of caffeine is varied and does not equal that of the blood plasma. 
Importantly, Berg and Werner (1971) further demonstrated that the muscle caffeine concentration was 
relatively high after 30 and 60 minutes compared to other tissues measured, and that the concentration 
in blood plasma remained relatively constant over the 30 minutes measured. Results from Berg and 
Werner (1971) in part confirm earlier findings suggesting that caffeine distributes in tissue in proportion 
to tissue water. In light of this evidence, 70µM caffeine concentration is deemed the most appropriate 
maximum physiologically relevant concentration in the context of the present work, as tissue distribution 
is dependent on the concentration absorbed into the blood.  In the present work skeletal muscle is 
isolated and placed in a flow through chamber with circulated oxygenated Krebs-Henseleit solution, which 
acts to mimic blood plasma. The caffeine in the Krebs-Henseleit solution is free to diffuse into the muscle 










1.5. Changes in Skeletal Muscle Function with Age 
Sarcopenia refers to a reduction in muscle mass, strength, and a slowing of contraction that is an 
inevitable occurrence with age (Williams et al. 2002). Sarcopenia affects mobility, increasing the risk of 
falls and fractures and reducing quality of life in the elderly. Despite the demonstrable benefits of training 
(specifically strength enhancing exercise) it is unfeasible to fully offset the age related decline in muscle 
performance and changes in body composition (Klitgaard et al. 1990). By taking measurements of muscle 
area, total fiber number, fiber size, proportion and distribution of fiber types of whole vastus lateralis in 
men aged between 15 and 83 years, Lexell et al. (1995) confirmed that muscle atrophy begins after 25 
years of age and accelerates during the later stages of life. Losses in absolute muscle force production 
were attributed to a decrease in muscle cross-sectional area (CSA) derived from a reduction in fiber size 
or fiber number or a combination of these factors. Decreases in physical activity, alterations in hormone 
release, chronic disease, and malnutrition are factors that have been identified to contribute to the loss in 
muscle mass and strength (Baumgartner et al. 1999). The ageing effect is known to negatively impact on 
force, power and endurance parameters of muscle performance. A key point to note here is that an age 
related decline in muscle performance occurs considerably before what is typically determined ‘aged’, 
thus a greater understanding in the rate of decline of skeletal muscle function at various points beyond 
physical maturity is needed. 
The Effect of Age on Muscle Strength & Power 
A reduction in muscle strength and power is a commonly recognised consequence of ageing (Doherty, 
2003; Deschenes, 2004). It is important to initially distinguish the differences between muscle strength 
and power. Muscle strength can be defined as the maximal amount of force exerted in a single attempt 
(Deschenes, 2004). Muscle power output is a product of load multiplied by velocity; this indicates that 
muscle power is the rate at which work can be produced (Macintosh, 2006). 
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Murray et al. (1980; 1985) reported that isometric strength of the knee flexor and extensor muscles 
reduced by an average of 55-65% and 56-78% in elderly men and women respectively. A loss in the 
capacity of aged muscle to produce isometric tension is also well supported by in vitro research using 
isolated mammalian muscle (Brooks & Faulkner, 1988; Zhang & Kelsen 1990). Muscle strength can be 
maintained fairly well up to middle age; however, the rate of decline increases more rapidly beyond this. 
Longitudinal studies such as Frontera et al. (2000) have shown 20-30% reductions in the isokinetic muscle 
strength of the knee and elbow extensors over a 12-year period in elderly men. An earlier 7 year follow up 
study Aniansson et al. (1986) examining quadriceps strength in elderly men demonstrated strength 
decreases of 10 - 20%.A reduction in muscle strength and power is evident in men and women beginning 
by age 40 (Metter et al. 1997). The decline in power has been shown to be significantly faster than 
strength (Metter et al. 1997). Skelton et al. (1994) examined muscle strength and power in 50 men and 50 
women evenly distributed over the age range 65-89. A yearly overall 1-2% and 3% loss of isometric 
strength and leg extensor power respectively was estimated, however the rate of decline was significantly 
faster in men. 
An age related depression in the force-velocity relationship and overall reduction in maximal unloaded 
shortening velocity (V0) has also been firmly established which may contribute to the increasingly rapid 
loss of muscle power (Raj et al. 2010). The two constituents of muscle power are force multiplied by 
velocity, the recognised age related decline in muscle strength and Vmax (the two constitutes of the power 
output equation) will result in a significant reduction in maximal muscle power output. Krivickas (2001) 
used slack testing to determine that V0 differed with age and gender. The V0 of type IIa fibers in elderly 
men was 83% of that of their younger counterparts; however V0was unchanged in type I fibers. On the 
other hand there was no difference in V0 in type IIa fibers in elderly women, however, V0 was reduced to 
93% in type I fibers. A decrease in soleus V0 in aged rat soleus has also been confirmed by Thompson and 
Brown (1999) using the same method. This is supported by an in vitro reduction is muscle isometric 
activation and relaxation time (Edstrom & Larsson, 1987). Conversely the in vitro reduction of muscle 
power output (78% and 73% for mouse EDL and soleus respectively) demonstrated by Brooks and 
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Faulkner (1988) was not matched by any age related changes in the force-velocity relationship. It was, 
therefore, concluded that the reduction in power output is mainly drawn from a reduction in the muscle 
force generating capacity via a decline in the number of cross bridges or a reduced force development by 
individual cross bridges. 
Although a reduction in muscle strength is common in concentric, eccentric and isometric measures, it is 
considered that the age related reduction in eccentric muscle strength is less pronounced (Deschenes, 
2004). Poulin et al. (1992) and Porter et al. (1995) have both demonstrated a greater maintenance of 
eccentric muscle torques in the elderly compared to that seen in concentric muscle action. It is considered 
that this may be the result of slower contractile properties or increased connective tissue contributing to 
increased stiffness in the aged muscle (Doherty, 2003) 
The Effect of Age on Muscle Endurance 
Muscular endurance is the ability of the muscle to resist fatigue. The age related effect of muscle fatigue 
is equivocal with some research providing evidence for a decrease in muscle endurance whereas other 
studies show no difference, or an increase, in the muscle endurance with increasing age (Deschenes, 
2004). 
Using a maximal multistage incremental cycling test, Izquierdo et al. (2001) reported a significant 
reduction (19 % when related to body mass) in maximal workload in older subjects. This was related to 
significantly reduced heart rate and blood lactate concentration in the older subjects. Research by 
Lennarken et al. (1985) and Davies et al. (1986) postulate that increased age leads to a reduction in 
skeletal muscle endurance. 
Pagala et al. (1998) examined fatigue in isolated muscle preparations in young and old rats using sub 
maximal isometric tetanic contractions. A significant increase in the resistance of soleus to fatigue was 
reported in the old mice. Interestingly, Pagala et al. (1998) also examined whole animal endurance 
performance and reported that running and swimming duration in the older mice was significantly 
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reduced. Therefore it was concluded that the increased fatigue that is attributed to old age is not a 
response to impairment of the muscle ability but due to central or extra muscular processes. In vivo 
research by Kent-Braun et al. (2002), in part, supports these findings, reporting a greater fatigue 
resistance during intermittent, sub maximal, isometric contractions in older adults. This effect was shown 
not to be significantly different between genders nor directly attributed to a reduction in neural activation 
during activity. 
In contrast Lindstrom et al. (1997) examined the effects of increasing age on muscle fatigue by comparing 
maximal knee extensor strength using isokinetic dynamometry between 28 year old and 73 year old men 
and women. Despite a reduction in maximal voluntary contraction elderly subjects showed no difference 
in rate of fatigue. Other studies report an age related decline in muscle strength with no significant effect 
on muscular endurance (Backman et al. 1995; Bemben et al. 1996). The conflicting findings are likely to 
occur due to differences in experimental methods (i.e. the fatigue protocol and the point at which the 
muscle is deemed fatigued), muscle groups tested, the intensity of exercise, and differences between 
maximal voluntary contraction and electrical stimulation of muscle. 
Mechanisms of Skeletal Muscle Ageing 
Ageing will affect all the major physiological systems in the body in some way; therefore it should be 
considered that the degenerative process leading to sarcopenia arises from a combination of molecular 
and cellular factors. These factors are outlined in Fig 1.5.1 and the key mechanisms relating to the 
















Changes in Excitation Contraction Coupling and Ca2+ handling 
The rate of muscle activation and force production is primarily determined by excitation contraction 
coupling and the intramuscular Ca2+ transient time (Berchtold et al. 2000). An age related reduction in 
functionality of this process has been established which would greatly contribute to the loss of muscle 
function (Navarro et al. 2001). 
Delbono et al. (1995) demonstrated a significant reduction in Ca2+ release in fast fibers of human 
quadriceps, attributed to DHPR-Ryanodine Receptor uncoupling. This conclusion was also confirmed by 
Renganathan et al. (1997) who demonstrated an age related reduction in RYR1 uncoupled to DHPR in rat 
EDL and soleus muscle. A reduction in the voltage gated SR Ca2+ release mechanism will result in a 
decreased Ca2+ availability for the contractile proteins and consequently a reduction in contractile force. 
In conjunction with this an age related decrease in the SR function of chemically skinned fast twitch 
Fig 1.5.1. - Overview of the interacting mechanisms that 
result is sarcopenia (from Ryan & Ohlendieck, 2004) 
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muscle of the rat was reported by Larsson & Salviati (1989). The reduction in SR Ca2+ concentration and 
Ca2+ pump activity were not transferable to slow twitch fibers. Evidence by Hunter et al. (1999) supports 
these finding in humans by reporting a significant reduction in SR Ca2+ uptake and Ca2+ -ATPase activity in 
aged Vastus Lateralis of elderly women. Narayanan et al. (1996) concluded a reduction in SR Ca2+ pump 
function in rat soleus that was not as pronounced in faster gastrocnemius muscle. Supplementary to this 
the results of Narayanan et al. (1996) failed to show any significant difference in the quantity of Ca2+-
ATPase, ryanodine receptor or calsequestrin (Ca2+ binding protein) in the aged population. No age related 
reduction in SR calsequestrin has been firmly demonstrated in both skeletal and smooth muscle (Klitgaard 
et al. 1989; Xu & Narayanan, 1998). Besides significantly affecting muscle force production these 
previously described mechanisms are likely to contribute to the age related increase in muscle activation 
and relaxation times (Hunter et al. 1999: Brooks & Faulkner, 1988).Evidence by Ray et al. (1995) and 
Saborido et al. (1995) further suggests that nerve stimulation and muscle activity can significantly affect 
muscular composition of dihydropyridine and ryanodine receptors. The reduction in physical activity that 
occurs during ageing is likely to negatively affect muscle receptor composition and further amplify the 
ageing effect via the previously described mechanisms. 
In an attempt to offset this reduction in excitation contraction coupling, and more importantly the 
reduction of SR Ca2+ release, Hill et al. (1996) demonstrated that the contractile proteins of aged rat EDL 
and soleus had an increased Ca2+sensitivity. In conjunction with this a greater resting concentration of 
intracellular Ca2+ has been demonstrated in aged rat EDL and, to a smaller degree, soleus muscle (Fraysse 
et al. 2006). Fraysse et al. (2006) hypothesised that this increase in homeostatic Ca2+concentration will 
contribute to age induced muscle weakness via changes in myosin heavy chain isoform and increased 
activity of calcium dependant calpain proteolytic enzymes. Interestingly the treatment of aged rats with 





Stalber and Fawcett (1982) used EMG to report a significant decrease in motor unit number in small 
muscles of the hand and foot after the age of 60; this was partly counteracted with an increase in motor 
unit size. The common cycle of denervation - renervation is diminished in aged muscle and a net 
denervation results in a loss of motor units and innervated fibers (Carlson, 2004; Deschenes, 2004). A 
progressive denervation of muscle fibers and a loss of fast motor units have been identified as the 
primary mechanisms for the deterioration of muscle function with age (Einsiedel & Luff, 1992; Wineinger 
et al. 1995; Kadhiresan et al. 1996, Carlson, 2004). It is considered that ageing greatly reduces the number 
of motor axons supplying muscles. The loss of alpha-motorneurons is greater at type II muscle fibers, 
therefore these fibers cannot be activated and thus degeneration occurs (Carlson, 2004). Lexell (1995) 
confirmed this notion via comparisons of muscle biopsies between younger and older individuals 
revealing that type II fibers were smaller in older individuals while type I fibers were less affected. 
Kadhiresan et al. (1996) displayed evidence of motor unit remodelling in aged rat gastrocnemius muscle. 
The number of slow motor units remained constant; however, the number of fibers per motor unit 
increased 3 fold. Conversely, the number of fast fatigable motor units decreased by 34% in conjunction 
with an 86% reduction in number of fibers per motor unit. There was only a limited motor unit 
remodelling in fast fatigue resistant units.  
Further considerations should also be given to the age related changes in neuromuscular junction 
morphology, particularly changes in acetylcholine receptor density (Courtney & Steinbach, 1981; 
Andonian & Fahim, 1987; Li et al. 2011). 
Muscle Mass & Fiber Type Composition 
The age induced reduction in muscle mass is primarily a consequence of a reduction in fiber number or a 
decrease in cross sectional area (Deschenes, 2004; Navarro et al. 2001).  In humans, muscle mass peaks at 
24 years, with only a small (10%) decrease by the 5th decade with a further, more rapid, 30% reduction by 
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the 80th year (Deschenes, 2004).Navarro et al. (2001) suggested that a reduction in motor unit number 
and size, decreased protein synthesis, disuse atrophy mechanisms, and alterations in hormone production 
made up a number of interacting factors that resulted in muscle wasting.  
A reduction in the synthesis of myofibrillar proteins, with age, would explain the age related loss in 
muscle function and mass (Navarro et al. 2001). Contractile fore is dependent on the quality and quantity 
of the contractile proteins that are continually remodelled via protein catabolism and synthesis (Balagopal 
et al. 1997). Balagopal et al. (1997) reported a progressive age related decline in myosin heavy chain 
synthesis; this is likely to reduce the muscle's ability to remodel contractile protein and is expected to 
contribute to the age induced loss of muscle mass and strength. Welle et al. (1993) reported a one third 
reduction in quadriceps strength between young and old subjects. This was consistent with a 21% 
reduction in muscle mass and was further supported by evidence highlighting a reduction in myofibrillar 
protein synthesis between young and old populations. In conjunction with a loss of oxidative capacity an 
age related reduction in mitochondrial protein synthesis may also affect muscle mass (Rooyackers et al. 
1996). 
Detraining or the loss of conditioning is primarily associated with highly trained individuals that reduce or 
cease to adhere to their training programme. The reduction in training stimulus results in disuse atrophy 
that should also be considered as a mechanism in the aged population. Frontera et al. (2000) reported 
isokinetic muscle strength reductions ranging from 20-30%, after analysing muscular performance in 
elderly men (65.4 ± 4.2 yr) over a 12-year longitudinal study. Fiber cross sectional area had decreased by 
up to 16.1%, and although not the only highlighted mechanism, a significant reduction in the amount of 
physical activity was reported. Further support for the disuse atrophy mechanism can be seen in the 
literature that demonstrates training in the elderly can significantly increase muscle force and muscle CSA 
(Roman et al. 1993; Fiatauone et al. 1990). In essence those that participate in a greater amount of 
physical activity have improved muscular function. 
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It is well established that different fiber types can be distinguished, in each muscle, dependant on 
functional and structural properties. Alnaqeeb and Goldspink (1986) reported that the loss of muscle 
mass should be attributed to a reduction in fiber size and number. A key aspect of ageing phenotype 
appears to be a shift towards a more oxidative metabolism as the reduction in the CSA of type IIx fibers 
appears to be more pronounced (Aniansson et al. 1986; Coggan et al. 1991). Alnaqeeb and Goldspink 
(1986) showed significant reductions in the aged rat soleus FOG fiber diameter by up to 35.8% with only a 
marginal reduction in SO fiber diameter. EDL had a significant 22.7% reduction in the CSA of FG fibers, 
whereas the CSA of FOG fibers increased by 12.4% in conjunction with a relatively small increase in SO 
CSA. Despite early work suggesting that muscle fiber number decreases more rapidly in type II fibers it is 
now widely established that muscle fiber number will decrease equally across fast and slow fiber 
types(Deschenes, 2004). Lexell et al. (1988) reported a loss of muscle fibers in aged human vastus lateralis 
muscle, but more significantly they reported that this reduction did not differ between fiber types. Lexell 
and Downham (1991) further suggested that the random dispersal of fiber types seen in young muscle 
decreases with old age and that there is evidence of grouping of particular fiber types into clusters 
demonstrating muscle regeneration. The overall conclusion here is that slower muscle fiber types 
represent a greater proportion of the CSA of the muscle in aged muscles. 
Increased Connective Tissue and Intramuscular Fat 
Fibrosis causes an increase in skeletal muscle connective tissue; this reduces the flexibility of the muscle 
and can restrict movement and circulation (Martini et al. 2000). Alnaqeeb et al. (1984) examined 
connective tissue in aged rat EDL and soleus muscle, and found that there was an age related increase in 
muscle stiffness (length-passive tension) attributed to an increased thickness of the endomysium and 
perymysium, and greater total muscle collagen. 
A further point to consider is the age related increase in intramuscular fat mass. Kent-Braun et al. (2000) 
reported an increase in intramuscular fat from 6% in young subjects to 15% in elderly subjects irrespective 
of gender. Kent-Braun et al. (2000) further reported the importance of physical activity in the elderly in 
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order to reduce intramuscular fat content. As a result of an increase in connective tissue and 
intramuscular fat content the aged muscle has a greater proportion of non-contractile mass, so is likely to 
generate a lower force per muscle cross-sectional area. 
Hormonal Factors that Affect Skeletal Muscle Ageing 
It is important to consider the effects of circulating hormones on aged muscle, many of which are 
involved in the anabolic process of muscle building. An age related reduction in such hormones could 
significantly contribute to sarcopenia (Deschenes, 2004). 
Testosterone 
Testosterone secreted in the testes of males is primarily a male sex hormone promoting androgenic and, 
more importantly in this instance, anabolic properties that cause skeletal muscle growth (Hebst and 
Bhasin, 2004). Gray et al. (1991) conducted a meta-analysis on the association between testosterone and 
male ageing and showed that, in research using only healthy subjects, a gradual age related decline in 
testosterone secretion occurred. A reduction in testosterone has been associated with a loss of muscle 
mass and strength, this may further be associated with impairment of the biological action of androgens 
in target cells (Gooren et al. 1998). 
The underlying mechanism for reduced testosterone is not fully understood, however it is likely that there 
are changes in the different levels of the hypothalamo–pituitary–testicular axis (Gooren et al. 1998; 
Deschenes, 2004). It has been shown that testosterone producing Leydig cells have a reduced 
responsiveness to luteinising hormone (LH) that is secreted by the pituitary gland to increase blood 
testosterone concentration (Kaufman et al. 1990). It is further proposed that there is a reduction in 
gonadotrophin releasing hormone, from the hypothalamus, which regulates the release of LH from the 
pituitary gland (Vermeulen et al. 1989: Kaufman et al. 1990). Further to this an age related increase in the 
binding of testosterone to high affinity sex hormone binding globulin (SHBG) occurs, rendering it to be 
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biologically unavailable (Gooren et al. 1998). Gooren et al’s (1998) review further suggested evidence of a 
reduction in testicular blood flow that would contribute to these aforementioned effects.  
The use of testosterone replacement treatment for its anabolic effects on skeletal muscle has been widely 
studied. Bhasin et al. (1996) reported that a supraphysiological dose of testosterone significantly 
increased fat free mass, muscle size, and strength in healthy young men and that these effects were 
further pronounced when combined with strength training. It has been firmly established that 
testosterone replacement treatment can be used to reduce the effects of sarcopenia. Urban et al. (1995), 
Ferrando et al. (2001), and Hebst and Bhasin (2004) are just a selection of studies that have indicated that 
increasing testosterone levels in elderly men significantly increases mRNA concentrations of IGF-I and that 
this in turn resulted in increased skeletal muscle protein and strength. 
Growth Hormone (GH) and Insulin-Like Growth Factor I (IGF-I) 
As well as acting on a number of target tissues GH, secreted from the anterior pituitary gland in response 
to hypothalamic signals, stimulates the production of IGF-I in the liver (Navarro et al. 2001; Deschenes, 
2004). IGF-1 has growth-promoting effects on almost all the cells in the body, particularly in skeletal 
muscle. As with testosterone, an age related decrease in free GH has been demonstrated (Rudman et al. 
1981; Veldhuis et al. 1997; Vermeulen, 2002). A reduction in GH secretion, and the supplementary 
decrease in IGF-I, has been coupled with a decrease in muscle mass and strength, and a reduction in 
muscle protein synthesis (Welle et al. 1998). 
In light of this, research has examined the effect of increasing GH on skeletal muscle performance. In a 
study by Papadakis et al. (1996) GH was given to elderly men with low IGF-I levels, over a 6-month period, 
then body composition and functional ability was assessed. The GH group displayed a 13.1% decrease in 
fat free mass but no significant effect on knee or handgrip strength, or systemic endurance. Yarasheski et 
al. (1995) investigated the interaction between GH secretion and resistance training in elderly men. The 
group that received GH treatment demonstrated a significant increase in fat free mass and whole body 
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protein synthesis; however this was not associated with improved muscle strength compared to controls. 
The majority of evidence tends to complement these trends suggesting that GH therapy is not effective in 
treating sarcopenia. Potential side effects and serious adverse health effects have also been suggested to 
occur with excessive GH administration (Yarasheski et al. 1995; Navarro et al. 2001).  
Satellite Cells 
Myosatellite cells are located within the basement membrane and the sarcolemma of muscle fibers 
(Mauro et al. 1961). These structurally undifferentiated cells are responsible for growth of muscle, 
undergoing proliferation and their nuclei fusing to existing muscle fibers to form new ones. Snow (1977) 
reported a 4.6% reduction in satellite cells in aged rat soleus muscle. A decrease in satellite cell number is 
a common response to ageing (Deschenes, 2004). 
Mitochondrial Theory of Ageing 
In skeletal muscle oxidative phosphorylation is the primary source of ATP regeneration. The mitochondria 
are the ‘power house’ of this process and as many other processes within muscle rely on ATP any 
reduction that may occur with ageing would significantly impede muscle function (Deschenes, 2004). 
Mitochondria are also the major site of formation of reactive oxygen species (ROS) and free radicals, that 
are responsible for cell oxidative damage of DNA, RNA, lipid and protein (Wei & Lee, 2002). Research by 
Short et al. (2005) supports the theory of DNA oxidative damage and reduced mtDNA with ageing, that is 
related to a loss of mitochondrial function in human skeletal muscle. ROS are formed via a leak of 
electrons from the electron transport chain, that then combine with oxygen to form superoxide anions 
(O2-·); these then proceed to form ROS (Turrens, 2003). A significant build-up of ROS can largely be 
prevented by various antioxidant systems (Turrens, 2003). 
As mitochondria function deteriorates with age it has been considered that this results in an increased 
leakage of electrons from the electron transport chain and increased formation of ROS. The production of 
antioxidants also significantly decreases with age exacerbating ROS accumulation (Wei & Lee, 2002).The 
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mitochondrial theory of ageing suggests that oxidative damage to mitochondria leads to a further 
production of ROS which develops into an escalating oxidative damage cycle, which over time causes 
mitochondrial dysfunction (Van Remmen & Richardson, 2001). It has been established that an 
accumulation of dysfunctional mitochondria occurs in ageing cells. de Grey (1997) proposed the 'survival 
of the slowest' hypothesis as a potential mechanism of this occurrence. Via this hypothesis it is thought 
that mitochondria selected for lysosomal degradation are those with high levels of membrane oxidative 
damage. The dysfunctional mitochondrial have reduced activity and are therefore inflicting reduced 
oxidative damage thus they are degraded at a slower rate. The development of this process over time 
results in an accumulation of dysfunctional mitochondria (Van Remmen & Richardson, 2001). A reduced 
turnover in mitochondria related to a reduction in mitochondrial protein synthesis will contribute to a 
decreased number of mitochondria with age (Rooyackers et al. 1996). 
It has been further suggested that an increased oxidative stress can result in an amplified occurrence of 
cell apotosis via activation of the mitochondrial membrane permeability transition. This increased 
permeability draws in more water causing the mitochondria to swell and possibly leading to rupture of 
the outer membrane releasing cytochrome c, which can in turn lead to a cascade of reactions resulting in 
cell apotosis (Van Remmen & Richardson, 2001). 
Besides significantly limiting skeletal muscle endurance capacity, the resultant decrease in ATP 
regeneration via oxidative phosphorylation, that results from reduced mitochondrial function, could also 
be a limiting mechanism for the discussed reduction in protein synthesis which requires large amounts of 
energy (Deschenes, 2004). 
The Circulatory System 
Reductions in cardiovascular performance cause a decrease in blood flow to the muscle at rest and at 
exercise (Martini et al. 2000). However, research has suggested that skeletal muscle capillary density is 
well maintained in the elderly (Chilibeck, 1997). In vitro research by Kano et al. (2002) used rat soleus and 
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plantaris muscle to also show the maintenance of skeletal muscle capillary supply in elderly muscle. 
Further to this the quality of the capillaries was also maintained, with the luminal size of each capillary 
being sustained with advancing age. Moller and Sylven (1981) reported slight increases in muscle 
myoglobin content in the aged population providing a further indication of the bodily desire to preserve 
skeletal muscle oxidative capacity.  
Reducing the Effects of Ageing via Physical Activity 
Ageing is related to a cycle of sarcopenia, whereby the age related reduction in muscle function results in 
muscle disuse and consequential disuse atrophy mechanisms and thus further sarcopenia. The elderly are 
encouraged to train within their physical limits in order to enhance their skeletal muscle function and in 
turn improves health and quality of life. The effect of a progressive training regime are well documented 
in mature adults, however, is it possible to offset the skeletal muscle ageing response via training and to 
what extent can this be achieved? 
Endurance Training 
Long-term endurance training in the elderly is associated with significant improvements in VO2max of up to 
20-30% (Seals et al. 1984; Hegberg et al. 1989; Coggan et al. 1992). The research of Coggan et al. (1992) 
exemplified the findings of the majority of literature within this area. They reported a 23% increase in 
VO2max after 9-12 months aerobic training. In conjunction with this there was found to be a 9.1% increase 
in type IIa fiber CSA, an 8.1% decrease in type IIb fibers, CSA of type I fibers increased by 12% and type IIa 
by 10%. A supplementary significant increase in capillary fiber ratio and activity of mitochondrial enzymes 
associated with aerobic metabolism were further reported. Menshikova et al. (2006) demonstrated an 
increased skeletal muscle mitochondrial content after long-term endurance training in elderly men and 
women. These adaptations provide evidence for an increase in aerobic metabolism. It is considered that 
an increased capillary density is the most important adaptation, leading to an increase in muscle oxygen 
delivery (Kirkenall & Garrett, 1998). 
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A key question with regard to the decline in exercise performance with ageing is to what extent is this 
true effect of ageing and how much is it due to a reduction in the level of physical activity? As there are 
no studies that monitor a maintained training program over such a prolonged time-course (i.e. maturity 
to aged) it is hard to fully answer this question. However some light can be shed by looking at a few 
longitudinal studies that have been conducted assessing the effect on endurance capacity. Rogers et al. 
(1990) looked at the effects of VO2max between elderly master endurance athletes and sedentary controls. 
Master athletes had been training from 10 years prior to the study and continued to train during the 8 
year follow up study. Master athletes’ VO2max declined by 5.5% per decade compared to a 12% decline per 
decade in the sedentary controls. Sedentary subjects’ HR decreased by 8 beats per minute which was not 
concurrent in the master athletes. Pollock et al. (1987) also assessed the effects of a maintained training 
program on VO2max of elderly master track athletes over a 10-year period. Those that became non-
competitive over this time had a significant reduction in VO2max, whereas those that remained 
competitive had no significant change in VO2maxafter 10 years. However, both subject groups displayed a 
7 beats per minute reduction in maximal HR. The results indicate that long-term training is efficient at 
delaying the ageing effect on physiological systems. Without knowing the similar fitness parameters of 
the subjects in these studies from maturity (i.e. 20-30 years of age) up to old age it is still difficult to make 
an accurate conclusion. However, from what we do know it is fairly evident that a reduction in physical 
activity works as an accelerator to the loss of physiological function. The first point to note is that in the 
research by Pollock et al. (1987) there was no significant improvement in VO2max, which you would expect 
in a progressive training program in younger adults. Further to this, the evidence presented shows the 
benefit of exercise in the elderly, but even longitudinal studies have failed to show that it is possible for 
elderly subjects to train their fitness parameters back to mature levels. 
Resistance Training 
Resistance training is employed as a method of improving a muscle’s ability to produce force. This should 
be an important consideration for the elderly in an effort to reduce the risk of falls and resultant fractures 
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and as a method of increasing the functional aspect of life (Kirkendall and Garrett, 1998). Evidence 
suggests that a progressive program of high-intensity resistance training can result in substantial 
improvements in skeletal muscle force. Roman et al. (1993) indicated a significant increase in elbow flexor 
strength after 12 weeks heavy-resistance training in elderly males. There was a 41% increase in the 
amount of work achieved over 25 reps which was concurrent with a 13.9% and 22.6% increase in CSA of 
the biceps brachii and the brachialis respectively, and a 37.2% hypertrophy of type II muscle fibers. 
Resistance training has also been proven to be beneficial for people at the very extremities of human 
ageing. Fiatauone et al. (1990) demonstrated that 8 weeks high-intensity resistance training increased 
quadriceps muscle strength by 174% and muscle area by 9% in frail residents of nursing homes with an 
average age of 90 years.  
The mechanisms of this increase in muscle strength will be the same as those that occur during resistance 
training in young adults. Besides the already reported increase in muscle CSA and changes in fiber type 
composition, Melov et al. (2007) showed that 6 months resistance exercise significantly increased 
muscular strength such that elderly subjects improved from 59% weaker than younger subjects to 38% 
weaker. This enhancement was partially attributed to the measured increase in mitochondrial function 
and, as previously suggested, partial reversal of the effects of the mitochondrial theory of ageing. Hunter 
et al. (1999) showed that high resistance training significantly increased the SR Ca2+ uptake and SR Ca2+ 
activity in vastus lateralis of elderly women. However this increase in SR Ca2+ uptake did not significantly 
improve muscle relaxation time and it was therefore concluded that Ca2+ uptake was not the rate-limiting 
mechanism for the slowing of relaxation time in aged muscle. The hypertrophic mechanism by which 
muscle responds to progressive training stimuli is likely to be limited in the elderly due to a reduced pool 
of satellite cells and the decrease in release of growth promoting hormones (Gray et al. 1991; Welle et al. 
1998; Deschenes, 2004). Kraemer et al. (1999) demonstrated that, as with younger individuals, elderly 
men respond to resistance exercise with increased release of anabolic hormones. Despite this increase, 
total growth promoting hormone level will still be significantly lower compared to younger adults. 
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Long-term resistance exercise is sufficient at increasing muscle strength but not back to the levels 
achieved in young adults. McCartney et al. (1995) investigated the effects of 42 weeks of progressive 
weight training on dynamic muscle strength in the elderly. A mean increase of up to 65% in one rep max 
performance was reported independent of gender, yet 47% of this increase had occurred after 12 weeks. 
The study also reported an increase in muscle CSA. Further evidence by Pyka et al. (1994) showed a 
plateau in the gains in strength after 3 months in elderly subjects undertaking resistance exercise. These 
findings support the earlier hypothesis that ageing is an inevitable effect and that a reduction in physical 
activity works as a substantial accelerator of this process. 
Ergogenic Effects of Caffeine in the Aged 
With what is presented in the literature regarding the age associated reduction in skeletal muscle 
performance and the likely mechanisms, particularly alterations in fiber type composition and changes in 
Ca2+ handling, the question now posed is; does ageing effect the ergogenic properties of caffeine when 
directly applied at the skeletal muscle?  
It is believed that in the elderly caffeine is metabolised in the same way as in young adults. However, due 
to changes in body composition a dose of caffeine consumed in the elderly will result in a higher plasma 
concentration. Caffeine is only distributed through lean body mass and ageing is associated with an 
increased adipose tissue to lean body mass ratio (Massey, 1998). Ageing affects all major physiological 
systems and little research has been conducted to investigate how the effect of caffeine supplementation 
changes with declining muscular function in aged populations.  
Rees et al. (1999) reported significant reductions in psychomotor and cognitive performance with age; 
however, significant improvements were established after caffeine treatment which tended to be greater 
in the older subjects. The study reported that caffeine treatment in the elderly was efficient at offsetting 
the deficit in psychomotor and cognitive performance, in some tests, when compared to younger 
participants. As with young adults (Pincomb et al. 1985), Conard et al. (1982) reported significant 
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increases in blood pressure but no concurrent positive inotropic on the heart with caffeine treatment in 
elderly men. 
A study by Norager et al. (2005) is the only study with any substance to assess the effects of caffeine 
supplementation on exercise performance in the elderly. They reported significant increases in cycling 
endurance (25%) and arm flexion endurance (54%), coupled with a reduction in RPE after 6mg/kg caffeine 
consumption in men and women aged over 70. No significant difference was found in muscle strength, 
walking speed and reaction time. Norager et al. (2005) noted that the increase in arm flexion was 
markedly higher than that seen in an earlier study on younger individuals. 
The effect of caffeine on exercise performance of the aged is a pertinent area with the growing number of 
physically active elderly citizens and those completing rehabilitation programs. The research planned for 
study 4 and 5 will be the first to provide an insight into the direct effects of physiological concentration of 
caffeine on aged skeletal muscle. As we have established the muscle physiology is markedly different in 
the elderly and we will be the first to asses if the ergogenic is still applicable for the elderly and to what 
extent the changes through ageing.  
Assessment of Skeletal Muscle Ageing 
Although muscle atrophy and a loss of strength are generally accepted as an inevitable concomitant of 
ageing, research is limited as to whether skeletal muscles used for different functions age at the same 
rate. This study aims to use isolated mouse EDL, as an example of a fast, voluntary activated, peripheral 
locomotor muscle, compared directly against diaphragm, a mixed fiber type, primarily involuntary 
innervated, core muscle used in respiration, to investigate this hypothesis. 
Voluntary Innervated Locomotory Muscles (EDL) 
Brooks and Faulkner (1988) compared the contractile properties of skeletal muscle from young, adult and 
aged mice. They reported a significant reduction in tetanic force to 78% and 73% for EDL and soleus 
respectively. Further to this significant increase in activation and relaxation times were reported for the 
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soleus muscle only. Edstrom and Larsson (1987) further reported significant increases in twitch 
contraction and relaxation times in single motor units of isolated rat soleus with increasing age.  
Gonzalez et al. (2000) investigated the isometric force of single intact fibers from elderly mouse EDL and 
soleus muscle. The study concluded a significant reduction in normalised force for both EDL and soleus 
that was more greatly pronounced in the predominantly fast twitch EDL. Later work by Gonzalez and 
Delbono (2001) investigated the relationship between age and isometric endurance, again using 
repetitive stimulation of single intact fibers from mouse EDL and soleus. The study concluded that age did 
not significantly affect the endurance of EDL and soleus muscle fibers irrespective of stimulation 
paradigm. Using similar methods Chan and Head (2010) further reported an age related reduction in the 
force generating capacity, an increase in twitch activation time, and a reduced fatigability in EDL of both 
male and female rats. Interestingly the aged muscle preparations showed no significant difference in 
muscle mass for female rats and an increase in EDL mass in male rats. This therefore indicates that the 
ageing response occurs before the establishment of muscle atrophy. 
As with the majority of the literature examining sarcopenia, discrepancies in results can be largely 
attributed to differences between subject groups used and what is deemed as aged. Also reports of 
fatigue are subjective to what the authors deem as a substantial drop in muscle performance; particularly 
during in vitro research the idea of muscle fatigue has not been accurately defined. 
Primarily Involuntary Innervated Respiratory Muscles (Diaphragm) 
Dilation of the alveoli, decreased surface area for gas exchange, and a reduction in the static and elastic 
recoil of the lung are a sample of the mechanisms that increase the work of breathing in the elderly 
(Janssens, 2001). In a human model Poley et al. (1997) measured transdiaphragmatic pressure during a 
maximal sniff test in order to test the contractile properties of elderly human diaphragm. Poley et al. 
(1997) concluded a small (13%) but significant reduction in diaphragm strength. This is supported by a 
reduction in maximal isometric tension reported by Zhang and Kelsen (1990) that used isolated strips of 
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diaphragm comparing ageing golden hamsters. The importance of physical activity has been shown to 
significantly enhance respiratory muscle strength in the elderly. Summerhill et al. (2007) compared 
inspiratory and expiratory pressures and diaphragmatic thickness in subjects over 65 that were physically 
active against those who were inactive. The diaphragm thickness and inspiratory and expiratory pressures 
were greater in the active group. 
As previously mentioned, physical inactivity in relation to ageing is a major contributor to muscle 
degeneration. This is likely to occur in soleus and EDL as these muscles are innervated voluntarily for 
whole body locomotion. On the other hand breathing occurs at a far more maintained rate with ageing 
and the diaphragm will be innervated to a greater extent. Therefore the level of decrement in muscle 













2. Aims and Hypotheses of the Research 
The rational for each study is discussed briefly in the general introduction and is explained in much 
greater depth in the introduction of each corresponding chapter. 
Study 1 (Chapter 4)-Effect of Physiological Concentrations of Caffeine on the Power Output of Maximally 
and Sub Maximally Stimulated Mouse EDL (Fast) and Soleus (Slow) Muscle  
Aims 
To answer the following questions: 
1. Are the effects of physiological concentrations of caffeine (70µM) different between muscles of 
predominantly different muscle fiber types (i.e. relatively fast EDL muscle versus relatively slow 
soleus muscle)? 
2. Is the magnitude of the caffeine response increased if the muscle is stimulated sub maximally 
rather than maximally? 
3. Does the ergogenic benefit of caffeine change over a range of physiological concentrations (35-
140 µM)? 
Hypotheses 
1. Both mouse EDL and soleus muscle will demonstrate a direct force potentiation in response to 
70µM caffeine treatment. 
2.  The effect of caffeine will be greater in muscles with a predominantly slow fiber type 
composition (e.g. soleus muscle). 
3. 70µM caffeine treatment will induce a greater force potentiating effect in muscle stimulated at a 
sub maximal intensity when compared with muscle stimulated at maximal intensity. 
4. There will be no dose dependant effect of caffeine treatment when used over a physiological 
concentration range. 
 70 
5. Regardless of concentration, the direct response of skeletal muscle to caffeine will be subject to 
individual variation between preparations. Furthermore there is likely to be subgroups of 
responders and non-responders to the caffeine treatment. 
Study 2 (Chapter 5)-Does a Physiological Concentration of Caffeine (70µM) Affect Endurance In 
Maximally or Sub Maximally Stimulated Mouse Soleus (Slow) Muscle? 
Aims 
To answer the following questions: 
1. Does the treatment of mouse soleus muscle (relatively slow fiber type) with 70µM caffeine 
improve muscle endurance? 
2. Are the caffeine-induced effects different when compared to previously studied mouse EDL 
muscle (James et al. 2005)? 
3. Does the effect of caffeine on muscle fatigue resistance differ between maximal and sub maximal 
stimulation? 
Hypotheses 
1. Treatment of mouse soleus muscle with 70µM caffeine will significantly enhance muscle 
endurance. The effect will be different to that shown in EDL muscle where muscle endurance was 
unchanged following caffeine treatment (James et al. 2005). 
2. The caffeine-induced enhancement of endurance will be significantly greater in sub maximally 




Study 3 (Chapter 6)- Does a Physiological Concentration of Taurine Increase Acute Muscle Power 
Output, Time to Fatigue and Recovery in Mouse Soleus (Slow) Muscle With or Without the Presence of 
Caffeine? 
Aims 
To answer the following questions: 
1. Does the direct treatment of mouse soleus muscle with physiologically relevant concentrations of 
taurine significantly enhance maximal muscle force, endurance or the ability of the muscle to 
recover from fatigue? 
2. Does taurine interact with physiological concentrations of caffeine to significantly enhance the 
ergogenic effects of caffeine? 
3. Will the direct treatment of mouse soleus with physiologically relevant concentrations of caffeine 
significantly enhance the ability of the muscle to recover from fatigue? A comparison of the effect 
of caffeine on the recovery of EDL in an earlier study by James et al. (2004).  
Hypotheses 
1. Treatment of isolated muscle with physiological concentrations of taurine will not significantly 
improve maximal muscle power output, endurance, or the ability of the muscle to recover from 
fatigue. 
2. Taurine when combined with 70µM caffeine will not significantly potentiate the effects of 70µM 
caffeine alone. 
3. In contrast to James et al. (2004) where mouse EDL muscle was used, the direct treatment of 
soleus muscle with physiologically relevant concentrations of caffeine may provide a small 
enhancement in the recovery of muscle power output following fatigue. 
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Study 4 (Chapter 7)-Is the Age Related Decline in Skeletal Muscle Function Muscle Specific? The Effect of 
Ageing on isolated Locomotory (EDL) and Respiratory (diaphragm) Skeletal Muscle Performance   
Aims 
1. To examine the muscle specific ageing and development of muscle mechanical properties 
2. To compare the effects of ageing between muscles with predominantly different fiber type 
compositions, anatomical function and location (EDL versus Diaphragm). 
Hypotheses 
1. The rate of muscle development and the reduction in performance due to ageing will be muscle 
specific. 
2. Diaphragm muscle will reach physiological maturity faster than EDL due to its importance in 
respiratory function and thus potentially highlighting a hierarchy of muscle development. 
3. The age related reduction in maximal muscle power output (and corresponding muscle activation 
and relaxation time) will be greater than the reduction in maximal force. 
4. The effect of ageing on fatigue resistance will be muscle specific; generally muscle will show a 
decrease in the ability to maintain force 
 
Study 5 (Chapter 8)-Does the Ergogenic Benefit of Caffeine Change with Age? The Effect of Physiological 
Concentrations of Caffeine on the Power Output of Maximally Stimulated Mouse EDL and Diaphragm 
Muscle  
Aims 
1. To examine the direct effect of physiologically relevant concentrations of caffeine on isolated 
skeletal muscle from development and with increasing age. 
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2. To assess if any potential change in the ergogenic benefit of caffeine is muscle specific (EDL versus 
Diaphragm). 
3. To uniquely examine whether the direct effect of physiological concentrations of caffeine can 
significantly enhance diaphragm muscle power output and thus potentially improve respiratory 
performance. 
Hypotheses 
1. The direct treatment of muscle with 70µM caffeine will significantly enhance muscle power 
output in developing and ageing muscle. 
2. The level of caffeine response will be significantly reduced in developing muscle, will peak at 
physiological maturity, and again decrease with increasing age. 
3. The sensitivity of skeletal muscle to70µM caffeine treatment will be muscle specific and during 












3. General Methods 
Animals 
The ethics committee of Coventry University approved the use of animals in the present series of studies. 
In all cases female white mice (strain CD1 mice, Charles River, UK) were used and were bred and kept in 
house at Coventry University. Unless stated otherwise, animals were housed in groups of 8-10, were kept 
on the same diet (STF maintenance diet and water ad libitum) throughout the duration of this body of 
work, and were subjected to 12 hour light-dark cycles. A qualified vet checked all animals regularly and 
any animals deemed unhealthy were removed. 
Mice selected for experimental use were weighed and then killed by cervical dislocation in accordance 
with British Home Office Animals (Scientific Procedures) Act 1986, Schedule 1.The hind limbs of each 
mouse were skinned and the limb with the target muscle removed and put into refrigerated (4°C) 
oxygenated (95% O2; 5% CO2) Krebs-Henseleit solution of composition (mM) NaCl 118; KCl 4.75; MgSO4 
1.18; NaHCO3 24.8; KH2PO4 1.18; glucose 10; CaCl2 2.54; pH 7.55 at room temperature (James et al. 
2005). 
Skeletal Muscle Dissection and Preparation 
The limb with the target muscle or the rib cage with the full diaphragm muscle intact, was then pinned 
out at approximately its resting length in fresh and frequently changed oxygenated Krebs-Henseleit 
solution at room temperature (19-24oC). Generally, for each muscle preparation the tendon and a small 
piece of bone were left attached at the proximal and distal ends. As shown in Figure 3.1 aluminium foil T-
clips were wrapped around each tendon leaving the bone at the back of the clip to help minimise tendon 
slippage when the muscle is producing force (James et al. 2005). The aluminium foil T-clips were used to 









Figure 3.1. Preparing the muscle isolation - The muscle was isolated with the tendon and a small piece of 
bone intact at the proximal and distal ends. Aluminium clips were attached around the tendons by folding 
the T-Pieces to prevent tendon slippage and to subsequently secure the preparation within the muscle 
bath. 
Experimental Set-Up (Figure 3.2.) 
The experimental set-up is a custom designed muscle rig that allows alterations in muscle stimulation 
parameters and length, permitting not only the measurement of isometric force, but dynamic power 
output (i.e. work loops). Once dissected the muscle preparation was attached using the foil T-clips to a 
25g force transducer (UF1, Pioden Controls Ltd, UK) and a motor (V201, Ling Dynamic Systems, UK) via 
crocodile clips in the muscle bath. Position of the motor arm was detected via a Linear Variable 
Displacement Transformer (DFG5.0, Solartron Metrology, UK). Changing the distance between the force 
transducer and the motor altered muscle length inside the muscle bath. Peristaltic pumps maintained a 
constant flow of oxygenated Krebs-Henseleit solution into the muscle bath at a physiological temperature 
(36-37oC). Krebs was pumped from a reservoir of Krebs where the target temperature was maintained via 
a heater/cooler bath (Grant LTD6G, Grant Instruments Ltd, UK). The temperature inside the bath was 
continuously measured with a digital thermometer (Checktemp C, Harvard Apparatus, UK). The force 
transducer measured the force the muscle produced during electrical stimulation and the signal from the 
 76 
force transducer was fed, via the rig box, to the oscilloscope to provide a visual representation, and to the 
PC running the custom written Testpoint software (Testpoint, CEC, Massachusetts, USA), via the data 
acquisition board(KPCI3108, Keithley Instruments, Ohio, USA). The muscle preparation was electrically 
stimulated via the parallel platinum electrodes in contact with the circulating fluid; the stimulation 
amplitude was controlled by the Thurlby. The rig box processes and amplifies the force and length signals, 
the oscilloscope is used for a rapid check of both force and length signals and during isometric studies it is 
used to measure maximal twitch and tetanus force and tetanus times. A PC running the Testpoint 
software controlled the variables of stimulation and length. These parameters were muscle specific and 
greater detail of this and the specific experimental protocol are discussed at length in each chapter. 
















Peristaltic Pump  Peristaltic Pump  
Relay 
 
Force Transducer Motor 





Calibration of the Force Transducer 
The force transducer was regularly calibrated by hanging known weights from it. Once these weights 
were applied, the change in electrical signal was measured on the oscilloscope and the data plotted 
as in Figure 3.3. Determining the slope and intercept of this data allowed the calculation of the 
calibration (in mN/V) of the force transducer. 
 
Figure 3.3. - Calibration of the force transducer; y = force production (dependant variable); x = 
voltage recorded on the oscilloscope (independent variable) 
Mechanical Measurements of in vitro Skeletal Muscle Performance 
10 minutes prior to the commencement of testing the muscle was allowed to equilibrate to the new 
environment. The primary mechanical measures of isolated muscle performance in the present 
research consisted of isometric and work loop assessments. Initially each muscle was subjected to a 
single stimulus to evoke a twitch response; muscle length and stimulation amplitude(generally 12-
16V for soleus; 14-18V for EDL; 10-16V for diaphragm) were varied until maximal twitch force was 
produced. The duration of electrical stimulation (generally 320 ms for soleus; 200 ms for EDL, 250ms 
for diaphragm) and the stimulation frequency (generally 140Hz for soleus and diaphragm; 200Hz for 
EDL) were then increased to evoke a maximal tetanic force response. A 5 minute rest period was 
y = 0.0049x - 0.0079 


























imposed between each tetanus in order to ensure the muscle had sufficient recovery time. Figure 
3.4.demonstrates the effect of increasing stimulation frequency on isometric tetanus response. 
Using this isometric force trace, measurements of activation time (time to half peak tetanus; THPT) 
and relaxation time (time from last stimulus to half tetanus relaxation; LSHR) were made. The 
stimulation amplitude, duration of electrical stimuli and stimulation frequency that elicited maximal 
tetanic response was muscle specific and is defined in each experimental chapter.  
The muscle length that corresponded to maximal isometric twitch and tetanus force was measured 
using an eyepiece graticule fitted to a microscope and was defined as L0.Mean muscle fiber length 
was calculated as 85% and 75% of L0 for soleus and EDL muscle respectively (James et al. 1995), this 
is generally used as an estimation of fiber length. As no such estimate of fiber length exists for 
diaphragm the physical measurement taken was used as L0.The optimal length for force generation 
under isometric contraction may not directly correspond to the optimal length for maximal net work 
generated by the work loop technique; however this measurement has been used as an estimation 
in previous work loop studies (Josephson, 1985: Askew et al. 1997; James et al. 1995; 1996; 2004; 
2005; Vassilakos et al. 2009).  
The work loop technique assesses the ability of the muscle to produce power whilst undergoing 
cyclical length changes (Josephson; 1985; James et al. 1996; 2005). Here the muscle was held at L0 
and the stimulation amplitude and frequency parameters that yielded maximal tetanic force were 
employed. Via movement of the motor arm each muscle was subjected to four sinusoidal length 
change cycles per set at a total symmetrical strain of 0.10, thus the muscle lengthened by 5% from L0 
followed by a shortening to 5% shorter than L0 before returning back to L0.Length change cycle 
frequency, electrical stimulation phase and burst duration were optimised to produce maximal work 
loop power. Typically the cycle frequency and strain employed were a gained from estimates of the 
values that elicit maximal power and/or are attainable in vivo as suggested in previous research 




Generally a burst duration of 100ms was found to elicit maximal power output in EDL, consistent 
with the findings of James et al. (2004; 2005). The burst duration dictates the number of stimuli that 
the muscle receives during the work loop; optimising this duration maximises power output.  
Commanlya burst duration of 65 ms was found to elicit maximal power output in soleus, consistent 
with the findings of James et al. (2004; 2005) and Vassilakos et al. (2009). However, on occasions 
when subjecting soleus to a submaximal stimulation frequency (i.e. 40Hz), the burst duration was 
lengthened to 76 ms adding a further stimulus during the shortening phase of the work loop.  This 
adjustment was determined by examining power output values. If the muscle is was too active 
during lengthening there is greater resistance to elongate the muscle back to resting length and 
therefore a decreased net power output. The strain of 0.10 was fixed for all experiments and was 
based on previous estimations of the strain required for production of maximal power in the muscle 
preparations used in the present thesis (Altringham and Young, 1991; James et al. 1995; Vassilakos 
et al. 2009). The stimulation phase shift dictates that stimulation of the muscle starts 10 ms prior to 
the muscle reaching maximal length, therefore with a stimulus duration of 65ms in soleus, 
stimulation continues until 45 ms prior to the muscle reaching its shortest length. 
In order to measure muscle power output, the muscle was subjected to four work loop sets. 
Commonly the second loop of each set of four work loops was used as an indicative measure for 
each trial as it produced the highest work. Following optimisation of the length and stimulation 
parameters, these variables were kept constant and a 10-minute rest between each trial was 
enforced in order to allow maximal recovery time (James et al. 2004). The specifics of each 
experimental protocol to examine the ergogenic effect of caffeine on muscle power output are 
explained in depth in each experimental chapter. 
Data were sampled at a rate of 10 kHz and then a work loop was formed, by plotting force against 
length, the area of which represents the net work done by the muscle during a single length change 














































shown in Figure 3.4. The use of the isometric and work loop techniques, as well as the specific 
protocols for each experiment are explained in much greater depth in the individual studies within 





Figure 3.4. – Typical tetanus response following 320ms stimulation duration (A) and work loop shape 
at 5Hz cycle frequency (B) for mouse soleus muscle stimulated at 140Hz, 70Hz, and 40Hz stimulation 
frequency 
Muscle Mass Measurements and Dimension Calculations 
At the end of the experiment the tendons were removed leaving the muscle intact. Following this 
the muscle was blotted on tissue paper to remove excess fluid. The muscle was then placed on an 
electronic balance (Mettler Toledo B204-S, Zurich, Switzerland) to determine the wet muscle mass 
to the nearest 0.0001g. Mean muscle cross-sectional area was calculated from mean fiber length, 
muscle mass and an assumed muscle density of 1060 kg m-3 (Mendez & Keys, 1960). Isometric stress 
was calculated as force divided by mean muscle cross-sectional area. Muscle power output was 





























The Correction Factor  
Before the commencement of the experiments of the present thesis, initial investigation of the 
response of the isolated muscle preparations over time were made in order to assess if muscle 
power output was altered in a predictable manner. The results indicated (Figure 3.5.) a linear 
reduction in mean maximal soleus muscle power output over time that is largely attributed to a 
build-up of an anoxic core causing the slow death of the contractile proteins (Barclay, 2005). The 
predictable liner relationship demonstrated here forms the bases of the correction factor used in 









Figure 3.5. – Decrease in mean power output over time in non-treated mouse soleus muscle [Data 
represented as mean ± SE] n=6. A first order regression line was fitted to the data (y= -0.153x + 100.3; 
r2 = 0.996). 
In order to avoid deterioration in muscle performance masking the effects of caffeine, a 1st order 
regression equation was calculated using the control data and washout data to identify the linear 




determine theoretical control muscle power output for each time point during caffeine treatment 
(see example in Figure 4.3.3.). 
 
Figure 3.6. – A typical example of the decline in actual muscle power output where the regression 









y = -0.0904x + 100.31 
































4. The Effects of Physiological Concentrations of Caffeine on the Power Output of Maximally and 
Sub Maximally Stimulated Mouse EDL (Fast) and Soleus (Slow) Muscle  
Caffeine Improves Maximal & Submaximal Muscle Performance   
Modified from Publication in the Journal of Applied Physiology: 
Tallis, J., James, R.S., Cox, V.M., Duncan, M.J. (2012) 'The effect of physiological concentrations of 
caffeine on the power output of maximally and sub maximally stimulated mouse EDL (fast) and 
soleus (slow) muscle' Journal of Applied Physiology 112 64-71  

















The ergogenic effects of caffeine in human exercise have been shown to improve endurance and 
anaerobic exercise performance. Previous work has demonstrated that 70µM caffeine (physiological 
maximum) can directly increase mouse extensor digitorum longus (EDL) muscle power output (PO) 
in sprint like activity by 3%. Our study used the work loop technique on isolated mouse muscles to 
investigate whether the direct effect of 70µM caffeine on PO differed between: 1) maximally and 
different sub maximally activated muscle; 2) relatively fast (EDL) and relatively slow (soleus) muscles; 
3) caffeine concentrations. 70µM caffeine treatment resulted in significant improvements in PO in 
maximally and sub maximally activated EDL and Soleus (P <0.03 in all cases). For EDL the effects of 
caffeine were greatest when the lowest, submaximal, stimulation frequency was used (p<0.001). 
140, 70 and 50µM caffeine treatments resulted in significant improvements in acute PO for both 
maximally activated EDL (3%) and soleus (6%) (P <0.023 in all cases), however there was no 
significant difference in effect between these concentrations (P>0.420 in all cases). Therefore, the 
ergogenic effects of caffeine on power output were higher in muscles with a slower fiber type (P 
<0.001). Treatment with 35µM caffeine failed to elicit any improvement in PO in either muscle (P 
>0.72 in both cases). Caffeine concentrations below the physiological maximum can directly 
potentiate skeletal muscle power output. This caffeine induced increase in force could provide 
similar benefit across a range of exercise intensities with greater gains likely in activities powered by 
slower muscle fiber type.  









Caffeine (common name for 1,3,7-trimethylxanthine) is a powerful ergogenic aid that has been 
extensively studied for its effects in improving exercise capacity (Graham, 2001). In vivo and in vitro 
studies have found enhancements in endurance exercise performance, power, and fatigue recovery, 
accredited primarily to the effects of caffeine on the CNS (Kalmar & Cafarelli, 2004). Despite its 
documented popularity as a performance enhancer, aiding training and competition, caffeine 
presently still falls short of the World Anti-Doping Agency’s prohibited list (Word Anti-Doping Agency 
2011). Reviews by Graham (2001) and Davis and Green (2009) suggest that caffeine can enhance 
performance during endurance (activity lasting greater than 30 minutes), power and strength 
activities.  
Following ingestion, caffeine can be readily absorbed into the blood stream with peak plasma 
concentration occurring 30-60 minutes after ingestion (Lorist & Topps, 2003). Its hydrophobic nature 
allows free passage of caffeine across all biological membranes resulting in distribution throughout 
all the tissues of the body (Magkos & Kavouras, 2005). Caffeine is also able to diffuse from the 
cerebral circulation across the blood brain barrier, entering the cerebrospinal fluid in sufficient 
quantity to promote pharmacological effects (McCalll et al. 1982; Wilkinson & Pollard, 1993; 
Fredholm et al. 1999; George, 2000). Caffeine is considered to act centrally as a competitive 
adenosine receptor antagonist, increasing transmission via dopamine D2 receptors (Fredholm et al. 
1999; Snyder et al. 1981).  Lorist and Tops (2003) explored behavioural and performance responses 
to caffeine ingestion demonstrating an increase in response to stimuli, an elevated state of arousal 
and a decreased rate of perceived exertion. Caffeine has also been demonstrated to have a direct 
effect on skeletal muscle by acting as an adenosine receptor antagonist on A1 receptors directly on 
the skeletal muscle membrane and/or by binding to the RYR receptors of the SR resulting in altered 





 Early in vitro studies demonstrated the direct potentiating effects of caffeine on acute muscle twitch 
and tetanus force, however many of these studies used supraphysiological, millimolar, 
concentrations of caffeine which would be toxic to humans (Luttgau & Oetliker, 1967; Endo et al. 
1970; Huddart, 1968; Weber & Herz, 1986; Fredholm et al. 1999). The primary mechanism by which 
caffeine can promote enhanced force output in skeletal muscle is believed to be via interference of 
excitation contraction coupling (Davis & Green, 2009). It has been established that the specific 
mechanism of action is alteration of intramuscular ion handling, primarily via an increased 
concentration of Ca2+ within the intracellular space (Magkos & Kavouras, 2005). However, little is 
known about whether variation in physiological conditions, such as intensity of exercise and caffeine 
dosage, will alter the direct response of muscle to caffeine during human physical activities. 
Tarnopolsky & Cupido (2000) reported that 6 mg.kg-1 body mass (approximately 60µM in blood 
plasma) of caffeine enhanced involuntary evoked skeletal muscle force in human subjects at low, but 
not high stimulation frequencies. This was attributed to a potentiation of calcium release at lower 
stimulation frequencies promoting a greater influx of Ca2+ in the presence of caffeine. However, no 
previous in vitro study has directly tested isolated muscle to determine whether the enhancement of 
force and power production in skeletal muscle, due to caffeine treatment, is greater at lower 
stimulation frequencies. Such findings would be of practical benefit to athletes, as they would 
indicate the types of physical activities in which the ergogenic effects of caffeine were greatest. In 
the context of the present study it is considered that a lower stimulation frequencies, SR calcium 
concentration will be greater. In light of the conclusions of Tarnopolski and Cupido (2000) it is likely 
that caffeine will have a more pronounced effect on sub maximally activated muscle due to a greater 
potentiation of calcium release.   
James et al. (2004; 2005) were the first to test the effect of physiologically relevant concentrations 
of caffeine (70µM human in vivo maximum, Graham, 2001) using the work loop technique. They 
found a small but significant, 2-3%, increase in mean net power output in maximally activated 




caffeine treatments had no significant effect on delaying the onset of fatigue or enhancing fatigue 
recovery. Evidence from use of millimolar concentrations of caffeine (which would represent toxic 
blood plasma concentrations in man, Fredholm, 1999), has shown that potentiation occurs to a 
greater extent in relatively slower muscle e.g. soleus (Fryer & Neering, 1989; Rossi et al. 2001; 
Wondmikun et al. 2006). This has largely been accredited to differences in Ca2+ kinetic properties 
(Magkos & Kavouras, 2005). However, no previous study has tested whether there is a difference 
between muscle fiber types in the direct effect of physiological concentrations of caffeine on power 
output. A dose dependant effect on direct muscle performance has further been demonstrated with 
high 0.07-20 millimolar concentrations of caffeine (Fryer & Neering, 1989; James et al. 2005), 
however this response has not been investigated over physiologically relevant caffeine 
concentrations, therefore, there are currently no studies to indicate the dosage of caffeine required 
for humans to maximise power output in muscle during physical activity. 
The present study aims to investigate whether maximal physiological concentrations (70µM) of 
caffeine directly affect the power output of isolated skeletal muscle during brief bouts of cyclical 
activity, being the first such study to compare between: 1) maximally and sub maximally activated 
muscle; 2) relatively fast extensor digitorum longus (EDL) and relatively slow soleus muscles; 3) a 
range of concentrations (35-140µM) of caffeine. In light of the previous research it is hypothesised 
that muscle power output of both EDL and soleus muscle will be increased in response to 70µM 
caffeine treatment, and there will be no dose dependant effect when used over a physiological 
range. Furthermore the performance enhancing effect of caffeine will be greater in soleus muscle 
compared to EDL. Finally it is considered that stimulating muscle at a submaximal intensity in the 





4.3. Materials and Methods 
A more detailed account of the methods is given in the general methods section (chapter 3). 
Soleus and EDL muscle were isolated from the right hind limb of 8-10 week old mice (body mass = 
30.2 ± 0.81g, mean ± SE, n = 108). Once placed in to the muscle rig, isometric studies were 
conducted. Muscle length and stimulation amplitude were optimised (12-16V for soleus; 14-18V for 
EDL) to produce maximal isometric twitch force. Following this, at a pre-determined burst duration 
(320 ms for soleus; 200 ms for EDL); stimulation frequency was optimised to induce maximal 
isometric twitch force (normally 140Hz for soleus; 200Hz for EDL). Tetanic responses were also 
measured at two submaximal stimulation frequencies (70 & 40Hz for soleus; 150 & 100Hz for EDL). 
The lowest stimulation frequency reduced muscle power output below 60% in both muscles. A 5-
minute rest period was imposed between each tetanus in order to ensure that the muscle had 
sufficient recovery time. 
The work loop technique was used to determine maximal and submaximal (stimulation frequencies 
140, 70 & 40Hz for soleus; 200, 150 & 100Hz for EDL) work loop power output at 5Hz cycle 
frequency for both soleus and EDL. 5Hz cycle frequency has previously been shown to elicit maximal 
power output in mouse soleus muscle and is attainable in running mice (Askew et al. 1997; James et 
al. 1995). 5Hz was also used for EDL preparations in order to enable a direct comparison with soleus 
muscles, however maximal power output for EDL is achieved at 10Hz cycle frequency (James et al. 
1995). 
In order to examine an acute effect of caffeine the muscle preparations were subjected to four work 
loops at 10-minute intervals over a 130-minute duration (Fig 4.3.1.).  A 10-minute rest interval was 
enforced between each set of four work loops, here, and throughout the remainder of the protocol, 
in order to allow ample time for recovery (James et al. 2004). The protocol consisted of three control 




Henseleit solution containing 70µM caffeine, concluding with a washout period of four 
measurements in standard Krebs-Henseleit solution (Fig 4.3.1.). In order to test for a possible 
interaction between caffeine and simulation frequency this procedure was repeated using 140, 70 or 
40Hz and 200, 150 or 100Hz stimulation frequencies for soleus and EDL respectively (n = 8 in all 
cases). To examine the effects of altered caffeine concentration the same procedure was followed, 
however the concentration of caffeine added to the Krebs-Henseleit solution was altered to 140, 50 
or 35µM (Fig 4.3.1.). i.e. caffeine concentration was reduced until no effect was demonstrated; we 
also wanted to determine if doubling the suggested physiological maximum would result in a greater 
response.. 
 
Figure 4.3.1. -  Schematic of the work loop protocol to examine the ergogenic effect of caffeine on the 
acute muscle power output of maximally and sub maximally stimulated mouse EDL and soleus 
muscle 
At the end of the experiment the muscle was detached from the rig, tendons removed, then 
weighed in order to calculate isometric stress (kN.m-2) and normalised muscle power (W.kg-1). 
Statistical Analysis of the Data 
Single factor analysis of variance (ANOVA) were performed in SPSS (Version 16, SPSS inc., IL, USA) in 
order to investigate the difference in isometric stress and work loop power between EDL and soleus 
muscles. Further single factor ANOVA’s were performed in order to examine the effect of 
stimulation frequency, before any caffeine treatment, on: isometric stress in soleus; isometric stress 




Prior to commencement of testing, muscle stress and power output at 140Hz, 70Hz and 40Hz for 
soleus and 200Hz, 150Hz and 100Hz for EDL were measured in all the preparations used. Two factor 
ANOVA’s (2x3 ANOVA’s) were conducted on this data to test for significant differences between 
stimulation frequencies and the caffeine treatment categories in which the preparations were 
subsequently placed. Therefore, stimulation frequency and caffeine treatment category were used 
as the fixed factors and power output as the dependant variable. Tukey post hoc tests were 
performed for stimulation frequency where any significant differences were found.   
Prior to testing the effect of 70µM caffeine over different stimulation frequencies, there was no 
significant difference in stress and power output between caffeine treatment categories in soleus 
and EDL (ANOVA p <0.65 in all cases) prior to caffeine treatment.  Prior to testing the effects of 
different caffeine concentrations there was no significant difference in stress and power output 
between treatment categories in EDL (ANOVA p = 0.723). In soleus the 50µM treatment group 
produced significantly more stress than 35µM group (ANOVA Tukey p<0.001), however there was no 
significant difference between any of the other treatment groups (Tukey p>0.505 in all cases). For 
soleus and EDL there was no significant difference in power output between the treatment 
categories (p=0.695 in both cases). A reduction in stimulation frequency resulted in a reduction in 
stress and power in all treatment groups for both EDL and soleus (ANOVA p<0.001 in all cases). 
Therefore it is fair to conclude the preparations were of similar quality prior to treatment. 
As explained in the general methods section (Chapter 3) a regression equation used to determine 
theoretical control muscle power output for each time point during caffeine treatment. The range of 
regression coefficients were R2 = 0.002-0.9972, the level of significance between these regressions 
varied between p < 0.001 - 0.883. Typically muscle preparations that demonstrated a degree of 
deterioration over time showed significant regression coefficients normally exceeding 0.8 (p<0.05 in 
each case). Preparations that were stable over time had low regression coefficients and the effect of 




A single factor ANOVA was conducted on each treatment group to determine any difference 
between prior treatment control and post treatment washout. For soleus and EDL muscles there was 
no significant difference between the prior and post treatment controls. Therefore, it is assumed 
that after the caffeine treatment the muscles returned to their previous state and any changes in 
performance during treatment were solely the effects of caffeine. These control data were pooled 
and subsequent analysis was conducted comparing caffeine treatment directly against controls.  
The effects of stimulation frequency (100Hz, 150Hz, 200Hz for EDL; 40Hz, 70Hz, 140Hz soleus) and 
caffeine treatment (70uM, control) on soleus power output were tested in 2-factor (3x2) ANOVA. 
The same statistical test was conducted in a separate 2-factor (3x2) ANOVA for the EDL muscle. In 
order to test for a significant effect of caffeine concentration a further 2 factor (2x3) ANOVA was 
conducted separately for soleus and EDL. Again power output was the dependent variable with 
caffeine treatment (70µM caffeine or control) and caffeine concentration as the fixed factors. A 
significant interaction between concentration and treatment was identified in EDL treated with 
70µM caffeine at different stimulation frequencies and both soleus and EDL treated with altered 
caffeine concentrations (two factor (2x3) ANOVA p<0.015 in all cases), therefore we conducted a 
single factor ANOVA on each treatment group to determine the effect of caffeine compared to 
control. 









EDL produced significantly greater maximum isometric stress and greater maximal WL PO than soleus 
(Table 4.4.1; single factor ANOVA main effect p<0.001 in both cases). Reducing stimulation frequency 
resulted in a significant reduction in isometric tetanic stress (to 87.8% and 66.4% of maximal for soleus 
when stimulated at 70 and 40Hz and to 91.1% and 69.6% of maximum for EDL when stimulated at 150Hz 
and 100Hz) for both soleus and EDL (Table 4.1.1; two factor (2x3) ANOVA main effect p<0.001 in both 
cases). A reduction in stimulation frequency also resulted in a significant decrease in maximum work loop 
stress (to 64.3% and 42.9% of maximum for soleus when stimulated at 70 and 40Hz and to 87.1% and 
59.5% of maximum for EDL when stimulated at 150Hz and 100Hz) in soleus and EDL (Table 4.1.1; two 
factor (2x3) ANOVA main effect p<0.001 in both cases).  
Table 4.4.1. – The mean effect of altered stimulation frequency on tetanus stress and work loop 
power in mouse EDL and soleus.   
Soleus 









Tetanus Stress (kN.m-2) 125.8±11 166.2±11.5 189.4±11.9 
Max Work Loop PO (W/kg) 13.6±1.2 20.4±1.9 31.7±1.8 
EDL 









Tetanus Stress (kN.m-2) 209±22.43 273.9±24.3 300.5±23.2 
Max Work Loop PO (W/kg) 50.7±5 74.2±6.4 85.2±7.1 





Effects of Stimulation Frequency and 70µM Caffeine Treatment on Muscle Power Output 
70µM caffeine treatment of soleus elicited significantly greater power output than controls in all cases 
(Figure 4.4.1; single factor ANOVA main effect p=0.02). Caffeine elicited a mean peak power output 
increase of 6.4%, 6.2% and 5.7% for 140Hz, 70Hz and 40Hz stimulation frequencies respectively. There 
was no significant difference in the effect of caffeine between stimulation frequencies (Figure 4.4.1; two 
factor (2x3) ANOVA main effect p=0.093). 
 
Figure 4.4.1. – The mean acute effect of 70µM caffeine on work loop power output in mouse soleus muscle 
at 140Hz, 70Hz, and 40Hz stimulation frequencies [Data represented as mean & SE] n=8 in each case. 
70µM caffeine treatment of EDL elicited significantly greater power output than controls (Figure 4.4.2; 
single factor ANOVA main effect p<0.005 in all cases). Caffeine elicited a mean increase in peak power 
output of 3.3%, 4.2%, and 6.7% for 200Hz, 150Hz and 100Hz stimulation frequencies respectively. There 
was no significant difference in the effect of 70µM caffeine between 200Hz and 150Hz (Figure 4.4.2; 
Tukey p=0.976). However, 70µM caffeine treatment elicited a significantly greater increase in PO at 100Hz 
compared to 200Hz and 150Hz (Figure 4.4.2; two factor (2x3) ANOVA Tukey p<0.005 in both cases).  The 






































transition between caffeine treatments in washout, is caused by altered environmental conditions due to 
altered solution. At these time points there is a period of a few seconds where the muscle is not fully 
saturated with solution and time is required for the temperature to equilibrate. 
A set of responders and a set of non-responders (those showing no noticeable improvement in response 
to treatment) were evident in soleus (Figure 4.4.3) and EDL (Figure 4.4.4) in all the treatment groups 
besides 100Hz sub maximally stimulated EDL. Caffeine treated EDL, stimulated at 100Hz, showed no 
obvious non-responders to the treatment (Figure 4.4.4C). 
 
Figure 4.4.2. – The mean acute effect of 70µM caffeine on work loop power output in mouse EDL  muscle 





































































































































Figure 4.4.3. – The acute effect of 70µM caffeine on work loop power output identifying the differences in 
response to caffeine between individual mouse soleus muscles at 140Hz(A), 70Hz(B), and 40Hz(C) 
stimulation frequencies. The magnitude of response to caffeine varies between individuals, with some 










































































































Figure 4.4.4. – The acute effect of 70µM caffeine on work loop power output identifying the differences in 
response to caffeine between individual mouse EDL muscles at 200Hz(A), 150Hz(B), and 100Hz(C) 
stimulation frequencies. The magnitude of response to caffeine varies between individuals, with some 












The Effect of 35, 50, 70 & 140µM Caffeine Treatment on WL Power Output 
Treatment of soleus muscle with 140µM, 70µM and 50µM caffeine resulted in a significant increase in 
maximal power of up to 6% (Fig 4.4.5 single factor ANOVA main effect p<0.015 in all cases). Treatment 
using 35µM caffeine failed to significantly increase soleus muscle’s maximal PO (Fig 4.4.5 single factor 
ANOVA main effect p= 0.072). There was no significant difference in the increase in PO between 140µM, 
70µM and 50µM caffeine treatments (Fig 4.4.5; two factor (2x3) ANOVA Tukey p< 0.473 in all cases).  
 
 
Figure 4.4.5. - The mean acute effect of 140, 70, 50 & 35µM caffeine treatment on work loop power 
output of mouse soleus muscle maximally stimulated at 140Hz stimulation frequency [Data represented as 
mean & SE] n=10 for 35, 50 and 140µM n=8 for 70µM. 
Treatment of EDL muscle with 140µM, 70µM and 50µM caffeine resulted in a significant increase in mean 
maximal power of up to 3.3% (Figure 4.4.6; single factor ANOVA main effect p<0.022 in all cases). 
Treatment using 35µM caffeine failed to significantly increase EDL muscles maximal PO (Figure 4.4.6; 





































between 140µM, 70µM and 50µM caffeine treatments (Figure 4.4.6; two factor (2x3) ANOVA Tukey p> 
0.421 in all cases).  
 
Figure 4.4.6. - The mean acute effect of 140, 70, 50 & 35µM caffeine treatment on work loop power 
output of mouse EDL muscle maximally stimulated at 140Hz stimulation frequency. [Data represented as 
mean & SE] n=10 for 35, 50, 140µM; n=8 for 70µM. 
As there was no significant difference in response between 140µM, 70µM and 50µM caffeine treatments 
these results were pooled and soleus was compared against EDL. Treatment of soleus muscles with 50µM 
- 140µM caffeine resulted in a significantly greater increase in power output (4.7%) compared to EDL 











































Figure 4.4.7. - The mean effect of caffeine treatment on acute maximal power output of mouse EDL and 
soleus muscle [140,70& 50µM data pooled for each muscle; Data represented as mean & SE; n = 28 in 





































The mean maximal isometric tetanic stress was 189 ± 12 kN m-2and 300 ± 23 kN m-2 for soleus and 
extensor digitorum longus (EDL) respectively (Table 4.4.1). This is similar to soleus but notably higher for 
EDL stresses previously reported by James et al. (1995; 2004) and Vassilakos et al. (2009) in studies using 
similar methods. The mean control maximal power output was 31.7 ± 1.8 W kg-1 and 85.2 ± 7.1 W kg-
1 (Table 1) again similar to the values reported by James et al. (1995; 2004), Askew et al. (1997) and 
Vassilakos et al. (2009). Any differences in stress and power output between studies could be attributed 
to muscle fiber type differences due to variation in strain and age of the mice and the environmental 
conditions at which they were kept. Variation in muscle mass and length will also affect the maximal 
stress and power that the muscle can achieve. 
The effects of 70µM caffeine on muscle power output at maximal and sub maximal stimulation 
frequencies. 
Treatment of mouse EDL and soleus muscle with 70µM caffeine elicited significantly greater net WL 
power output. A mean increase in soleus power output of approximately 6% occurred at each stimulation 
frequency (Fig 4.4.1). In EDL the caffeine induced enhancement of net power output decreased with 
increased stimulation frequency from 6.7% at 100Hz to 3.3% at 200Hz (Fig 4.4.2). The ergogenic benefit 
was not significantly different between stimulation frequencies in soleus, however a lower stimulation 
frequency (100Hz) produced significantly greater force in EDL compared to higher stimulation 
frequencies. Therefore, in EDL the effects of caffeine on power output were greater when the lowest, 
submaximal, stimulation frequency was used.  
A caffeine treatment induced elevation in muscle power output supports the finding of James et al. (2005) 
who also used a physiologically relevant 70µM caffeine concentration to treat maximally stimulated EDL. 
The 3.3% increase obtained in EDL in the present study using the same parameters is similar to the 2-3% 




soleus in the present study. These results from the present study suggest that in mammals physiological 
levels of caffeine treatment will directly induce small increases in power output in short term high 
intensity activity (e.g.100m sprint in athletics) however, it seems likely that caffeine will have greater 
ergogenic benefit during lower intensity sporting activities that are primarily powered by slow muscle 
fiber types. 
It has long been established that caffeine can alter excitation-contraction coupling (Magkos & Kavouras, 
2005). The mechanism by which this increase in power output has occurred in the present study can be 
attributed to the ability of caffeine to alter intramuscular ion handling. The mechanism for this action of 
caffeine is still unclear, however, it is believed that caffeine operates directly as an adenosine receptor 
antagonist on A1 receptors on the skeletal muscle membrane and/or binds to RYR receptors of the SR as 
shown in vitro with 10mM caffeine treatment and in RYR -/- mice (Damiani et al. 1996; Bhat et al. 1997; 
Fredholm et al. 1999; Rossi et al. 2001).  These processes probably result in a combination of improved 
opening of the RyR2 channels of the SR stimulating a greater release of Ca2+ into the intracellular space, 
an increase in myofibrillar Ca2+ sensitivity, a decrease in the sensitivity of the SR Ca2+ pump, and an 
increased SR Ca2+ permeability. Consequently the rate of Ca2+ efflux from the intracellular space back to 
the SR may be significantly slower resulting in a greater basal and activated intracellular Ca2+ 
concentration, hence increased relaxation time (Allen et al. 1989; Allen & Westerblad, 1995). The work 
loop shapes for both EDL and soleus (Fig 4.4.8) show that caffeine treatment caused a direct increase in 
muscle force during shortening, however, no appreciable change in relaxation time can be seen.  As the 
muscle was only subjected to 4 work loop cycles it is unlikely that the proposed increase in basal 
Ca2+ between stimulations will occur over this short time period. Fryer and Neering (1989) reported that 
the primary effect of caffeine (0.2 – 20 mM) on Ca2+ transient was an increase in basal and stimulus 
evoked release of Ca2+ accompanied by an elevation of the plateau phase leading to an increase in twitch 
and tetanus force in rat EDL and soleus. Magkos & Kavouras (2005) further suggested that if Ca2+ is 
released from SR at a quicker rate then this will result in quicker initiation of the Ca2+ induced 




initially allowing faster and greater availability of the actin binding sites due to a quicker movement of 
troponin-C, thus promoting greater formation of cross bridges and hence higher force production. 
Maintaining an elevated concentration of intracellular Ca2+ between stimulus intervals will result in a 
higher net quantity of calcium when the muscle receives further stimuli. Muscle force is dependent on the 
concentration of free Ca2+, thus a caffeine-induced elevation in this manner will result in greater force 
production. With an increased intracellular Ca2+ concentration and a decreased sensitivity of the SR Ca2+ 
pump the time required to regain intracellular resting concentration of Ca2+ and replenish the SR stores of 
Ca2+ will be significantly elongated (Allen & Westerblad, 1995).  
Figure 4.4.8. – Typical effects of caffeine treatment on work loop shapes in mouse EDL (A) and soleus (B) 
stimulated maximally at 5Hz cycle frequency [solid line = control work loop; dashed line = caffeine treated 
work loop] 
Generally in vivo and in vitro studies report the benefit of caffeine as a group mean (Allen & Westerblad, 
1995; James et al. 2004; Norager et al. 2005; Bridge& Jones, 2006), however a degree of inter-individual 
variability in response is common and studies have shown that not all individuals show a performance 
improvement (Bridge & Jones, 2006; Davis & Green, 2009; James et al. 2005). In the present study there 
were also individual muscles that showed no appreciable change in power output in response to caffeine 
(Fig 4.4.3 & 4.4.4). To the authors knowledge caffeine has not been demonstrated to cause a reduction in 
acute muscle force, therefore from a human perspective, micromolar concentrations of caffeine in human 




Tarnpolsky & Cupido (2000) suggested that at a sub maximal stimulation frequencies caffeine would 
promote greater release of Ca2+. The present study doesn’t fully support this finding, as there were no 
significant increases in soleus muscle power output with decreased stimulation frequency. EDL showed a 
similar response when 200Hz (maximal) was compared against 150Hz, however, a significant 
enhancement in muscle power did occur at 100Hz. For this treatment group there appeared to be no ‘non 
responders’ to the caffeine treatment (Fig 4.4.4; C) hence the mean increase in power output was 
significantly higher than at 200Hz and 150Hz. As the precise mechanism of the action of caffeine is still 
unknown we are unable to suggest that a greater number of responders occur at lower stimulation 
frequencies. Overall our findings suggest that there is a limit to the level of calcium influx that caffeine 
promotes and further highlights the need for greater investigation into the mechanisms of the response. 
The effects of 35, 50, 70 and 140µM concentrations of caffeine on maximal force production 
140µM, 70µM and 50µM caffeine treatment resulted in significant improvements in mean power output 
of mouse soleus (up to 6%; Fig 4.4.5) and EDL muscle (up to 3.3%; Fig 4.4.6). There were no significant 
differences in the level of ergogenic benefit between each concentration. Treatment of soleus and EDL 
with 35µM caffeine failed to potentiate force. 
Human physiological concentrations of caffeine are very rarely above 70µM with common plasma levels 
being between 20-50µM (Fredholm et al. 1999; Graham, 2001). The present study indicates that there 
appears to be a threshold level of caffeine concentration, below which there is no response and above 
which there is no further effect of increasing concentration within the physiological range. The effect of 6 
or 9 mg.kg-1 body mass caffeine treatment on 2000m rowing performance was considered by Bruce et al. 
(2000). The Low dose caffeine trial resulted in a significant 1.3% improvement in time to complete the 
2000m whilst the high dosage resulted in a significant 1% improvement. Above the physiological range 
Fryer and Neering (1989) demonstrated a dose dependant potentiation of twitch force in EDL (1- 5 mmol 
l-1) and soleus (0.2 – 1 mmol l-1) fibers of rat. James et al. (2005) reported that fatigued mouse soleus and 




contractions with 10mM caffeine treatment compared to those treated with 70µM caffeine and controls 
in conjunction with the present findings these previous studies suggest there is no dose dependant effect 
of caffeine over the human physiological range. 
The effects of caffeine on different muscle fiber types 
The ergogenic benefit was significantly greater in mouse soleus (4.7%) compared to EDL (2.5%; Fig 4.4.7). 
This is comparable to previous evidence, using non-physiological concentrations of caffeine, where fast 
twitch fibers yielded a greater response to caffeine treatment than slow twitch fibers. Rossi et al. (2001) 
reported a greater response to 2-30mM caffeine concentrations in mouse soleus compared to EDL. Fryer 
and Neering (1989) further demonstrated that soleus was more sensitive to a lower dose (200µM) of 
caffeine compared to EDL. This can be attributed to muscle specific differences in Ca2+ kinetic properties 
and muscle specific expression of RYR isoforms between type I and II fiber types (Magkos & Kavouras, 
2005). Rossi et al. (2001) reported that mouse skeletal muscle RYR3 receptors have a greater sensitivity to 
caffeine than RYR1. It has been established that muscles with the greatest response have a greater 
quantity of RyR3. A higher quantity of RyR3 is evident in soleus muscle explaining the elevated response 
of soleus in the present study (Rossi et al. 2001).  
When relating these results in a broader context to human performance it should be considered that 
caffeine has a shorter half-life in rodents and differences in metabolism also occur between rodents and 
primates (Fredholm et al. 1999). Fibers treated with caffeine may in vivo be modulated to produce the 
same power as controls with the activation of fewer muscle fibers. In vivo the pattern of fiber stimulation 
along with length change waveforms are likely to be manipulated throughout movement in order to 
maximise muscle economy and prevent the onset of fatigue (Wakeling 2005). However, these differences 
are unlikely to affect the overall findings of the study. 
In conclusion physiological levels of caffeine (50 & 70µM) can directly enhance mouse soleus and EDL 




dependant effect on skeletal muscle when used over a relatively small concentration range (50-140µM). 
The current study shows that caffeine doses lower than the physiological maximum can produce 
significant improvements in muscle force. Treatment with 35µM caffeine showed no appreciable change 
in the power output of either soleus or EDL, therefore it is assumed that a relatively high concentration of 
caffeine is needed to evoke physiological benefit directly at the skeletal muscle. From the results of the 
current study it appears that the extent of caffeine-induced potentiation of power output is unlikely to 






















5. Does a Physiological Concentration of Caffeine (70µM) Affect Endurance in Maximally or Sub 
Maximally Stimulated Mouse Soleus (Slow) muscle? 
Modifeid from publication in The Jourmal of Physiological Sciences 
Tallis, J., James, R.S., Cox, V.M., and Duncan, M.J. (2013) 'The effect of a physiological concentration of 
caffeine on the endurance of maximally and submaximally stimulated mouse soleus muscle.' The Journal 
of Physiological Sciences 63 (2) 125-132. 


















The use of caffeine as an ergogenic aid to promote endurance has been widely studied, with human 
literature showing the greatest benefit during sub maximal muscle activities. Recent evidence from 
isolated muscle studies suggests that the acute treatment of skeletal muscle with physiological 
concentrations of caffeine (70µM maximum) will directly potentiate force production. The aims of the 
present study are: firstly to assess the effects of a physiological concentration (70µM) of caffeine on 
endurance in maximally activated mouse soleus (relatively slow) muscle; secondly to examine whether 
endurance changes when muscle is activated sub maximally during caffeine treatment. Maximally 
stimulated soleus muscle treated with 70µM caffeine resulted in a significant (17.6%) decrease in 
endurance. In contrast, at a sub maximal stimulation frequency caffeine treatment significantly prolonged 
endurance (by 19.2%).Findings are activation dependent such that during high frequency stimulation 
caffeine accelerates fatigue, whereas during low frequency stimulation caffeine delays fatigue. 














The ergogenic effect of caffeine in man has been studied extensively and performance-enhancing effects 
have been clearly established in endurance, strength, and power based activities (Graham 2001, Davis & 
Green 2009). Recent work by James et al. (2004; 2005) and Tallis et al. (2012: Chapter 4) have 
demonstrated a direct effect of physiologically relevant (70µM) caffeine concentrations on isolated 
mammalian muscle. However, further investigation is needed in order to assess the direct effects of 70µM 
caffeine on skeletal muscle endurance.  
Skeletal muscle fatigue is defined as a reduction in force generating capacity associated with muscle 
activity, and is further associated with a reduced relaxation rate and changes in the force-velocity 
relationship (Fitts 1994; Askew et al. 1997). The aetiology of muscle fatigue is influenced by the intensity 
and duration of physical activity and mechanistically arises from a combination of central and peripheral 
physiological actions (Allen et al. 2008; Favero 1999). The primary mechanism for the reduction in skeletal 
muscle force relates to a reduction in the efficiency of excitation-contraction coupling arising from a 
fatigue induced impairment in sarcoplasmic reticulum (SR) Ca2+ release and a reduction in myofibrillar 
sensitivity to Ca2+ (Fabiato & Fabiato 1978; Godt & Nosek 1988; Millar & Homsher 1990; Lamb et al. 1992; 
Allen et al. 1995; Allen et al. 2008).  
It has been proposed that caffeine may be effective at reducing skeletal muscle fatigue during human 
endurance based activities via a reduction of the effects brought on by fatigue (Graham 2001, Magkos & 
Kavouras 2005). Caffeine acts as an adenosine receptor antagonistic, specifically at the A1 receptors on 
the skeletal muscle membrane, but can also bind directly to ryanodine receptors (RYR) of the SR 
(Daminani & Margreth 1994; Fredholm et al. 1999; Rossi 2001). The treatment of isolated skeletal muscle 
with high, millimolar, concentrations of caffeine has been demonstrated to affect Ca2+ handling, primarily 
by inducing an increased Ca2+ concentration in the intracellular space (Allen et al. 1989; Allen & 




Many in vitro studies have demonstrated the direct force potentiating effect of caffeine using millimolar 
concentrations that would be toxic for human consumption (Luttgau & Oetliker 1967; Huddart 1968; 
Weber & Herz 1968; Endo et al. 1970; Damiani & Margreth 1994). Previous work by Tallis (chapter 4), 
James and co-workers (2004, 2005) was the first to show a direct force potentiating effect of caffeine 
using physiologically relevant concentrations (70µM maximum). However, the direct significance of such 
concentrations of caffeine on muscle endurance requires greater exploration (James et al. 2004; 2005; 
Tallis et al. 2012; (chapter 4) Damiani & Margreth 1994). 
The effects of 70µM caffeine on the time to fatigue on net power output of maximally stimulated mouse 
EDL (relatively fast) muscle has previously been determined by James et al. (2005), where treatment 
failed to elicit any significant effect. Tallis et al. (2012; chapter 4) was the first to demonstrate that 70µM 
caffeine treatment caused greater acute improvements in muscle force and power in soleus (relatively 
slow) when compared to EDL (6% and 3% improvements, respectively), however, it is not known whether 
micromolar caffeine can affect endurance in soleus muscle. The greater acute response of soleus muscle 
to caffeine suggests that caffeine treatment is more likely to offset the fatigue induced reduction in 
sarcoplasmic reticulum Ca2+ release in soleus than in EDL, which may result in a prolonged endurance. 
Therefore, the present study aims to build on the previous work by James et al. (2005) by assessing the 
effects of 70µM caffeine on the endurance of mouse soleus muscle. As the aetiology of fatigue is not only 
influenced by muscle fiber type but the intensity of activity, and slow oxidative fibers are of primary 
importance during prolonged submaximal exercise, this study will uniquely examine if the effect of 
caffeine is altered in soleus muscle fatigued at high compared with low frequencies of stimulation. 
Furthermore findings from Tarnopolsky & Cupido (2000) in a whole body human study, suggest that the 
ergogenic effect of caffeine may be greater at lower stimulation frequencies due to a greater potentiation 
of SR calcium release. Although no effect was observed in our previous work examining one off muscle 
power output (Tallis et al. 2012: Chapter 4), exposing the muscle to caffeine over prolonged contracture 




 James et al. (2005) further reported a reduced recovery from fatigue following the treatment of EDL with 
micromolar caffeine. Therefore, the effect of recovery from fatigue will be analysed in the present study 
in order to determine whether caffeine treatment reduces the subsequent recovery of mouse soleus 
muscle from fatigue. Caffeine treatment may potentially affect the post fatigue recovery of muscle power 
output due to a potential increase in muscle stiffness resulting in muscle damage (James et al. 2004). 
Furthermore, if caffeine treatment results in improved muscle performance the muscle will be working at 
a relatively greater intensity compared to controls and hence recovery may be prolonged.  
In contrast to the findings of James et al. (2005) (no effect of 70µM caffeine on maximally fatigued mouse 
EDL) the present study predicts that the treatment of mouse soleus muscle with 70mM caffeine will 
significantly enhance fatigue resistance. Furthermore it is suggested that the caffeine enhanced 














5.3. Materials and Methods  
A more detailed account of the methods is given in the general methods section (chapter 3). 
Soleus muscle was isolated from the right hind limb of 8-10 week old mice (body mass = 30 ± 1.6g, n = 32). 
Once dissected the muscle was placed in the muscle bath and circulated with oxygenated Krebs-Henseleit 
solution at 36±0.4oC. Muscle length and stimulation amplitude (12-16V) were optimised to elicit maximal 
isometric twitch force.  Maximal isometric tetanic force was measured by subjecting the preparation to a 
burst of electrical stimuli (320 ms) at a pulse width of 1.5 ms. Stimulation frequency was optimised to 
yield maximal tetanic force (usually 140Hz), by measuring the response over a stimulation frequency 
range (100Hz-160Hz). Following this the tetanic force response was measured at two sub maximal 
stimulation frequencies (40 and 70Hz). A 5-minute rest period was imposed between each tetanus in 
order to ensure that the muscle had sufficient recovery time. Isometric tests were carried out in the same 
way on all muscle preparations used in this investigation. Thereafter, each muscle preparation was 
subjected to work loop experiments. 
Prior to the fatigue protocol, muscle power output was measured using the work loop technique at 
stimulation frequencies that yielded maximal (140Hz; high) and sub maximal (40Hz; low) power in all the 
preparations used at the previously defined parameters.  As in chapter 1, during work loop experiments 
soleus muscle power was measured at 5Hz cycle frequency using a strain of 0.10, and a fixed phase shift 
of -10ms. Each muscle was subjected to sets of four work loops at 10-minute intervals; the second loop of 
each set of four was used as an indicative measure of performance. A 10-minute rest interval was 
enforced between each set of four work loops, here, and throughout the remainder of the protocol, in 
order to allow ample time for recovery (James et al. 2004). The fatigue protocol was then conducted at 
one of either maximal (140Hz) or sub maximal (40Hz) stimulation frequency, and was composed of four 
distinct phases, the control phase, the treatment phase, the fatigue run, and the recovery phase, lasting a 
total of 130 minutes (four work loops at 10 minute intervals – Fig 5.3.1.). During the control phase (30 




output were made in order to determine the stability of the preparation (Fig 5.3.1.). Immediately after the 
control phase, during the treatment phase (40 min), the circulating fluid was changed to Krebs-Henseleit 
solution containing 70µM caffeine and a further 3 assessments of muscle power output made (Fig 5.3.1.).  
10 minutes later, whilst the muscle was still incubated in 70µM caffeine, the muscle was subjected to a 
fatigue run. Here all muscle preparations were subjected to 200 consecutive work loops at a cycle 
frequency of 5Hz using the same stimulation parameters as used in the rest of the protocol. A fatigue run 
of 200 work loops cycles was chosen in order to ensure that the muscle had sufficient time to fatigue until 
no net positive work was produced. Regardless of when fatigue occurred, all muscles were subjected 
equally to 200 consecutive loops. Endurance was defined as the time until each muscle preparation failed 
to produce net positive work. Subsequently muscle power output was recorded for every second loop 
until the muscle produced net negative work (i.e. work produced during shortening was less than the 
work required to re-lengthen the muscle), consequently statistical analysis for endurance uses this data 
(Figure 5.4.1). Forty minutes of caffeine treatment was allowed prior to the fatigue run in order to allow 
sufficient time for each preparation to reach its peak response to the caffeine treatment (James et al. 
2005; Tallis et al. 2012; chapter 4). Typical work loop shapes at fixed time points during the fatigue run 
were plotted in order to make comparisons of the mechanical characteristics of the preparations between 
control and treatment muscle (Figure 5.4.3). The experiment concluded with 6 measurements (60 min) of 
power output in standard Krebs in order to monitor recovery of the muscle preparation post fatigue 
(Figure 5.4.3). In order to provide an experimental control the same protocol was followed, however, the 
muscle was incubated in standard Krebs-Henseleit throughout this recovery period. During the fatigue 
protocol each muscle preparation was used in only one experimental condition (control or treatment) and 









Figure 5.3.1. -  Schematic of the work loop protocol to examine the ergogenic effect of 70µM caffeine on 
the fatigability of maximally and sub maximally fatigued mouse Soleus muscle  
At the end of the experiment the muscle was detached from the rig, tendons removed, then weighed in 
order to calculate isometric stress (kN.m-2) and normalised muscle power (W.kg-1). 
Statistical Analysis of the Data 
Single factor analysis of variance (ANOVA) was performed in SPSS (Version 16, SPSS inc., IL, USA) in order 
to investigate the effect of stimulation frequency on isometric stress and work loop power in all muscle 
preparations used in the study. Single factor ANOVA with Tukey post hoc tests were used to test for 
differences in pre-treatment isometric stress and work loop power output between each experimental 
group (Pre-treatment muscle stress and power output for 140Hz and 40Hz were compared between 
muscles to be used in the control protocol and muscles to be used in the treatment protocol).  
A two factor ANOVA was used to determine if the fatigue run induced a significant reduction in muscle 
power output over time and to assess whether this effect was significantly different between treatment 
groups. Tukey post hoc tests were conducted in order to assess whether endurance was significantly 
different between; 140Hz and 40Hz controls; 140Hz control and 140Hz caffeine; 40Hz control and 40Hz 
caffeine. As caffeine treatment was shown to have a significant effect on endurance, two-sample t-tests 
were conducted (Microsoft Excel 2007 version) at each time point for the same stimulation frequency in 




muscles at the same stimulation frequency (i.e. 2 t-tests at each time point; 40Hz control compared with 
40Hz caffeine treated; 140Hz control compared with 140Hz caffeine treated). 
A two factor ANOVA with Tukey post hoc tests was conducted on the data post the fatigue run in order to 
test for significant differences in the muscle’s ability to recover from fatigue over the 60-minute duration 
and to test whether recovery differed between treatment categories. Therefore, treatment and time 
were used as the fixed factors and percentage of maximal power output the dependant variable. As 
before, two sample t-tests were conducted at each time point in order to assess specific differences in 
power output between control and caffeine treatments at the same stimulation frequency. 

















The mean untreated maximal isometric tetanic stress and maximal work loop power for the entire 
population of soleus muscles used in the present study was 202 ± 11 kN m-2 and 33.1 ± 2.2 W kg-1 
respectively, and was not significantly different to soleus muscle in Chapter 4 (Tukey p>0.05 in both 
cases).Reducing stimulation frequency from 140 to 40 Hz resulted in a significant reduction in both 
isometric stress (by 26%) and work loop power output (by 51%) in mouse soleus muscle (Table 5.4.1; 
ANOVA p<0.001 in both cases). Mean pre-treatment isometric stress and work loop power output at 
140Hz were not significantly different between muscles to be used in the control protocol and muscles to 
be used in the caffeine treatment protocol (202 ± 15 kN m-2 and 32.4 ± 2.1W kg-1in control, compared to 
202 ± 18 kN m-2 and 33.8 ± 2.3 W kg-1in caffeine treated, for stress and power respectively: Tukey p>0.9 in 
both cases). Similarly, there was no significant difference in sub-maximal stress or power output between 
muscles to be used in the control protocol and muscles to be used in the caffeine treatment protocol 
when tested at 40Hz (154 ± 20 kN m-2 and 15.9 ± 1.9 W kg-1in control, compared to 146 ± 13 kN m-2 and 
16.6 ± 1.4 W kg-1in caffeine treated, for stress and power respectively: Tukey p>0.95 in both cases). This 
confirms that the muscles were of similar quality prior to treatment, of similar quality to previous studies 











Table 5.4.1.  The effects of stimulation frequency on maximum isometric tetanus stress (force 
normalised to muscle cross-sectional area) and work loop power output (power output normalised 
to muscle mass) in mouse soleus muscle (n=32 pooled data pre allocation of preparations to control 
or caffeine treatment) 




Tetanus Stress (kN.m-2) 
* 
Net Max Work Loop PO (W.kg-1) 
40Hz 150±17 16±2 
70Hz 188±17 24±2 
140Hz 202±11 33±2 
   [Data represented as Mean ± SE; * represent significant differences between stimulation 
frequencies] 
 
Effects of Stimulation Frequency and 70µM Caffeine Treatment on Endurance 
For all treatments, the fatigue protocol elicited a significant decrease in active net power output of soleus 
muscle over time (Figure 5.4.1; ANOVA p< 0.001). Time to fatigue was significantly affected by treatment 
group (Figure 5.4.1; ANOVA p<0.001). In control muscle, 140Hz stimulation frequency resulted in 
significantly decreased endurance compared to 40Hz (Figure 5.4.1; Tukey p=0.003).  Control muscle 
stimulated at 40Hz stimulation frequency, maintained power output above 80% of maximum for nearly 
twice as long as controls at 140Hz stimulation frequency.  
After examination of individual time points, 140Hz control muscle produced significantly greater power 
than 140Hz caffeine treated from 3.6 seconds of the fatigue run onwards (Figure 5.4.1; two-sample t-test, 
d.f. = 14, p< 0.05 in each case). Treatment with 70µM caffeine caused a significant decrease in mean 
endurance (by 17.6%) compared to controls when soleus muscle was stimulated maximally at 140Hz 
(Figure 5.4.1; Tukey p=0.001). Mean net muscle power output was significantly higher for controls in work 




measurement at every second loop). Soleus muscle treated with 70µM caffeine when stimulated sub 
maximally demonstrated a significant mean increase (by 19.2%) in endurance compared to controls 
(Figure 5.4.1; Tukey p<0.001). Despite this no significant difference in mean muscle power output was 
found between 40Hz control and 40Hz caffeine treated at any individual time point throughout the 
fatigue run (Figure 5.4.1; two-sample t-test, d.f. = 14, p> 0.2 in each case). An increase in standard error 
over time represents an increase in individual variation in the rate of fatigue. However, in the 140Hz 
caffeine trial standard error remains low throughout fatigue, thus suggesting that the response to caffeine 
treatment varies little between individuals. 
 
 
Fig.5.4.1 The effects of 70µM caffeine treatment and stimulation frequency on the rate of fatigue in 
mouse soleus muscle. Values are displayed as a percentage of maximal work loop power output [Data 
represented as mean & SE; n = 8 in each case;  * represent significant differences in power output at each 






































There was very little variation in cumulative work between maximally stimulated control and caffeine 
treated muscles. Although power was slightly reduced in 40Hz caffeine treated muscle compared to 
control, the total cumulative work in soleus muscle treated with caffeine at 40Hz was 10% higher than in 
controls. It should be noted that the increased muscle power output demonstrated in control muscles 
compared to those treated with caffeine at 40Hz, should not be attributed to a caffeine effect. For 
example caffeine may still be acting to cause a significant increase in at 40Hz compared to controls, 
however generally the mean power output of control muscles is higher. The acute effect of caffeine at 
140Hz and 40Hz has been previously discussed in chapter 4. 
 
 
Fig.5.4.2 The effects of 70µM caffeine treatment and stimulation frequency on changes in the relationship 
between power output andcumulative work in mouse soleus muscle. [Data represented as mean & SE for 
every second loop of the fatigue protocol; n = 8 in each case] Note, that for clarity, not all error bars have 



























The Effects of 70µM Caffeine on Work Loop Shape   
The area of the work loop represents the net work of that particular cycle; the typical work loop shapes 
presented in Figure 5.4.3 clearly demonstrate that initial net work is larger at 140Hz stimulation frequency 
(Figure 5.4.3; A) compared to 40Hz stimulation frequency (Figure 5.4.3; C). At 140Hz stimulation 
frequency there is a significant reduction in peak and sustained force through shortening in the caffeine 
treated muscle (Figure 5.4.3; B) compared to controls (Figure 5.4.3; A). The shape of the loop 2.4 seconds 
after that start of fatigue indicates that there is an increase in relaxation time that is more pronounced in 
the caffeine trial (Figure 5.4.3; B) compared to controls (Figure 5.4.3; A). There is little difference in work 
loop shapes between controls (Figure 5.4.3; C) and those treated with 70µM caffeine (Figure 5.4.3; D) at 
40Hz stimulation frequency. However the net work throughout fatigue appears to be greater in the 













Fig. 5.4.3. Typical effects of fatigue on work loop shape for control soleus stimulated at 140Hz and 40Hz 
(A & C respectively) compared with those treated with 70µM caffeine (B 140Hz caffeine and D 40Hz 
caffeine) [Arrows indicate where stimulation typically started, towards the end of lengthening, and 
finished, during shortening; 0.4s, 2.4s, 4.8s, & 7.2s represent time since the start of the fatigue protocol] 
 
Treatment Effects on Recovery from Fatigue  
Soleus muscle fatigued at 140Hz in control Krebs recovered significantly better than the soleus muscle 
stimulated at 140Hz and fatigued in caffeinated Krebs (89% maximum after 30 minutes Vs. 63% maximum 
after 50 minutes; Figure 5.4.3; Tukey p<0.001).  Muscle power output was significantly greater in control 
treatment at time points 20-60 minutes (Figure 5.4.3; two-sample t-test, d.f. = 14, p>0.004 in each case). 




those muscles fatigued in caffeine (71% maximum after 50 minutes) at 40Hz (Figure 5.4.3; Tukey p= 
0.795). Control muscles stimulated throughout at 140Hz recovered significantly better, relative to pre 
fatigue maximum, than those stimulated throughout at 40Hz (Figure 5.4.3; Tukey p<0.001).  
 
 
Fig. 5.4.4. Effect of 70µM caffeine treatment and stimulation frequency on recovery of soleus muscle 
following fatigue [Time 0 represents the end of the fatigue run; Data represented as mean & SE; n = 8 in 
each case; * represent significant differences in power output at each individual time point between 





































5.5. Discussion  
The mean untreated maximal isometric tetanic stress and maximal work loop power for the entire 
population of soleus muscles used in the present study was 202 ± 11 kN m-2 and 33.1 ± 2.2 W kg-1 
respectively (Table 5.4.1), comparable to that previously reported for mouse soleus muscle (James et al. 
2004; Askew et al. 1997; James et al. 1995; Vassilakos et al. 2009).Any potential variation in stress and 
power output between published studies could be attributed to muscle fiber type differences due to 
variation in strain and age of mice used and the environmental conditions at which they were kept.  
The Effect of 70µM Caffeine Treatment on Endurance in Maximally Stimulated Muscle 
Incubating soleus muscle in 70µM caffeine resulted in significantly shorter endurance (by 17.6%) at 
maximal (140Hz) stimulation frequency when compared to controls (Figure 5.4.1). Germinario et al. 
(2004) reported a faster decrease in isolated mouse soleus force when stimulated via repeated tetani 
after treatment with 2-5 millimolar caffeine (toxic to humans). The present results contrast those of 
James et al. (2005) who reported that 70µM caffeine failed to elicit any significant change in the 
endurance of maximally stimulated EDL. This suggests a fiber type specific effect of physiologically 
relevant concentrations of caffeine on muscular fatigue. 
Skeletal muscle fatigue is associated with impaired SR Ca2+ release and reduced intramuscular 
Ca2+ concentration that is correlated with a reduction in muscle force (Allen et al. 1989; Allen et al. 2007). 
In relation to this, the fatigue induced increase in muscle relaxation time has also been attributed to 
reduced SR Ca2+ pump activity and an inability to decrease intramuscular Ca2+ between stimuli (Allen et al. 
1989; Fitts 1994; Askew et al. 1997). An earlier study by Askew et al. (1997), using the work loop 
technique, demonstrated a fatigue induced increase in soleus muscle relaxation time. An increased 
relaxation time significantly accelerates fatigue when using the work loop technique by increasing the 
muscle’s resistance to stretch and elevating the proportion of negative work per cycle [Askew et al. 1997; 




As previously discussed caffeine has been shown to augment excitation-contraction coupling, primarily by 
altering intramuscular Ca2+ handling (Magkos & Kavouras, 2005). The demonstrated combined effects of 
greater release of Ca2+ into the intramuscular space, increased myofibrillar Ca2+ sensitivity, slowing of the 
SR Ca2+ pump, and increased SR Ca2+ permeability, significantly modify skeletal muscle performance (Allen 
et al. 1989; Westerblad & Allen 1991; Allen & Westerblad 1995). The consequential decrease in rate of 
Ca2+ efflux from the intracellular space, due to the reduced action of the SR Ca2+ pump, is attributed to the 
caffeine induced increase in muscle relaxation time (Allen et al. 1989; Westerblad & Allen 1991). 
In light of our previous findings (Tallis et al. 2012; chapter 4), it is likely that the caffeine treatment in the 
present study is having a muscle fiber type specific (when compared with EDL in the previous study by 
James et al. 2005) and activity level specific (i.e. only affecting maximally activated muscle) effect on 
relaxation rate and consequently power output during fatigue. Net power output attained via the work 
loop technique is the sum of the shortening work minus the energy required to elongate the muscle 
(Proske & Morgan 2001). If still active at the end of shortening a greater amount of energy is required to 
elongate the muscle as lengthening occurs against a greater resistance. The further elevated increase in 
relaxation time in caffeine treated, maximally activated soleus muscle, and the accumulation of this effect 
over time, is likely to result in a greater degree of muscle activation at the end of shortening. 
Consequently, in maximally activated muscles, the proportion of negative work per work loop cycle will 
be greater than in controls causing the muscle to fatigue faster. This is supported via examination of the 
work loop shapes. The later work loops in the fatigue run suggest that soleus muscle is failing to relax 
completely before re-lengthening when maximally stimulated, especially when treated with caffeine 
(Figure 5.4.3 loops 2.4s and 4.8s). The fact that a similar mechanism was not prevalent in EDL (James et al. 
2005) highlights the enhanced ability of a faster muscle phenotype to remove calcium form the 
intramuscular space. 
With reference to the cumulative work produced in maximally fatigued muscle, although the caffeine 




therefore indicates that the caffeine treated muscles were producing greater power output per cycle 
compared to controls, in agreement with the findings of Tallis et al. (2012; Chapter 4). 
The Effect of 70µM Caffeine Treatment on Endurance in Sub Maximally Stimulated Muscle 
Treatment of soleus with 70µM caffeine resulted in a mean significant increase in endurance in sub 
maximally stimulated soleus muscle (by 19.2%) compared to controls (Figure 5.4.1). In addition a 10% 
increase in the cumulative work over the period of fatigue was found (figure 5.4.2). Producing a greater 
amount of power, or applying that power over a greater duration (as demonstrated in figure 5.4.1) will 
contribute to this phenomenon. In contrast to all previous literature (James et al. 2005; Germinario et al. 
2004; Reading et al. 2004) the present results are the first to indicate a caffeine induced direct increase in 
skeletal muscle endurance. In this instance, it is difficult to make a direct comparison to previous findings 
primarily due to differences in the method used and the previously high concentrations of caffeine being 
significantly greater than the physiologically relevant dose (Germinario et al. 2004; Reading et al. 2004). 
Most previous studies have induced fatigue via repeated isometric tetani, however, this would be a poor 
predictor of fatigue induced by the patterns of cyclical muscle length changes used in vivo as in isometric 
studies the muscle is held at constant; therefore changes in the force-velocity, length-force and passive 
properties of the muscle are not considered (Josephson 1985). The present work is the first to indicate a 
caffeine induced, direct increase in skeletal muscle endurance, and further suggests a complex muscle 
specific caffeine response affected by the intensity of muscle activity.  
Examination of the work loop shapes (Figure 5.4.3) indicates that, in contrast to maximally activated 
muscle, there appears to be no difference in the ability of the muscle to relax in the caffeine treated 
muscle (Figure 5.4.3;D) when compared to controls (Figure 5.4.3;C). At this reduced stimulation 
frequency, the interval between individual stimuli will be increased allowing a greater duration for the 
reduction in intramuscular Ca2+ between successive stimuli. Therefore, in this instance, it is probable that 
fatigue is less affected by an increased relaxation time and largely results from a decline in force. As with 




fatigue is attributed to the direct effect of caffeine to increase force via augmented Ca2+ release without 
the prevalent effects of amplified negative work observed in maximally activated caffeine treated muscle. 
With the muscle stimulated at 40Hz, significantly below the 140Hz required for maximal activation, any 
caffeine induced increase in intramuscular Ca2+ is likely to still be well within the calcium handling 
capabilities of the SR Ca2+ pump. Subsequently, unlike with maximally activated muscle, the level of 
activation at the end of work loop shortening is unlikely to vary between control and caffeine treated 
muscles thus limiting the occurrence of increased negative work observed in maximally activated soleus 
muscle.  
Recovery from Fatigue Following Treatment with 70µM Caffeine  
Fatigue of maximally stimulated (140Hz) soleus muscle treated with caffeine resulted in a significant 
reduction in recovery of net power (by 26%) compared to controls (Figure 5.4.4). The previously 
highlighted caffeine induced increase in negative work during fatigue at this intensity is the likely cause of 
this, as elevated eccentric activity is associated with increased muscle damage (Dickinson et al. 2000). 
Damage brought about by eccentric exercise would result in a decrease in the ability to recover after 
fatigue, and is an effect previously observed by James et al. (2005) using 10mM caffeine treatment on 
mouse EDL and soleus. At submaximal, 40Hz, stimulation frequency there was no significant difference 
between mean recovery of controls and those fatigued in caffeine (Figure 5.4.4).  
Practical Implications of the Present Findings 
The present findings are the first to investigate the effects of physiological caffeine concentration on the 
fatigability of predominantly slow twitch muscle and demonstrate decreased endurance when maximally 
stimulated, and prolonged endurance when sub maximally stimulated. This, in conjunction with our 
earlier findings in predominantly fast twitch EDL (James et al. 2005), indicates a muscle specific caffeine 




Tallis et al. (2012; chapter 4) further demonstrated a potentiation in acute muscle power output, 
independent of stimulation frequency, that was greater in mouse soleus muscle (up to 6%) compared to 
EDL (up to 3%). If applied uniformly across the fatigue data, a 6% potentiation would result in a slight 
upwards shift in the fatigue curve, but is unlikely to significantly affect the overall findings. 
Although the sinusoidal length change pattern used in the current study provides an approximation of in 
vivo cyclical muscle activities, it is a simplification of the length change waveforms used in real life 
locomotion (Dickinson et al. 2000). In vivo the pattern of fiber stimulation and length change waveforms 
are likely to be manipulated throughout movement (Wakeling & Rozitis 2005). Therefore if a muscle is 
producing too much eccentric force the duration of stimulation is likely to be reduced in order to lessen 
any associated muscle damage. Subsequently, in vivo, the activation of caffeine treated fibers may be 
reduced to produce the same power as controls, with the activation of fewer muscle fibers, thus 
prolonging endurance. However, these proposed differences between our experimental protocols and 
what may happen in vivo are unlikely to affect the overall findings of this study. 
Conclusion 
The direct treatment of mouse soleus muscle with 70µM caffeine resulted in a stimulation frequency 
specific effect on endurance. When fatigued at a stimulation frequency that elicited maximal force 
(140Hz), soleus treated with caffeine fatigued significantly faster, which may relate to a caffeine induced 
increase in muscle relaxation time. However, when the same experiment was conducted on soleus muscle 
stimulated at a low stimulation frequency (40Hz) that yielded a submaximal force, caffeine treatment 
resulted in a significant increase in time to fatigue. The present findings indicate a complex response 
between activation intensity and the effect of caffeine that should probably be examined over a greater 
range of stimulation frequencies. The current findings highlight an enhanced ergogenic benefit of caffeine 
in prolonged sub maximal activities that are primarily powered by slower muscle fibers. This extends our 
earlier work (Tallis et al. 2012; chapter 4), by being the first to demonstrate a stimulation frequency 




6. Does a Physiological Concentration of Taurine Increase Acute Muscle Power Output, Time 























The value of energy drinks in providing ergogenic benefit across a range of sporting activities has been 
firmly established. It is widely recognised that caffeine, a constitute of many energy drinks, can promote 
performance enhancing effects on endurance, strength, and power activities. Recently, physiological 
concentrations of caffeine have been shown to directly affect skeletal muscle performance (Tallis et al. 
2012; chapter 4). Additionally, taurine is also found in high quantities in many energy drinks, although the 
benefit of acute ingestion of taurine is less well understood. In vitro models have demonstrated that 
supraphysiological caffeine induced contracture can be further potentiated when combined with high 
concentrations of taurine. The present study used isolated mouse soleus muscle to investigate the effects 
of physiological concentrations of taurine alone and taurine and caffeine combined on: 1) acute muscle 
power output; 2) time to fatigue; and 3) recovery from fatigue. Treatment of mouse soleus muscle with 
taurine failed to elicit any significant difference in any of these parameters when compared to controls. 
Treatment with taurine and caffeine combined resulted in a significant increase in acute muscle power 
output and faster time to fatigue. The ergogenic benefit posed by taurine and caffeine combined was not 
different from the effects of caffeine alone. In conclusion, an acute muscle taurine treatment, which could 
be achieved via consumption of energy drinks, does not directly improve skeletal muscle performance.  











The consumption of energy drinks to provide an ergogenic benefit in psychological and physical 
performance is widely recognised and common practice for many athletes (Alford et al. 2001; Graham et 
al. 2001, Davis & Green, 2009; Duncan & Oxford, 2011). The carbohydrate content of such products 
provides the addition fuel for energy production; in addition a number of supplementary ingredients are 
included as mechanists for other performance enhancing reactions. The ergogenic effect of energy drinks 
is largely related to the presence of caffeine; however the scientific understanding of other ingredients in 
their ability to enhance sporting performance has received far less attention. In addition to high 
concentrations of caffeine and various sugars, the amino acid taurine (Amino ethane Sulfonic Acid) is a 
constituent of many energy drinks and is believed to contribute to the performance enhancing effect 
(Geib et al. 1994). Therefore, the present study aims to assess the benefit of acute taurine 
supplementation to promote a direct enhancement of muscle performance.   
Taurine is readily synthesized by the body and is found in high concentrations in mammalian tissue 
particularly the heart and skeletal muscle (Schaffer, 2010). Although the mechanism of action are unclear 
it has been established that taurine affects a number of electro physiological and biochemical parameters, 
with its greatest functions relating to osmoregulation, regulation of oxidative stress, and cell signalling 
(Cuisinier et al. 2002; Matsuzakiet al. 2002; Oja & Saransaari, 2007; Scaffer et al. 2010). Renal uptake of 
taurine is low and hence taurine is the major urinary amino acid with diet dependant losses ranging from 
65-250mg (Galloway et al. 2008). A clear role of taurine in maintaining mammalian myocardial and 
skeletal muscle contractile function has been demonstrated throughout previous research (Schaffer, 
2010).Warskulat et al. (2004) used -/- mice to identify taurine as a crucial amino acid for the maintenance 
of total function and exercise capacity of skeletal muscle. The almost complete depletion of skeletal 
muscle taurine that resulted caused a reduction of total exercise capacity by more than 80%. 




skeletal muscle function, primarily resulting in a decrease in muscle force production (Hamilton et al. 
2006). 
In vivo and in vitro evidence strongly suggests that chronic taurine supplementation can positively 
enhance skeletal muscle performance (Imagawa et al. 2009). Chronic taurine supplementation in rats has 
been shown to lead to large increases in muscle taurine concentration and a consequential enhancement 
of muscle force. This in turn corresponds to an increase in muscle calsequestrin content indicating a 
greater Ca2+ SR concentration (Goodman et al. 2009).  
The present study evaluates the skeletal muscle specific response to acute supplementation of taurine 
that may occur via one off consumption of energy drinks prior to sporting performance. From a whole 
body human perspective Geib et al. (1994) concluded that ‘Red Bull’ energy drink had a greater effect at 
increasing endurance if the taurine content was present.  However, evidence discussing the one off 
effects of taurine supplementation on physiological performance is limited. In vitro high concentrations of 
taurine have been shown to increase isometric force in fast skeletal muscles of rat and slow abdominal 
extensor muscle of crayfish (Galler & Hutzler, 1990; Bakker & Berg 2002). The mechanism of action is 
believed to occur via modification of ion channel function and Ca2+ homeostasis (Galler & Hutzler, 1990; 
Bakker & Berg 2002; Camerino et al. 2004; Cuisiner et al. 2000).  
There is little evidence examining the maximal one off dosage of taurine for human consumption and 
furthermore, research regarding the maximal blood plasma concentration is scarce. In humans taurine 
has been used in doses up to 6g per day and has been used intravenously in doses up to 5g without a 
toxic effect (Milei et al. 1992; Mizushima et al. 1996). Galloway et al. (2008) reported a peak blood plasma 
concentration of 750µM following oral ingestion of 1.66g of taurine. Based on the results of Galloway et 
al. (2008), the taurine concentration used in the present study (2.64mM) would compare to 5.8g taurine 




The performance enhancing benefits of caffeine in human performance has been widely established in 
endurance (activity lasting greater than 30 minutes), power and strength activities (Graham, 2001; Davis 
& Green, 2009). James et al. (2005) and Tallis et al. (2012; 2013; chapter 4 & 5) used mouse EDL (relatively 
fast) and soleus (relatively slow) isolations to demonstrate the direct effect of physiologically maximal 
concentrations of caffeine (70µM) on acute muscle power output and time to fatigue. These studies 
indicated a potentiation of acute muscle power output across maximal and submaximal intensities with a 
greater response in soleus muscle compared to EDL. Caffeine treatment had various effects on time to 
fatigue depending on muscle fiber type and the intensity of stimulation. This caffeine induced muscle 
force potentiation has been shown to occur via direct adenosine receptor antagonism resulting in 
alterations in excitation contraction coupling primarily due to changes in intramuscular Ca2+ handling 
(Daminai et al. 1996; Bhat, 1997; Fredholm et al. 1997; Rossi et al. 2001; Davis & Green, 2009; Magkos 
&Kavouras, 2005). A limited number of diverse studies examining skinned rat heart to whole body human 
performance have demonstrated that taurine, when combined with caffeine, could result in further 
potentiation of the effects of caffeine alone (Geib et al. 1994; Steele et al. 1990). However, this effect has 
never been established using physiologically relevant concentrations of taurine and caffeine directly on 
skeletal muscle. With the caffeine induced increase in Ca2+release and the proposed increase in 
Ca2+myofilament sensitivity a combination of treatments may produce a greater ergogenic benefit.  
Although verified to a greater extent in predominantly fast muscle, a reduction in taurine concentration 
with prolonged muscle activation has been identified in all skeletal muscle fiber types (Kim et al. 1986; 
Matsuzaki et al. 2002). The present study will aim to investigate whether a physiological dose of taurine 
can reduce the rate of muscle force deterioration. The time to fatigue will also be assessed with taurine 
and caffeine combined to establish if the effect is greater than caffeine treatment alone. Further to this 
the effects of increasing the concentration of taurine following fatigue will be examined in order to 
investigate whether the intracellular concentration can be restored and a consequential increase in the 
efficiency of recovery induced. The present study will also assess the effects of physiologically relevant 




The aims of the present study are to use isolated mouse soleus muscle to assess the direct effects of 
physiologically relevant concentrations of taurine alone (2.64mM), caffeine alone (70µM), and taurine 
and caffeine combined on: 1) acute maximal muscle power output; 2) time to fatigue; 3) recovery 
following fatigue. The information regarding the effects of caffeine alone is derived from previous 
publications by Tallis et al. (2012, 2013; chapter 4 & 5) and in this instance the data will be used solely for 
comparison. Normal plasma concentration of taurine is 30-60 µmol/l which is significantly lower in 
relation to an intramuscular content between 50-60 mmol/kg (Galloway et al. 2008). Subsequently it is 
suggested that an acute, direct taurine concentration equivalent to a typical dose from energy drinks, will 
not be great enough to cause significant improvements in the power output, endurance or recovery from 
fatigue of mouse soleus muscle. Furthermore when combined with 70µM caffeine, taurine treatment will 















6.3. Materials and Methods 
A more detailed account of the methods is given in the general methods section (chapter 3). 
Soleus muscle was isolated from the right hind limb of 8-10 week old mice (body mass = 31.1±0.24 g, 
mean ± SE, n =72). Each muscle preparation was then placed in to the muscle bath that was continually 
circulated with Krebs-Henseleit solution at a constant temperature of 36 ± 0.02oC. Initially muscle length 
and stimulation amplitude (12-16V) were optimised to elicit maximal isometric twitch force. Using these 
parameters and a burst duration of 320ms the muscle preparation was subjected to a series of isometric 
tetani. Stimulation frequency (usually 140Hz) was further optimised to evoke maximal tetanus force. To 
ensure sufficient recovery a 5-minute rest period was imposed between each tetanus. 
Work loop experiments were conducted in order to assess the effects of taurine and taurine combined 
with caffeine on each of acute muscle power output, fatigability, and fatigue recovery. A concentration of 
2.64 mM was used for taurine treatment; this was estimated from the maximal concentration available if 
the taurine from a single can of Red Bull (1g) was instantaneously absorbed and equally distributed 
throughout the blood plasma. The comparison to Red Bull has been made as it is a widely recognised 
energy drink with a taurine content representative of similar products available; therefore, testing this 
taurine concentration seemed ecologically valid. We recognise that the maximal concentration of taurine 
cannot be instantaneously absorbed and equally distributed following human ingestion; however it 
should be considered a high physiological concentration that could be derived via multiple consumption 
of such energy drinks.  In order to test whether 2.64 mM of taurine alone (TAU) or 2.64 mM taurine 
combined with 70µM caffeine (maximal human physiological concentration) (TC) affected acute muscle 
power output, time to fatigue, or recovery from fatigue, each soleus muscle preparation was subjected to 
one of the following protocols. i.e. each muscle preparation was used to determine the effects of 
treatment on acute power output or time to fatigue or recovery from fatigue. 70µM is recognised as the 
human physiological maximum, the caffeine only treatment data at this concentration has been published 




Acute Power Output 
As in chapter 1 and 2, during work loop experiments soleus muscle power was measured at 5Hz cycle 
frequency using a strain of 0.10, and a fixed phase shift of -10ms. In order to test the acute effect of a 
given treatment the muscle was subjected to four work loop cycles at 10 minute intervals over 130 
minutes (Fig 6.3.1.). During the initial three measurements the muscle was maintained in standard Krebs-
Henseleit solution. The fluid was then changed to Krebs-Henseleit solution containing either 2.64 mM 
taurine (TAU) or 2.64 mM taurine combined with 70µM caffeine (TC). This experimental treatment was 
maintained for 60 minutes. Following this, the solution was then changed to  standard Krebs-Henseleit 
solution, for a wash out period of 40 minutes, to establish if the effect of treatment was reversed, 
returning the muscle to its pre-treatment state (Fig 6.3.1.).  The second work loop of four was always used 
as the indicative measure of muscle power output at each time point. 
 
Figure 6.3.1. -  Schematic of the work loop protocol to examine the ergogenic effect of Taurine and 
caffeine on acute muscle power output of maximally stimulated mouse soleus muscle 
Time to Fatigue 
In order to test the effect of a given treatment on time to fatigue the muscle was again subjected to sets 
of four work loops at 10-minute intervals over a 130-minute duration. During the initial 3 measurements 
the muscle was maintained in standard Krebs-Henseleit solution. For the subsequent 40 minutes the fluid 
was changed to TAU or TC. The fourth measurement in the treatment solution was a fatigue run 
consisting of 100 consecutive work loop cycles; data was collected for every second loop. Forty minutes of 




each preparation to respond to the treatment (Tallis et al. 2012; 2013; chapter 4 & 5). Fatigue was 
determined to have occurred when the muscle preparation produced net negative work. Directly after 
the fatigue run the circulating fluid was changed back to standard Krebs-Henseleit solution and recovery 
was monitored for 60 minutes by subjecting the muscle to a set of four work loop cycles at 10 minute 
intervals over this duration. The control protocol followed the same process however the muscle was 
maintained in standard Krebs-Henseleit solution throughout. 
 
Figure 6.3.2. -  Schematic of the work loop protocol to examine the ergogenic effect of Taurine and 
caffeine on mouse soleus muscle maximally stimulated to fatigue 
Recovery from Fatigue 
The protocol for testing the recovery from fatigue was the same as that used in the time fatigue protocol 
above, however, in the time up to and inclusive of the fatigue run the muscle was incubated in standard 
Krebs-Henseleit solution. Immediately after the fatigue run the solution was changed to TAU, TC or 
Caffeine (CAF) and recovery was monitored for the next hour (Fig 6.3.3).  
 
Figure 6.3.3. -  Schematic of the work loop protocol to examine the ergogenic effect of Taurine and 





At the end of the experiment the muscle was detached from the rig, tendons removed, then weighed in 
order to calculate isometric stress (kN.m-2) and normalised muscle power (W.kg1). 
Statistical Analysis of Data  
In order to compare the quality of muscle between treatment groups a single factor ANOVA was 
conducted on maximal untreated isometric stress and work loop power output data. 
Due to the gradual development of an anoxic core in control conditions muscle power output will very 
gradually decrease over time (Barclay, 2005). For the muscles tested in the present study power output 
decreased to an average 96 ± 1% of initial power over the 130-minute duration of the work loop protocol. 
In order to avoid the deterioration in muscle performance masking the effects of treatment, a 1st order 
regression equation was calculated using the pre-treatment control data and post treatment washout 
control data in order to identify the linear relationship between muscle power output and time. This 
regression equation was then used to determine theoretical control muscle power output for each time 
point during caffeine treatment (as in James et al. 2005; Tallis et al. 2012; chapter 4 & 5).  
Initially, for the acute power output data, pre-treatment controls were compared against post treatment 
washout controls for each experimental group. There was no significant difference between this control 
data (Fig 6.4.1; paired t-test p>0.6 in all cases) therefore, it was assumed that any subsequent change in 
muscle power when incubated in TC, TAU or CAF was an effect of the given treatment. In order to assess 
the effects of treatment for each acute response the control data was compared directly against 
treatment data via paired t-tests. A single factor ANOVA was conducted in order to identify whether the 
given increase in power output was different between treatments (TC vs.TAU vs. CAF). Tukey post hoc 
tests were used to establish where these differences occurred. 
A two factor ANOVA was used to determine whether muscle power output changed over time. A second 
two factor ANOVA was used to determine whether the time to fatigue differed between treatment 




used at each time point in order to assess whether power output was significantly different between 
treatments at each time point of the fatigue run. 
A two factor ANOVA was implemented to identify whether power output increased significantly over 
recovery time and whether recovery differed between treatment groups, Tukey post hoc tests were used 
for treatment. Single factor ANOVA were conducted at each time point in order to identify if muscle 
power output differed between treatments. 


















The mean maximal isometric twitch and tetanus stress for soleus muscle (n=76) was 38.6 ± 1.5 kN m-2and 
219 ± 7 kN m-2respectively. Mean untreated maximal muscle power output was 32.8 ± 1 W kg-1(n=76). 
Untreated mean maximal isometric tetanus stress and work loop power output were not significantly 
different between experimental groups (single factor ANOVA main effect p>0.35 in both cases) or to that 
in chapters 4 and 5 (Tukey p>0.05 in both cases). Therefore, it is assumed that the muscles were of a 
similar quality between the experimental groups and that any subsequent differences in response occur 
due to the effects of treatment. 
The Effect of Physiological Concentrations of Taurine and Caffeine on Muscle Power Output 
Treatment of soleus muscle with caffeine alone or taurine combined with caffeine resulted in a significant 
increase in acute maximal muscle power output of 4.1% and 6.4% respectively (Fig 6.4.1; paired t-test 
p<0.03 in both cases). Treatment with taurine alone failed to elicit any significant increase in muscle 
power output (Fig 6.4.1; paired t-test p=0.118).  
The treatment induced benefit was significantly dependant on treatment (Fig 6.4.1; single factor ANOVA 
main effect p=0.03). There was no significant difference between the benefit imposed by caffeine alone 
when compared with taurine and caffeine combined (Fig 6.4.1; Tukey p=0.628). The treatment effect of 
caffeine was significantly higher than that of taurine alone (Fig 6.4.1; Tukey p=0.027), however there was 











Figure 6.4.1. – The mean acute effect of physiological concentrations of taurine alone (TAU), caffeine 
alone (CAF), and taurine and caffeine combined (TC) on net work loop power output in maximally 
stimulated mouse soleus muscle [Data represented as mean & SE] n=10 for TAU and TC, n=8 for CAF. 
 
The Effect of Physiological Concentrations of Taurine and Caffeine on Time to Fatigue 
The fatigue protocol was effective in inducing soleus muscle fatigue as net power output reduced 
significantly over time (Fig 6.4.2; two factor ANOVA main effect of time p<0.001). There was a significant 
effect of treatment on time to fatigue (Fig 6.4.2; two factor ANOVA main effect p<0.001). Treatment of 
soleus muscle with caffeine alone or with taurine and caffeine combined resulted in a significantly 
decreased time to fatigue (time to net negative work increased by 30% and 15% respectively) compared 
to controls (Fig 6.4.2; Tukey p<0.001 in both cases). Soleus muscle treated with caffeine fatigued 
significantly faster than muscle treated with taurine and caffeine combined (Fig 6.4.2; Tukey p<0.001). 
There was no significant difference in time to fatigue between soleus muscles treated with taurine alone 


































Soleus muscle treated with caffeine produced significantly less normalised power compared with muscle 
treated with taurine from 3.2s onwards, from 3.6s onwards when compared with controls, and from 4.8s 
when compared with taurine and caffeine combined (Fig 6.4.2; Tukeyp<0.04 in all cases). There was no 
significant difference in the mean net power output at each time point in any other treatments (Fig 6.4.2; 
single factor ANOVA Tukeyp>0.05 in all cases). 
 
Figure 6.4.2. –The effects of physiological concentrations of taurine alone (TAU), caffeine alone (CAF), and 
taurine and caffeine combined (TC) on time to fatigue in maximally stimulated mouse soleus muscle. 
Values are displayed as a percentage of maximal net work loop power output. [Data represented as mean 
& SE] n=8 in each case. 
When plotted as cumulative work, a similar pattern to that demonstrated with differences in time to 
fatigue is observed. Although initial power output was similar between muscles, caffeine treated muscle 




































Figure 6.4.3. The effects of physiological concentrations of taurine alone (TAU), caffeine alone (CAF), and 
taurine and caffeine combined (TC) on the relationship between power output and cumulative work in 
mouse soleus muscle. [Data represented as mean & SE for every second loop of the fatigue protocol; n = 8 
in each case] Note, that for clarity, not all error bars have been added. 
 
The Effect of Physiological Concentrations of Taurine and Caffeine on Recovery from Fatigue 
Net power output significantly increased over time during recovery from fatigue (Fig 6.4.4; two factor 
ANOVA main effect p<0.001). The level of soleus muscle recovery was significantly dependant on 
treatment (Fig 6.4.4; two factor ANOVA main effect p=0.035). Soleus muscle treated with caffeine had a 
mean peak recovery at 91.5% of the pre fatigue maximum; this was significantly better than the 80.8% 
recovery with taurine and caffeine combined (Fig 6.4.4; Tukey p=0.031). Controls and taurine alone 
recovered to 89.2% and 86.3% of pre fatigue maximum and there was no significant difference in 
recovery between any other treatments (Fig 6.4.4; Tukey p>0.105 in all cases). Despite highlighted 



























treatments at any given time point during the recovery period (Fig 6.4.4; single factor ANOVA Tukey 
p>0.156 in all cases). For all treatments mean peak recovery occurred between 80 and 90 minutes 
following the start of the work loop protocol (Fig 6.4.4). 
 
Figure 6.4.4 - Effect of physiological concentrations of taurine alone (TAU), caffeine alone (CAF), and 
taurine and caffeine combined (TC) on the recovery of mouse soleus muscle following fatigue at maximal 












































The mean maximal tetanus stress of 219 kN m-2and net power output of 32.8 ± 1 W kg-1were comparable 
to those reported in previous studies using similar methods (Askew et al. 1997; James et al. 2004; 
Vassilakos et al. 2009). More significantly the present results for maximal stress and net power output 
were directly comparable to 189 and 202 kN m-2and 31.7 and33.1 W kg-1 previously reported by Tallis et 
al. (2012; 2013; chapter 4 & 5). This signifies that the muscle preparations used across the studies were of 
similar quality and vindicates the use of the caffeine only results from Tallis et al. (2012; 2013; chapter 4 & 
5) for comparison to the results reported in the present study from which the caffeine only treatment 
results are drawn. 
 The Effect of Physiological Concentrations of Taurine and Caffeine on Muscle Power Output 
Treatment of mouse soleus muscle with 2.64mM of taurine failed to elicit any significant increases in 
mean maximal net muscle power output compared to controls. When taurine was combined with 70µM 
caffeine, mean maximal net power output was significantly increased by up to 4.1% compared to controls. 
This acute increase in maximal net power output was not significantly different from the up to 6.4% 
induced with caffeine treatment alone. Therefore, acute supplementation of taurine did not directly 
improve short-term maximal muscle net power output and failed to further potentiate the effects of 
caffeine alone.  
The evidence in the present study contradicts the findings of Galler and Hutzler (1990) who demonstrated 
that physiological intramuscular concentrations of taurine (5mM) increased the submaximal isometric 
force of pig heart muscle and slow abdominal extensor muscle of crayfish. Similarly to Galler and Hutzler 
(1990), force-potentiating effects were reported by Bakker and Berg (2002) in skinned rat EDL (relatively 
fast muscle). In this instance the mechanism of action was attributed to short-term modification of ion 
channel function and Ca2+ homeostasis that has further been confirmed by Camerino et al. 




taurine (20 mM) acted as a modulator of contractile function by sufficiently increasing the myofilament 
sensitivity to Ca2+.  Additionally, Cuisinier et al. (2000) demonstrated that taurine did not modify Ca2+ 
sarcoplasmic reticulum uptake.  However, it has been suggested that the antioxidant properties of taurine 
may reduce oxidative stress on the sarcoplasmic reticulum Ca2+ pump (Schaffer, 2010). The 
concentrations of taurine in this research are markedly higher (5-20mM) than the concentration used in 
the present study and implementation of dynamic muscle function (i.e work loop power output) may 
further explain differences between previous research and the present results. As no detectable increase 
in muscle power output occurred, our evidence suggests that physiological concentrations of taurine at 
the level used in the present study do not significantly affect skeletal muscle Ca2+ handling.  
The present results are also contradictory to the findings of Steele et al. (1990) who suggested that 
taurine could further potentiate the effects of caffeine.  Steele et al. (1990) demonstrated that taurine 
concentrations greater than 1mM contributed to larger caffeine induced contracture of skinned rat heart 
tissue. However, it is widely established that the effects of taurine are more profound in heart tissue 
(Scaffer, 2010). The caffeine concentration used by Steele et al. (1990) (10mM) is markedly higher than 
that used on skeletal muscle in the present study and would be toxic for human consumption (Fredholm 
et al. 1999).  
The effect of 70µM caffeine to directly increase skeletal muscle power output has been attributed to a 
greater release of Ca2+ into the intracellular space, an increase in myofibrillar Ca2+ sensitivity, a decrease in 
the sensitivity of the SR Ca2+ pump, and an increased SR Ca2+ permeability (Tallis et al. 2012, 2013; chapter 
4 & 5; Allen et al. 1989, 1995). We believed by further increasing muscle Ca2+ sensitivity via treatment 
with taurine a greater caffeine induced potentiation would occur. As this wasn’t the case this adds further 






The Effect of Physiological Concentrations of Taurine and Caffeine on Time to Fatigue 
Treatment with 2.64mM of taurine failed to significantly affect the time to fatigue in maximally stimulated 
mouse soleus muscle compared to controls. When taurine was combined with caffeine time to fatigue 
was significantly decreased, although treatment of soleus muscle with caffeine alone resulted in 
significantly faster time to fatigue than all other treatments. These results suggest that in this instance 
adding taurine to caffeine may in part block the effects of caffeine alone. Futhermore there was little 
variation in the total amount of work produced during the fatigue protocol between controls, taurine and 
taurine and caffeine combined treated muscles. Interestingly this may indicate an ability of taurine to 
reduce the increased relaxation time previously demonstrated in caffeine treatment alone in chapter 5. 
Contradictory to the findings in chapter 5, caffeine treated muscles had reduced cumulative work 
compared to controls. Although this maximally stimulated fatigue of mouse soleus muscle was not 
significantly different (TTest p=0.14) between the muscles preparations used in chapters 5 and 6, time to 
fatigue for soleus muscle in the present study was 1 second greater therefore allowing power to be 
applied over a greater duration and potentially a reason for increased cumulative work. This further 
highlights in inter-individual variation in fatigue between muscle preparations. 
A reduction in skeletal muscle taurine content following prolonged muscle stimulation has previously 
been established in vitro (Kim et al. 1986; Matsuzaki et al. 2002). Chronic supplementation has been 
shown to significantly increase muscle taurine concentration resulting in increased muscle force 
production and partially counteracting the effect of intramuscular taurine depletion that occurs during 
fatigue (Goodman et al. 2009). Yatable et al. (2002) used a whole animal model to assess the effects of 7 
days of 0.5g/kg taurine supplementation on rat skeletal muscle taurine content. Skeletal muscles of the 
leg displayed a significant increase in taurine concentration post treatment which was followed by an 
increased time to fatigue of subsequent treadmill running until exhaustion. Post exercise the 
supplemented rats demonstrated a reduction in the decrease in skeletal muscle taurine concentration 




not prevail in the present acute study suggesting that any increase in soleus muscle taurine concentration 
from the given treatment was not sufficient enough to substantially increase total muscle taurine 
concentration. 
Tallis et al. (2013; chapter 5) demonstrated a decreased time to fatigue in caffeine treated soleus muscle 
which was attributed to an increase in eccentric work during the lengthening phase of the work loop. In 
fatigue under control conditions muscle relaxation time is prolonged due to an increase in intracellular 
Ca2+ concentration (Askew et al. 1997). It is believed that this effect is amplified in the presence of 
caffeine resulting in the muscle being active to a greater extent at the end of shortening, hence greater 
work is required to stretch the muscle back to its resting length (Tallis et al. 2013; chapter 5). This 
provides a partial explanation as to why TC fatigues faster than controls. A combination of increased 
eccentric work during fatigue in caffeine treated soleus muscles and a higher starting power output may 
result in a greater oxidative stress and damage to muscle tissue. Silva et al. (2011) demonstrated that 
chronic supplementation of taurine in rats (1-ml 300mgkg−1 per body weight) had a cytoprotective role in 
exercise induced muscle injury. Although this mechanism is not ruled out by the authors it is unlikely that 
the taurine concentration used in the present study will increase intramuscular taurine levels enough to 
generate this mechanism. Moreover, Tallis et al. (2012; chapter 4) highlighted the diverse individual acute 
response to 70µM caffeine and a clear division of responder and non-responders to the treatment. The 
difference in time to fatigue between CAF and TC are most likely to be due to individual differences in 
response to the caffeine treatment and the ratio of responders and non-responders between the 
treatment groups. This is partly supported in the present study by the increase in SE for the TC trial 
compared to CAF that (Fig 6.4.2). 
The Effect of Physiological Concentrations of Taurine and Caffeine on Recovery from Fatigue 
Treatment of mouse soleus muscle with taurine (T), caffeine (CAF), or taurine and caffeine (TC) combined 
failed to significantly increase recovery compared to controls. This is similar to the findings of James et al. 




both mouse soleus and EDL following fatigue. The established ergogenic benefit of caffeine on direct 
muscle power output of non-fatigued muscle is not great enough to offset the problems in calcium 
handling that occur during fatigue (Tallis et al. 2012; chapter 4; Allen et al. 2008). 
Intramuscular taurine concentration will decrease during fatigue (Kim et al. 1986; Matsuzaki et al. 2002). 
In light of the present results, it is likely that the given concentration of taurine used in the present study 
is not great enough to significantly increase intramuscular taurine concentration to a level which would 
evoke such effects; therefore, there was no enhancement of muscle recovery. With no significant effect 
of either taurine or caffeine alone, it is unsurprising that combining these treatments also failed to elicit 
an enhanced fatigue recovery.   
Practical Implications of the Present Findings 
The present findings infer that taurine does not provide any acute ergogenic effect directly on skeletal 
muscle. This questions the inclusion of taurine into energy drinks that are designed to promote short-
term increases in physical performance. However, further research investigating the effect of taurine on 
other physiological systems, particularly central effects, should also be considered. Although evidence for 
the prolonged supplementation of taurine has been well established, achieving this through the regular 
consumption of caffeine containing energy drinks would not be ideal. Regular consumption of caffeine 
has been shown to result in habituation and a dampening of the ergogenic effects, therefore increasing 
muscular taurine via this method may sacrifice the benefit of caffeine (Bell & Mcleellan, 2002). In addition 
to the high quantity of carbohydrate in such drinks, the present findings and the previous work by Tallis et 
al. (2012, 2013; chapters 4 & 5) have demonstrated that caffeine is likely the key ingredient in energy 
drinks to provide an acute effect directly on skeletal muscle performance. 
Acute treatment of taurine on isolated skeletal muscle failed to elicit any significant effect on mouse 
soleus muscle performance. One off maximal muscle power output, time to fatigue and recovery from 




the same parameters. In conclusion, a physiological level of taurine did not provide any direct short-term 























7. Is the Age Related Decline in Skeletal Muscle Function Muscle Specific? The Effect of Ageing on 






















The present study is the first to use the work loop technique to examine the alteration in skeletal muscle 
mechanical properties over a range of ages. The decline in skeletal muscle function occurs relatively early 
in life and should not be soley considered a syndrome of old age. The present research considers 
developmental alterations that occur in skeletal muscle function as well as changes at various stages 
beyond physiological maturity. Measurements of maximal isometric stress, activation and relaxation time, 
maximal power output, fatigue resistance and recovery are compared in muscle isolated from mice 3, 10, 
30 & 50 weeks old. This study uniquely compares the ageing response between peripheral locomotory 
EDL and core diaphragm muscles to examine if any differences in the ageing effect are related to 
anatomical location and function. A progressive age related reduction in maximal isometric stress that 
was of greater magnitude to the decrease in maximal muscle power output occurred in both muscles. 
Maximal force and power developed earlier in diaphragm muscle compared to EDL, but demonstrated a 
greater age related decline. These results are also the first to provide evidence to rationalise the equivocal 
literature that examines the relationship between increasing age and endurance capacity. The present 
study indicates that skeletal muscle fatigue resistance is age and muscle dependant. Despite this, both 
EDL and diaphragm displayed a typical trend of increased fatigue resistance from 10 to 30 week old, 
followed by a decrease thereafter to 50 week old. The recovery of muscle power output post fatigue was 
significantly greater in 3 week old mice; there was no age dependant effect on recovery of diaphragm 
muscle. In EDL, the age related decline in muscle performance is prevalent without significant atrophy 
indicating, at least in part, that ageing affects skeletal muscle contractile performance independently of 
atrophy.  







Sarcopenia is commonly associated with old age and refers to the age related reduction in skeletal muscle 
function; primarily a loss of muscle mass, strength and a slowing of contractile function that greatly 
reduces mobility and subsequently the quality of life in elderly populations (Williams et al. 2002). 
However, it has been established that muscle atrophy and associated decline in skeletal muscle 
performance can occur as early as 25 years of age in humans, which is greatly accelerated in the later 
stages of life (Lexell et al. 1995). Despite the maintenance of a physically active lifestyle it is impossible to 
fully offset the age related decline in muscle function and changes in body composition (Klitgaard et al. 
1990). Little is known about the rate of decline in muscle performance between peak performance and 
‘old age’. Subsequently the present study aims to assess the mechanical properties of mammalian skeletal 
muscle during development and at various stages post physiological maturity in an attempt to assess early 
signs of an age related decline in muscle performance. 
A reduction in skeletal muscle strength (maximal force in a single attempt) and power (the rate at which 
work is done; the product of force produced and the speed of muscle shortening) are commonly 
established effects of the ageing process (Doherty, 2003; Deschenes, 2004). Murray et al. (1980; 1985) 
reported that isometric strength of the knee flexor and extensor muscles reduced by an average of 55-
65% and 56-78% in elderly men and women respectively. A range of human and in vitro research studies 
using mammalian muscle isolations have supported the age related reduction in the maximal force 
generating capacity (Brooks & Faulkner, 1988; Zhang & Kelsen 1990, Gonzalez & Delbobo, 2001). Some 
studies have demonstrated that the decline in muscle power is significantly faster than the loss of 
strength, which has been in part attributed to a reduction in the muscle force-velocity relationship and 
maximal unloaded shortening velocity (V0) (Metter et al. 1997; Thompson and Brown, 1999; Krivickas, 
2001; Raj et al. 2010). However, Brooks and Faulkner (1988) demonstrated a reduction in mouse EDL (by 




The evidence investigating the effect of ageing on muscle endurance (the ability of the muscle to resist 
fatigue) is somewhat equivocal, and discrepancies in results are likely to stem from the variation in 
experimental methods. Differences are apparent in the fatigue protocol, the duration for which muscle 
endurance is measured and the muscle groups tested (Deschenes, 2004). Izquierdo et al. (2001) reported 
a significant reduction (19 % when related to body mass) in the maximal workload of elderly subjects 
following a multistage incremental cycling test. A similar relationship between increasing age and reduced 
skeletal muscle endurance has been established in other in vivo research (Lennmarken et al. 1985; Davies 
et al. 1986). In contrast Lindstrom et al. (1997) failed to demonstrate any significant effect of ageing on 
muscular endurance of the knee extensor muscles of elderly subjects despite the characteristic reduction 
in maximal voluntary contraction; findings further supported by Backman et al. (1995) and Bemben et al. 
(1996). Furthermore in vitro research by Pagala et al. (1998) reported a significant increase in the fatigue 
resistance of rat soleus muscle stimulated via repeated isometric contractions. Interestingly, this did not 
correspond to the reduction in whole animal endurance in a running and swimming task. Pagalaet al. 
(1998) therefore concluded that the age related increase in fatigue was attributed to central or extra-
muscular processes. Despite this an increased fatigue resistance following isometric contraction of ankle 
dorsiflexor muscle in older human subjects has been demonstrated without subsequent reduction in 
neural activation (Kent-Braun et al. 2002).  
As ageing affects a number of physiological systems, the degenerative process resulting in sarcopenia is 
likely to arise from numerous molecular and cellular factors. Muscle wasting correlates strongly to an age 
related reduction in muscle performance. It has been suggested that a reduction in motor unit number 
and size, decreased protein synthesis, disuse atrophy mechanisms, and alterations in hormone production 
make up a number of interacting factors that result in muscle wasting (Gray et al. 1991; Veldhuis et al. 
1997; Welle et al. 1998; Navarro et al. 2001). Furthermore, age related changes in muscle contractile 
performance also seem to be related to both a shift to a more oxidative muscle composition and a 
reduction in the excitation contraction coupling performance (Aniansson et al. 1986; Coggan et al. 1991; 




Although the effects of sarcopenia are well documented within the literature, discrepancies in the 
evidence exist as to the level at which muscle performance is lost. Much of the previous ageing research 
that measure muscle contractility in rodents compare a physiologically mature population against an aged 
population and such use rodents older than those in the present study. The current research aims to 
uniquely examine skeletal muscle function at various time points between physiological maturity and ‘old 
age’ in order to develop a greater understanding of the ageing process and determine the rate of decline 
in muscle performance beyond physical maturity. Furthermore studies that assess age related changes in 
muscle power output in isolated muscle are scarce, and calculations of muscle power constructed form 
force velocity data and maximal isometric force, as by Brooks and Faulkner (1998), have been 
demonstrated to be poor estimates of power output obtained from the work loop technique (James et al. 
1996).The present study is the first to use the work loop technique to form a closer representation of in 
vivo muscle usage (Josephson, 1985) to improve our understanding of the age related changes in skeletal 
muscle performance. Although research examining the phenomenon of skeletal muscle ageing using 
isometric measures has provided a valuable insight, this form of muscle action is relatively rare in vivo and 
may relate to the discrepancies in relating these results to whole animal performance (Chan & Head, 
2010). Furthermore, it is likely that the age related decline in muscle performance is muscle specific, the 
greater reduction in the cross sectional area of type II fibers suggests that skeletal muscle with a 
predominantly faster fiber type will show the greatest response to ageing (Aniansson et al. 1986; 
Alnaqeeb & Goldspink, 1986; Coggan et al. 1991). In addition, beyond physiological maturity increasing 
age is associated with a reduced physically active lifestyle and as a consequence related disuse atrophy 
might play an important part in the loss of locomotory muscle performance that may not be as 
predominant in core respiratory skeletal muscle. 
The present study aims to use isolated mouse EDL (relatively fast fiber type) and diaphragm (more mixed 
fiber type) muscle to build a unique profile of the age related changes in muscle mechanical properties 
that occur at various age between developmental and ‘middle aged’ mice by examining changes in: 1) 




of muscle power output; 4) post fatigue recovery. By eliminating CNS, peripheral nerve, and 
neuromuscular junction innervations the present study will quantify the magnitude of the ageing 
response by direct stimulation of skeletal muscle. 
By making further comparisons between mouse EDL and diaphragm muscle the present study is also the 
first to assess the effects of increasing age between a peripheral and a core muscle with different 
anatomical location, function and predominant fiber type. It is predicted that the rate of muscle 
development and the reduction in performance due to increasing age will be muscle specific as 
locamotrory muscle may be subject to disuse atrophy mechanisms to a greater degree than core 
diaphragm muscle. Furthermore difference in predominant fiber type expression between EDL and 
diaphragm are likely to be subjected to developmental changes at different rates. Increasing age beyond 
physiological maturity will be associated with a reduction in maximal muscle power output (and 
corresponding muscle activation and relaxation time) that will be greater in magnitude than the reduction 
in maximal force. The effect of increasing age on fatigue resistance will again be muscle specific; generally 












7.3. Materials and Methods 
A more detailed account of the methods is given in the general methods section (chapter 3). 
From birth mice were housed in groups of 8 without access to running wheels and aged to 3 weeks, 10 
weeks, 30 weeks, and 50 weeks (n = 20 for each age group) before sampling. Pups were weaned 21 days 
postpartum, thus 3-week-old mice were used to represent muscle in a developmental stage. 10 week old 
mice where used to represent physical maturity. Mice at 50 weeks were used to represent ‘middle age’. 
Results presented by Lang & White (2000) demonstrate a good survival rate of CD1 mice during the first 
12 months. At 50 weeks survival rates were above 85%, however beyond this point mortality rate 
increased more rapidly. Lang & White (2000) further showed a  mortality rate of approximately 50% at 18 
months, thus mice beyond this would be deemed ‘old aged’ and are representative of rodents used in 
previous work (Brooks & Faulkner, 1988; Gonzalez et al. 2000; Gonzalez & Delbono, 2001). 12 month old 
mice were also used to represent a ‘middle aged’ group by Gonzalez et al. (2000) who investigated the 
reduction in specific force of EDL and soleus muscle fibers. 
Either EDL muscle (9.3% type IIX, 86.8% type IIB in 90 day old mice; Agbulut et al. 2003) was dissected 
from the left hind limb and immediately frozen in liquid nitrogen. EDL from the right hind limb was used in 
the muscle mechanics assessments. Or whole diaphragm muscle (15.6% type I, 43.6% type IIA, 34.6% type 
IIX, 6.2% type IIB in 90 day old mice; Agbulut et al. 2003) was dissected from a separate mouse and 
subsequently split in half; the right hand side was immediately frozen in liquid nitrogen while the central 
portion of the second section was used in the muscle mechanics protocol: aluminium foil T-clips were 
wrapped around the central tendon at one end, however, at the opposing end two ribs anchoring the 
muscle were left intact. 
Once dissected the muscle was placed in the muscle bath in circulated oxygenated Krebs solution at 37oC. 
Muscle length and stimulus amplitude (14-18V for EDL; 10-16V for diaphragm; current fixed at 160 mA) 




Maximal isometric tetanic force was measured by subjecting each muscle preparation to a 250ms burst of 
electrical stimulation. The frequency of stimulation was further optimised in order to yield maximal 
tetanic force; this was usually 200Hz for EDL, 140Hz for diaphragm and did not change with age. Time to 
half peak tetanus (THPT), or the time from the start of force production until half the peak force is 
achieved, and time from last stimulus to half tetanus relaxation (LSHR), the time between the end of 
stimulation and the reduction in force to half of maximum, were measured as indicators of muscle 
activation and relaxation time. A 5-minute rest period was imposed between each tetanus in order to 
allow sufficient time for the muscle to recover. 
All EDL and diaphragm muscle followed this process of isometric measures before proceeding on to the 
subsequent work loop protocol. 
 The Work Loop Technique 
A cycle frequency of 10Hz and 7Hz was used for EDL and diaphragm muscle, respectively. 10Hz represents 
the cycle frequency that has been previously shown to elicit maximal power output in isolated mouse EDL 
(James et al. 1995). 7Hz was the cycle frequency found to elicit maximal power concurrent with the 
finding of Altringham and Young (1991). Usually a 49ms burst of electrical stimulation applied through the 
shortening phase of the work loop was used for EDL in keeping with that used at 10Hz cycle frequency in 
James et al. (1995). The burst duration commonly used to elicit maximum power output in diaphragm 
muscle was 55 ms. On occasions the burst duration had to be increased or decreased to adjust the 
number of stimuli given to maximise power output in individual muscle preparations. A stimulation phase 
shift of -2 ms and -5 ms were used for EDL and diaphragm respectively as they elicited maximal power 
output. 
The work loop protocol lasted 180 minutes; during this time assessments of each muscles maximum 






Figure 7.3.1. -  Schematic of the work loop protocol to examine fatigue when maximally stimulated, the 
recovery of maximal muscle power output after fatigue, and the ergogenic effect of 70µM caffeine on 
acute muscle power output in developmental and middle aged mouse EDL and Diaphragm muscle 
Maximal Acute Power: The parameters employed to elicit maximal work loop power output for both EDL 
and diaphragm have been outlined above. Each muscle was subjected to four sinusoidal length change 
cycles at 10-minute intervals until maximal muscle power output was achieved. It can take time for 
muscle to equilibrate to the protocol; however, maximal power output was usually achieved within 3 
measurements. The third work loop of each set of four typically produced the highest power and was 
therefore taken as the indicative measure of muscle power output in all work loop experiments. A 10-
minute rest interval was imposed between each set of four work loops in order to allow the muscle 
sufficient recovery time. 
The Effect of 70µM Caffeine Treatment: The protocol (Fig 7.3.1.) to test the effects of 70µM (physiological 
maximum) different aged muscle was 130 minutes. The methods and results are discussed in a separate 
chapter (Chapter 8). 
Time to Fatigue: Following the treatment of each muscle preparation with caffeine the muscle was 
allowed to equilibrate in standard Krebs-Henseleit solution for 40 minutes prior to the fatigue run (Fig 
7.3.1.). This time duration has previously been shown to adequately washout any effects of 70µM caffeine 
treatment (James et al. 2005; Tallis et al. 2012; chapter 4). In order to test fatigability each muscle was 
then subjected to 50 consecutive work loop cycles using the stimulation and length change parameters 
that elicited maximal power output. In light of our previous findings in chapter 2, 50 consecutive work 




for every second loop until force had significantly reduced and a plateau occurred, or until net work was 
negative.  In contrast to the methods in chapters 5 and 6 fatigue was plotted until net power was below 
50% as not all muscles fatigued until net negative work was produced and it was difficult to accurately 
determine where the plateau had occurred. 
Recovery from Fatigue: The ability of the muscle to recover from fatigue was monitored for 30 minutes 
following the fatigue run. Three measurements of maximal work loop power output were made every 10-
minutes and were compared directly to the pre fatigue maximum muscle power output (Fig 7.3.1). 
At the end of the experiment the muscle was detached from the rig, tendons removed, then weighed in 
order to calculate isometric stress (kN.m-2) and normalised muscle power (W.kg-1). 
Statistical Analysis of Data 
In order to assess the effect of age on isometric twitch stress, maximal tetanus stress, isometric times, 
and maximum work loop power output single factor ANOVA were conducted in SPSS (Version 16, SPSS 
inc., IL, USA) on each data set for EDL and diaphragm. Tukey post hoc tests were conducted to see where 
specific differences occurred. Unpaired TTests were used at each age to identify differences in these 
parameters between EDL and diaphragm muscles. 
Separate two factor ANOVA were conducted on each muscle to determine if there was an effect of age on 
time to fatigue/recovery from fatigue, and if muscle power output changed overtime. Tukey post hoc 
tests were conducted on age in order to identify where these differences occurred. In the present study 
muscle fatigue was defined as when the muscle produced less than 50% of its pre fatigued maximal 
power output. Therefore, statistical analysis was only performed on the data up to this point. 







Body & Muscle Mass 
Increasing age resulted in a significant increase in mean mouse body mass (Fig 7.4.1.). At 50 weeks of age 
mean body mass had increased by 73% compared to that at 3 weeks of age. The largest increase occurred 
between 3 and 10 weeks of age with the mean body mass of 10-week-old mice being 50% greater than 3-
week-old mice (Fig 7.4.1; Tukey p<0.001). A statistical tendency for an increase in body mass (by 23%) was 
shown between 10 and 30 weeks of age (Fig 7.4.1; Tukey p=0.076). Mean body mass at 50 weeks of age 
was significantly higher (by 28%) compared to that at 30 weeks of age (Fig 7.4.1; Tukey p<0.001). By 50 
weeks of age individual body masses had either increased above 70g (Fig 7.4.1; A) or appeared to stay 
below 50g (Fig 7.4.1; B) which is similar to the mean body mass at 30 weeks of age. If the 7 individuals in-
group A are omitted and mean body mass between 30 weeks of age and 50 weeks of age is compared, 
there is no significant difference (Fig 7.4.1; TTest p=0.89). These two distinct groups at 50 weeks infer that 
body mass will either plateau or continue to significantly increase.   
For EDL, muscle mass was significantly affected by age (ANOVAp<0.001). Mean muscle mass at 3 weeks of 
age was 6.7±0.5mg and significantly lower than all other age groups (Tukey p<0.001 in all cases). Peak 
muscle mass was 16±0.8mg and occurred in animals aged 50 weeks of age, this proved to be significantly 
greater than the 12.4±0.4mg at 10 weeks of age. Similar measures were not made for diaphragm as 











Figure 7.4.1 – The effect of age on the mean and individual body mass of CD1 mice. A subdivision in the 
50 week data is highlighted by A & B. Data labelled A represents 50 week old mice with body mass greater 
than 70g, whereas data labelled B represents 50 week old mice with body mass below 50g [Data 
represented as mean ± SE; n=20 for each age group] 
 
Maximal Isometric Twitch Stress 
Mean twitch stress was significantly affected by age in both EDL and diaphragm muscle (Fig 7.4.2; ANOVA 
p<0.006 in both cases). For EDL mean twitch stress was greatest in mice at 10 weeks of age and was 
significantly reduced (by 39%) at 3 and (by 27%) 50 weeks of age (Fig 7.4.2; Tukey p<0.007 in both cases). 
Furthermore EDL twitch stress had a tendency to be reduced (by 20%) at 30 weeks of age when compared 
to 10 weeks of age (Fig 7.4.2; Tukey p=0.054).EDL stress in 3-week-old mice had a tendency to be lower 
than at 30 weeks of age (Fig 7.4.2; Tukey p=0.063), but was not significantly different to 50 weeks of age 
(Fig 7.4.2; Tukey p=0.336). There was no significant difference between twitch stresses at 30 and 50 
























In diaphragm muscle mean twitch stress was greatest at 10 weeks of age and had significantly reduced at 
30 (by 34%) and 50 weeks of age (by 27%) (Fig 7.4.2; Tukey p<0.04 in both cases). There were no further 
significant differences in mean twitch stress between 3, 10, 30 and 50 weeks of age (Fig 7.4.2 Tukey 
p>0.17 in all cases).  
Mean isometric twitch stress of EDL was significantly higher than diaphragm at 10, 30 and 50 weeks of 
age (Fig 7.4.2; TTest p<0.001 in each case).However, at 3 weeks of age there was no significant difference 








Figure 7.4.2 – The effect of age on mean maximal isometric twitch stress of mouse EDL and diaphragm 
muscle [Data represented as mean ± SE: n=10 in each case 
 
Maximal Isometric Tetanus Stress  
For both EDL and diaphragm mean maximal isometric tetanus stress was significantly affected by age (Fig 
7.4.3; ANOVA p<0.03 in each case). For EDL mean maximal isometric tetanus stress was achieved at 10 

































had a tendency to be lower at 3 (by 17%) and 30 weeks of age (by 18%)(Fig 7.4.3; Tukey p<0.1 in both 
cases). There were no significant differences in maximal isometric tetanus stress between 3, 30 and 50 
weeks of age (Fig 7.4.3; Tukey p>0.9 in all cases). At 10 weeks maximal isometric twitch stress was 
significantly higher than the value at 8 weeks reported in chapter 4 (Tukey p<0.005). 
In the diaphragm muscle the highest value for mean maximal tetanus stress was achieved at 10 weeks of 
age andwas significantly reduced at 30 (by 28%) and 50 weeks of age (by 33%) (Fig 7.4.3; Tukey p<0.004 in 
both cases).There was no significant difference in mean tetanus stress between 3 weeks of age and 10, 30 
weeks of age (Fig 7.4.3; Tukey p>0.1 in both cases). However, mean tetanus stress at 3 weeks of age was 
significantly greater than at 50 weeks of age (Fig 7.4.3; ANOVA Tukey p=0.024). Furthermore there was no 
significant difference in stress between 30 weeks of age and 50 weeks of age (Fig 7.4.3; Tukey p=0.924).  
When compared to diaphragm, EDL produced significantly greater isometric tetanus stress at each age 
group (Fig 7.4.3 TTest p<0.001 in all cases).  
 
Figure 7.4.3 – The effect of age on mean maximal isometric tetanus stress in mouse EDL and diaphragm 



































Isometric Activation and Relaxation Times 
For EDL mean Time to Half Peak Tetanus (THPT) and Last stimulus to Half Relaxation (LSHR) were 
significantly affected by age (Fig 7.4.4; ANOVA p<0.004 in both cases). Mean THPT at 3 weeks of age was 
significantly longer (by up to 46%) than at 10, 30, and 50 weeks of age (Fig 7.4.4A; Tukey p<0.001 in all 
cases). THPT was not significantly different between 10, 30 and 50 weeks of age (Fig 7.4.4A; Tukey p>0.6 
in each case). LSHR was significantly prolonged at 50 weeks of age(by up to 32%) compared to 3, 10 and 
30 weeks of age (Fig 7.4.4B; Tukey p<0.05 in all cases). There were no further significant differences in 
THPT between 3, 10 and 30 weeks of age (Fig 7.4.4; Tukey p>0.6 in all cases).  
In diaphragm muscle mean THPT was significantly affected by age (Fig 7.4.4; ANOVA p=0.036). Mean THPT 
was significantly longer (by 19%) at 30 weeks of age compared to at 10 weeks of age (Fig 7.4.4; Tukey 
p=0.021). There were no further significant differences in THPT between 3, 10, 30, and 50 weeks of age 
(Fig 7.4.4; Tukey p >0.3 in each case). For diaphragm muscle mean LSHR was not significantly different 
between age groups (ANOVA p = 0.103).  
Mean THPT and LSHR times were significantly shorter in EDL compared to diaphragm at each age tested 
















































Figure 7.4.4 – The effect of age on mean isometric tetanus muscle activation time (A: THPT; time to half 
peak tetanus) and relaxation time (B: LSHR; last stimulus to half tetanus relaxation) in mouse EDL and 
diaphragm muscle [Data represented as mean ± SE: n=10 in each case) 
 
Work loop Power Output  
Work Loop Power Output Normalised to Muscle Mass (Watts/kg) 
For both EDL and diaphragm mean maximal work loop power output, normalised to muscle mass, was 
significantly affected by age (Fig 7.4.5; ANOVA p<0.025 in both cases).  For EDL mean maximal work loop 
power output peaked at 10 weeks of and was significantly higher than at 3 weeks of age (Fig 7.4.5; Tukey 
p=0.014).Despite a 13% decrease in mean work loop power output by 50 weeks of age this did not prove 






In diaphragm mean maximal work loop power output was achieved at 10 weeks of age and was 
significantly reduced at 50 weeks of age (by 23%) (Fig 7.4.5; Tukey p=0.012). Work loop power output at 3 
weeks of age had a tendency to be greater than that 30 weeks of age (Fig 7.4.5; Tukey p=0.064), 
otherwise there were no further statistical significances in this data set (Fig 7.4.5; Tukey p>0.4 in all 
cases). 
Maximal work loop power was greater at 10 weeks compared to 8 weeks as presented in chapter 4 (Tukey 
p=0.045). Furthermore, mean work loop power output was significantly greater in EDL compared to 
diaphragm at 3, 10, 30 and 50 weeks of age (Fig 7.4.5; TTest p<0.001 in all cases). 
 
Figure 7.4.5 – The effect of age on mean maximal work loop power output plotted as Watts per kilogram 
muscle mass for mouse EDL and diaphragm muscles [Data represented as mean ± SE: n=10 in each case) 
 
Work Loop Power Output Normalised to Whole Animal Body Mass (Watts/g) 
Locomotory muscles produce power to move the mass of the body, therefore, a key issue is the ability of 
the muscle to produce power relative to the mass of the body. Mean muscle PO, normalised to body 



































work loop power output, when normalised to body mass, was highest at 10 weeks of age and had 
significantly decreased (by 22%) at 50 weeks of age (Fig 7.4.6; Tukey p=0.023). Furthermore body mass 
specific power output at 3 (by 20%) and 30 weeks (by 19%) of age had a tendency to be reduced (Fig 
7.4.6; Tukey p<0.07) in comparison to 10 weeks of age. There was no significant difference in mean body 
mass specific muscle power output of EDL between 3, 30 and 50 weeks of age (Tukey p>0.9 in all cases). 
Similar calculations cannot be made for diaphragm muscle as whole diaphragm muscle mass was not 
measured. 
 
Figure 7.4.6 – The effect of age on mean maximal work loop power output plotted as Watts per gram 
body mass for mouse EDL [Data represented as mean ± SE: n=10) 
The Effect of Increasing Age on Work Loop Shape of Maximally Stimulated Muscle  
The area of the work loop represents the net work of that particular cycle; the typical work loop shapes 
presented in Figure 7.4.7 clearly demonstrate that for EDL net work is the greatest at 10 and 30 weeks, 
net work is reduced at 50 weeks and is again lower at 3 weeks (Figure 7.4.7; A). Similarly for diaphragm 
(Figure 7.4.7; B) net work is greatest at 10 weeks and this is similar to that at 30 weeks. Net work is 






























(Figure 7.4.7; A) show an increased relaxation time, a phenomenon that is not as pronounced in 







Figure 7.4.7 - The effect of age on typical work loop shapes of: A) mouse diaphragm maximally stimulated 
at 7Hz cycle frequency and B) EDL maximally stimulated at 10Hz cycle frequency 
Fatigue Resistance 
The fatigue protocol resulted in a significant reduction in mean muscle power output over time for both 
EDL and diaphragm muscle (Fig 7.4.8 & 7.4.9; ANOVA p<0.001 in both cases). Time to fatigue was also 
significantly affected by age in both EDL and diaphragm muscle (Fig 7.4.8 & 7.4.9; ANOVA p<0.001 in both 
cases). 
For EDL, time to 50% fatigue at 50 weeks of age was significantly faster than that at 3 (by 31%), 10 (by 
18%) and 30 weeks of age (by 25%)(Fig 7.4.8; Tukey p<0.001 in all cases). Time to 50% fatigue of EDL at 10 
weeks of age was significantly faster than 3 (by 15%) and 30 weeks of age (by 8%)(Fig 7.4.8; Tukey 
p<0.001 in each cases). There was no significant difference in time to 50% fatigue between 3 weeks of age 
and 30 weeks of age (Fig 7.4.8; Tukey p=0.97). 
In diaphragm muscle time to 50% fatigue was significantly faster at 10 weeks of age compared to 3 (by 









fatigue at 50 weeks of age was significantly faster than at 3 (by 21%) and 30 weeks of age (by 8%) (Fig 
7.4.9; Tukey p<0.001 in both cases). Diaphragm at 30 weeks of age fatigued significantly faster than that 
at 3 weeks of age (Fig 7.4.9; Tukey p=0.001). 
 
 
Figure 7.4.8 – The effect of age on fatigue of maximal muscle power output in mouse EDL [Data 































   
Figure 7.4.9 – The effect of age fatigue of maximal muscle power output in mouse diaphragm [Data 
represented as mean ± SE: n=10 in each case; wks = weeks of age 
Figures 7.4.10 & 7.4.11 depict typical work loop shapes at various points of the fatigue run for EDL and 
diaphragm muscle, whereby in general fatigue is associated with reduced net work over time as the area 
of the work loops reduce. 3 week EDL (Figure 7.4.10; A) had the smallest reduction in the area of the work 
loop with fatigue, this is also associated with minimal change in muscle relaxation time over this period. 
Work loop shapes from 10 and 50 weeks (Figure 7.4.10; B & D) demonstrate a much larger increase in 
muscle relaxation time over the time course of the fatigue run. The area of the work loop 18 appears to 
be less at 50 weeks (Figure 7.4.10; D) compared to other age groups. For diaphragm muscle the work loop 
shapes indicate that fatigue is associated with an increased relaxation time, which is more greatly 
pronounced in 10 week old muscle (Figure 7.4.11; B). Changes in relaxation time during fatigue at 30 











































Figure 7.4.10 - The effect of age on typical work loop shapes of mouse EDL muscle maximally fatigued at 
10Hz cycle frequency; (A) 3 week old mice (B) 10 week old mice (C) 30 week old mice (D) 50 week old 



























Figure 7.4.11 - The effect of age on typical work loop shapes of mouse diaphragm muscle maximally 
fatigued at 7Hz cycle frequency; (A) 3 week old mice (B) 10 week old mice (C) 30 week old mice (D) 50 
week old mice; the figures depict work loops 2 (0.29s of the fatigue run), 10 (1.43s) and 18 (2.57s) of the 
fatigue run 
Although EDL muscle from 10 week old mice produced the greatest power, there was little difference in 
total cumulative work between 3 and 10 weeks (Fig 7.4.12). Cumulative work was reduced in EDL muscle 
from 30 week old mice and again further at 50 weeks (Fig 7.4.12). Diaphragm muscle from 3 week old 
mice produced the greatest cumulative work compared to all other age groups tested (Fig 7.4.13). Despite 
10 week old diaphragm producing greater power than in 30 week old mice the total cumulative work was 










Figure 7.4.12. – The effect of increasing age on the relationship between power output and cumulative 
work in mouse EDL muscle. [Data represented as mean & SE for every second loop of the fatigue protocol; 
n = 10 in each case] Note, that for clarity, not all error bars have been added. 
 
 
Figure 7.4.13. – The effect of increasing age on the relationship between power output and cumulative 
work in mouse diaphragm muscle. [Data represented as mean & SE for every second loop of the fatigue 






















































Recovery from Fatigue 
For EDL, the 30-minute recovery period was sufficient to induce a significant increase in mean muscle 
power output over time. (Fig 7.4.14; ANOVA p=0.002). There was a significant effect of age on the 
recovery of muscle power output post fatigue (Fig 7.4.14; ANOVA p<0.001). The peak recovery over the 
30-minute duration was 67%, 47%, 34% and 45% for 3, 10, 30 and 50-week groups respectively. Mean 
recovery of EDL at 3 weeks of age was significantly greater than that at 10, 30 and 50 weeks of age (Fig 
7.4.14; Tukey p<0.02 in all cases). Recovery at 30 weeks of age was significantly reduced compared to 10 
and 50 weeks of age (Fig 7.4.14; Tukey p<0.001). There was no significant difference in recovery between 
10 and 50 weeks of age (Fig 7.4.14; Tukey p=1). 
Peak recovery for diaphragm muscle occurred 10 minutes post completion of the fatigue run; there was 
no further subsequent recovery following this time (Fig 7.4.15; ANOVA p=0.499). The level of recovery 
was not significantly different between age groups (Fig 7.4.15; ANOVA p=0.385). Peak recovery was 89%, 








Figure 7.4.14 – The effect of age on mean recovery of power output from fatigue in mouse EDL [Data 




Figure 7.4.15 – The effect of age on mean recovery of power output from fatigue in mouse diaphragm 









































































Effect of Age on Maximal Skeletal Muscle Force, Power Output, and Activation and Relaxation 
Times 
From the age range used in the present study, muscles dissected from 10-week-old mice were deemed to 
be at physical maturity in terms of mechanical performance of skeletal muscle. For both EDL and 
diaphragm muscle 10-week-old mice produced the highest isometric stress, lowest activation and 
relaxation times, and highest power output. As was concluded by Chan and Head (2010), the present 
results indicate that the response of EDL muscle to ageing occurs independent of muscle atrophy as there 
was no age related reduction in muscle mass in this instance.  
Development 
EDL muscle from 3-week-old mice demonstrated lower maximal isometric stress and power, and 
increased activation time compared to the 10 week old. In contrast, there were no significant differences 
in maximal isometric stress, activation time, relaxation time, or work loop power in diaphragm muscle 
from 3-week-old mice compared to diaphragm from 10-week-old mice. Initially, this suggests that 
diaphragm muscle reaches its mature peak performance at a younger age than EDL and subsequently may 
underline the importance of the physiological function of breathing in comparison to locomotory 
performance in the early stages of life. 
The reported differences between the tested muscles are likely to relate to the speed of development of 
the contractile properties. Skeletal muscle maximal force and the rate that this force is developed are 
largely related to the efficiency of the excitation contraction coupling process, and more specifically, the 
rate and quantity of SR Ca2+ release into the intramuscular space (Berchtold et al. 2000). It has been 
established that at birth the quantity of skeletal muscle SR is limited and occurs as only a loose network of 
tubes (Schiaffino & Margreth, 1969; Luff and Atwood, 1971). Luff and Atwood (1971) further 




volume at birth to 5.5% in adult EDL. Conversely, the SR content of soleus muscle (relatively slow) 
occupied 1.7% of the total muscle volume at birth, which increased to 2.9% in adult soleus. Luff and 
Atwood (1971) quantified the rate of SR development in these muscles, reporting that the majority of 
growth occurred in the initial 20 days and had reached adult values by 30 days in soleus and was still 
increasing after 60 days in EDL. This suggests that muscles with a predominantly faster phenotype at 
maturity take longer to develop the optimised process of excitation contraction coupling. The maturation 
of the SR Ca2+ release mechanism is related to age related shifts in predominant phenotype. Agbulut et 
al. (2003) demonstrated that after 21 days post gestation type IIb myosin heavy chain represented 54% of 
the total proportion of EDL, which increased to 87% at 90 days. As is widely recognised these fibers 
coincide with a greater normalised maximal force and power output and more rapid activation time due 
to enhanced contractile characteristics and glycolytic potential  (Zierath & Hawley, 2004; Tallis et al. 2012; 
chapter 4).  These findings help to explain the more rapid maturation of mechanical properties in 
diaphragm then EDL in the present study.  
A further point to note is that maximal isometric stress and work loop power at 10 weeks was significantly 
greater (by 20% and 14% respectively) than the values at 8 weeks reported in chapter 4. This difference 
further highlights the speed of development in the muscle mechanical properties of the mouse. 
Post Physical Maturity  
After reaching maturity at 10 weeks of age, a relationship between increased age and reduced maximal 
isometric stress was evident in both EDL and diaphragm muscle. Interestingly the rate of decline in 
maximal stress was more greatly pronounced in diaphragm muscle. A reduction in maximal strength is a 
well-documented phenomenon in human studies and is supported by a reduction in isometric stress in 
previous in vitro research using older mammalian muscle isolations (Murray et al. 1980; 1985; 




In agreement with the findings of Chan and Head (2010), the present results indicate that an age related 
reduction in the mechanical performance of muscle may occur without associated atrophy. Interestingly, 
the muscle mass of EDL was significantly increased at 50 weeks of age and probably relates to a greater 
morphological size of the animal, with mice in this age range demonstrating an 83% increase in body mass 
when compared with 10 weeks of age. Evidence suggests that significant muscle atrophy only takes place 
in the final 20% of the animal’s lifespan and subsequently the ages of mice in the present study 
potentially precede this (Brooks & Faulkner, 1988; Brown & Hasser, 1996; Pagala et al. 1998; Chan & 
Head, 2010). With the relatively small reduction in EDL muscle mass indicated in these studies, it is 
especially likely that atrophy is not the sole contributor to reduced muscle performance during early 
ageing. 
The given reduction in the force generating capacity of EDL and diaphragm muscle is likely to relate to an 
age related decline in contractile function and fiber type composition.The age related reduction in 
functionality of excitation contraction coupling would greatly contribute to the loss of muscle function 
(Navarro et al. 2001). A decrease in the SR function associated with DHPR-Ryanodine Receptor uncoupling 
has been established; resulting in a reduction in the voltage gated SR Ca2+ release mechanism and 
consequently reduced Ca2+ availability at the contractile proteins (Larsson & Salviati 1989; Delbono et al. 
1995; Renganathan et al. 1997). Furthermore the reported age related reduction in Ca2+ pump activity 
would correlate with the increase in relaxation time seen in EDL muscle in the present study (Larsson & 
Salviati 1989; Hunter et al. 1999; Narayanan et al. 1996). 
Despite early work suggesting a higher age related decline in type II muscle fibers, it is now widely 
established that fiber number will decrease equally across all muscle fiber types (Lexell et al. 1988; 
Deschenes, 2004).A key aspect of the ageing phenotype appears to be a shift towards an oxidative 
metabolism with reduction in the cross sectional area of type II fibers being more pronounced (Aniansson 




likely that a slower muscle fiber type represents a greater proportion of the whole muscle cross sectional 
area and subsequently a reduced potential to produce high force. 
Results of the present study fail to support research suggesting that the decline in muscle power output 
occurs more rapidly than the reduction in strength (Metter et al. 1997; Skelton et al. 1994; Deschenes, 
2004). The magnitude of the reduction of maximal diaphragm power output was 23% compared to a 33% 
reduction in maximal isometric stress. Furthermore a significant reduction in muscle stress occurred at 30 
weeks of age whilst maximal power output was maintained until 50 weeks of age. Despite a significant 
decrease in maximal EDL muscle stress production and elevated relaxation time, increasing age from 30 
weeks to 50 weeks failed to have any significant effect on maximal muscle power output. This may 
suggest that the previously reported loss of power with age is a consequence of the further interaction of 
atrophy and CNS effects. The 13% decline in EDL power output between 10 and 50 weeks of age follows 
the same trend of that demonstrated in diaphragm (Fig 7.4.5); it is likely that this did not prove to be 
statistically significant due to the inter-individual variation in the data, possibly due to inter-individual 
differences in the rate of ageing.   
With no significant change in actual muscle power output (W.kg-1) with age in EDL muscle, we decided to 
examine how this would relate to whole animal performance by normalising muscle power output to 
body mass (W.g-1). In this instance increasing age resulted in a significant reduction in power output in 
equal magnitude to that seen in maximal force. Even though the actual power output (W.kg-1) of EDL 
muscle varies little with increasing age, whole animal in vivo locomotory performance is likely to be 
significantly reduced. In essence, for 50 week old mice, EDL muscle would be acting to move almost 
double the body mass compared to that of 10 week old mice and subsequently the animal is likely to 






Effect of Age on Skeletal Muscle Fatigue 
Results of the present study suggest that skeletal muscle fatigue resistance is affected by age and the 
pronunciation of the effects is muscle dependant. Despite these muscle dependent differences, a clear 
trend in the age related response has been established in the present study. Muscle in the development 
stage (3 weeks) has the greatest fatigue resistance; a significant reduction then occurs when the muscle 
reaches maturity (10 weeks). Following this, fatigue resistance significantly increases (30 weeks) before a 
second wave of reduced fatigue resistance with a further increase in age (50 weeks). This diverse and 
complex spectrum in the age related fatigue resistance response likely gives rise to the equivocal in vivo 
and in vitro results from studies that have previously examined this model (Lennmarken et al. 1985; 
Davies et al. 1986; Backman et al. 1995; Bemben et al. 1996; Lindstrom et al. 1997; Pagala et al. 1998; 
Izquierdo et al. 2001; Kent-Braun et al. 2002).  
Cumulative Work 
Cumulative work considers the total amount of work done by the muscle over the time course of the 
fatigue protocol and is related to the relationship between maximal work and fatigue resistance. During 
development cumulative work was greatest in 3 and 10 weeks old in EDL and is likely to be similar due to 
a greeter fatigue resistance at 3 weeks and subsequently a work can be produced over a longer duration. 
A similar principal can be applied for diaphragm muscle at 3 weeks where the greatest cumulative work 
was produced. 
For 30 weeks cumulative work was reduced in EDL compared to 3 weeks, although power output was 
similar this reduction in cumulative work should be attributed to a faster time to fatigue in these muscles. 
This decrease occurs beyond a reduction in power below 50% and thus differences in time to fatigue 
between these groups are not shown in fig 7.4.8. Although producing a similar power output to EDL at 3 
and 30 weeks, cumulative work for 50 week EDL was significantly reduced due to a reduced fatigue 




work was similar to 10 weeks due to a greater fatigue resistance. Cumulative work was lowest at 50 
weeks due to a reduced power and reduced fatigue resistance. 
Development 
In part, the complexity of these results may be explained by investigating the age related changes in 
muscle phenotype. Agbulut et al. (2003) quantified myosin heavy chain isoforms from birth to maturity in 
a number of skeletal muscles obtained from mice. At 21 days of age, EDL and diaphragm had a greater 
proportion of fibers with an oxidative capacity compared to mature levels. At this age EDL muscle was 
composed of 46% type I, IIa and IIx compared to these fibers making up 13% at 90 days. Consequently, 
type IIb fibers occupied the greatest percentage, which increased from 54% to 87% over this period. 
Although in diaphragm muscle from the same study there was little variation in the percentage of 
oxidative fibers (87% at 21 days compared to 94% at 90 days) unlike EDL neonatal myosin heavy chain was 
still present in diaphragm at 21 days. As demonstrated by Agbulut et al. (2003) it is likely that developing 
muscle from 3-week-old mice is composed of fibers with greater oxidative properties than at mature 
levels and subsequently show a greater resistance to fatigue. 
With these potential differences in fiber type composition of developing diaphragm, the question beckons 
as to why maximal force, power, and activation and relaxation times are similar between 3 and 10-week 
muscle? Results by Agbulut et al. (2003) indicate that in 21-day-old diaphragm muscle, the higher level of 
neonatal fibers may be compensated by an increased type IIb fiber expression. 
Post Physical Maturity  
The current study is the first to provide evidence that rationalizes the previous equivocal data that 
examines the relationship between ageing and fatigue resistance. The present results indicate that at the 
skeletal muscle level, fatigue resistance is age and muscle dependent and likely to relate to predominant 
fiber type expression. In vitro evidence demonstrating an increased fatigue resistance via repetitive 




mechanism promoted by this method (Gosselin et al. 1994; Pagala et al. 1998; Chan and Head, 2010). 
Unlike isometric measurements that primarily consider the decline in peak force, the work loop 
technique, as for in vivo power producing muscles, considers muscle force production over dynamic 
contractions accounting for the interaction of force production during shortening, resistance to muscle re-
lengthening and changes in activation and relaxation time (Josephson, 1985). Subsequently, any age 
related changes in muscle activation and relaxation time, ability of the muscle to maintain force through 
shortening, and an increase in passive resistance to stretch will have profound additional effects on 
muscle fatigue resistance than the decline in force alone.      
The augmented fatigue resistance at 30 weeks of age compared to maturity is likely to correlate with the 
age related shift to a more oxidative muscle fiber type (Aniansson et al. 1986; Alnaqeeb & Goldspink, 
1986; Coggan et al. 1991). The progressive decrease in fatigue resistance at 50 weeks of age may 
therefore highlight the contribution of the previously discussed age related decline in muscle function. A 
further contributor to the given reduction in fatigue resistance may also relate to a potential age related 
increase in muscle collagen and fat content resulting in a larger non-contractile mass and subsequent 
muscle stiffness (Alnaqeeb et al. 1984; Kent-Braun et al. 2000; Martini et al. 2000). This increased 
resistance to stretch would amplify the proportion of negative work and offset the theoretical equation 
for maximal work loop power output (work loop power output = positive work – negative work: 
Josephson 1985). Unlike diaphragm muscle, EDL from 50-week-old mice fatigued significantly faster than 
EDL from 10-week-old mice, with such a finding likely to relate to the age related increase in relaxation 
time that is demonstrated in the work loop shapes examining the fatigue response. In this instance, the 
muscle will be active to a greater extent at the end of the shortening phase in each work loop thus 
increasing the eccentric work contribution and, as a consequence decreasing net work production. A 
further fatigue induced increase in relaxation time has been demonstrated and an accumulation of these 
effects will result in a further pronunciation in a faster fatigue time in the present study (Askew et al. 
1997: Allen et al. 2008; Tallis et al. 2012; chapter 4). A relationship between time to fatigue and work loop 




an increased muscle relaxation time, thus negatively impacting the net work the muscle produces per 
cycle. Conversely, the ability of the muscle to maintain force through shortening throughout the fatigue 
shows little age related variation.  
Effect of Ageing on Recovery from Fatigue 
For diaphragm muscle, the level of peak recovery following the fatigue stimulation protocol was similar 
across all age ranges. Conversely, EDL muscle from 3-week-old mice recovered to the greatest degree and 
recovery at 30 weeks of age was significantly reduced. 
Although the acute response of the contractile properties following muscular fatigue in the aged 
population has received little attention, particularly in vitro, human and animal evidence suggests that 
recovery is largely unaffected. Allman and Rice (2001) failed to demonstrate a difference in the degree of 
low-frequency fatigue between young and elderly human subjects following repeated contractions at 60% 
of maximal voluntary contraction. Likewise, Gonzalez and Delbobo (2001) concluded that despite changes 
in maximal tetanic stress of mouse EDL and soleus muscle with increasing age, recovery time and stress 
production following fatigue via repetitive isometric contractions were unaffected by age. 
Previous findings using the work loop technique have demonstrated that the recovery of power output 
occurs faster in muscle with a slower fiber type (Tallis et al. 2013; chapter 5). Consequently this may 
explain why EDL muscle from 3-week-old mice recovered quicker in the present study.  
Practical Implications of the Study 
With the populations of most western nations growing older and the related increase in healthcare costs, 
having a greater understanding of the ageing response is important in the potential development of 
innovations to improve human health and quality of life (Deschenes, 2004). Initially the study highlights 
significant reductions in skeletal muscle performance that occurs at a relatively young age. Early ageing 
was associated with a greater loss of diaphragm force and power compared to locomotory EDL muscle. 




performance of diaphragm muscle in relatively young populations, given its importance to 
cardiorespiratory function. Furthermore chronic obstructive pulmonary disease (COPD) is associated with 
reduced respiratory muscle strength and this coupled with the ageing effect demonstrated in the present 
findings may contribute to the severity of the symptoms observed in elderly patients (Polkey et al. 1996; 
Ottenheijm et al. 2008).  
With falls causing greater rates of morbidity and mortality in elderly citizens, the importance of 
understanding the ageing effects on peripheral muscle performance is of equal importance (Aschkenasy & 
Rothenhaus, 2006). It has been demonstrated that impaired muscular endurance contributes to the 
instance of falls among the elderly (Schwendner et al. 1997).  
Subsequently the reduction in maximal skeletal muscle force and substantial decrease in fatigue 
resistance, as shown in relatively young EDL muscle in the current findings, is likely to be further 
accelerated in an older population and would greatly contribute to this phenomenon if transferable to 
humans.The present study further indicates that the reduction in locomotory performance in vivo may be 
additionally pronounced when muscle function is related to whole animal body mass. This highlights an 
important interaction between muscle weakness and body mass, where increasing body mass would 
accelerate the age related reduction in whole animal locomtory performance. At 50 weeks of age two 
distinct groups in whole animal body mass were evident (Fig 7.4.1). Further research should be conducted 
to establish the relationship between skeletal muscle performance, increasing age and adipose tissue in 
order to further our understanding into the interaction between ageing and obesity. A further area of 
interest would be to examine the effect of increased physical activity to offset the demonstrated age 
related decline in direct muscle performance. This is explored in greater depth in the future work section 
of the thesis (chapter 10). 
The present study furthers our understanding of the relationship between ageing and the direct effect on 
muscle function. However, the suggested age related increase in central fatigue that occurs in endurance 




to in vivo performance (Bilodeau et al. 2001; Deschenes, 2004). Furthermore the present research is 
conducted using female mice and although the trends demonstrated in the present study are unlikely to 
change, the time course and magnitude of the ageing response is likely to differ in male mice and is liable 
to relate to sex related differences in hormone secretion (Moran et al. 2005; Chan & Head, 2010).  
Conclusion 
The present study demonstrates a muscle specific change in skeletal muscle mechanical properties at 
different ages. Diaphragm muscle appears to reach physiological maturity at a faster rate than EDL, which 
highlights selective rapid development for cardiorespiratory function when compared to locomotory 
performance. Although muscle specific, the present findings infer that increasing age beyond physical 
maturity is associated with a reduction in the mechanical performance of skeletal muscle. The study uses 
mice much younger than those in previous work and still demonstrates significant reduction in muscle 
contractility. In contrast to in vivo evidence, the reduction in maximal force was more greatly pronounced 
than the loss of power output in both of the investigated muscles. This subsequently suggests that the 
greater reduction in muscle power in human research is a consequence of the further interaction of 
atrophy and neuromuscular innervation. Interestingly, the loss of maximal muscle force and power were 
greater in diaphragm muscle compared to EDL. In contrast however, in the oldest age group, fatigue 
resistance of EDL was significantly impaired. Furthermore findings of the present research may help to 
rationalise the previous equivocal data examining the effects of age on muscle fatigue. Again although the 
magnitude of the response was muscle specific, a distinct pattern in the change of fatigue resistance has 
been identified. Without a demonstrated reduction in EDL muscle mass, the present results indicate that 
the age related decline in skeletal muscle performance occurs prior to associated atrophy mechanisms. 
Therefore it is likely that the reduction in skeletal muscle function demonstrated in early ageing is a result 





8. Does the Ergogenic Benefit of Caffeine Change with Age? The Effect of Physiological Concentrations 






















The effects of caffeine as an ergogenic aid have been widely studied in mature human populations with 
well-established improvements during endurance and high intensity exercise. However, the potential age 
related ergogenic response of caffeine has received less attention and could be an important area of 
investigation due to age related changes in muscle composition and contractility. The present study aims 
to build upon previous work using the work loop technique to assess the direct effect of 70µM caffeine 
(physiological maximum) on the maximal power output of isolated mouse EDL and diaphragm muscle 
from four different age groups (3, 10, 30 & 50 weeks). In both mouse EDL and diaphragm muscle 70µM 
caffeine treatment resulted in a significant increase in maximal muscle power output that was generally 
greatest at 10 and 30 weeks (up to 5% & 6% improvement respectively). This potentiation of maximal 
muscle power output was significantly lower at 50 weeks (up to 3% & 2% improvement for EDL and 
diaphragm respectively) and in mice in the development stage at 3 weeks (up to 1% & 2% improvement 
for EDL and diaphragm respectively).The previously established muscle specific caffeine response appears 
to be prevalent in skeletal muscle but is likely affected by both muscle development and the age related 
decline in muscle contractility. Consequently, caffeine could be used to enhance muscle force in a more 
senior population; however this established effect may be significantly reduced when compared to 
skeletal muscle from younger individuals. 










The ergogenic benefit of caffeine to promote performance enhancing effects has been extensively 
studied, and is well recognised to induce increases in endurance, strength and power activities (Graham 
et al. 2001; Davis & Green, 2009).  
The majority of research evaluating the ergogenic effects of caffeine has been conducted on subjects 
within the range of physiological maturity. The benefit of supplementation in a more senior population 
has received very little attention. We have previously demonstrated (Chapter 7) a muscle specific change 
in contractility with age, which is likely to affect the direct ergogenic response of caffeine. Associated age 
related changes in fiber type composition and the efficiency of the excitation-contraction coupling 
process that have previously been demonstrated as factors influencing the performance enhancing affect 
of caffeine support this notion (Delbono et al. 1995; Navarro et al. 2001; Deschenes, 2004; Tallis et al. 
2012; chapter 4). 
It is believed that caffeine in older adults is metabolised in the same way, however a given dose may 
represent a greater plasma concentration due to the age related changes in body composition resulting in 
an increased adipose tissue to lean body mass ratio (Massey, 1998). Rees et al. (1999) investigated the 
central effects of 250mg caffeine supplementation 50-65 year olds compared with a younger 20-25 year 
old group. Age was associated with a significant reduction in psychomotor and cognitive performance, 
and as with the young subjects, caffeine was effective at increasing both psychomotor and cognitive 
performance, particularly by offsetting the decline in performance overtime. Swift and Tiplady (1988) 
further suggested that an older population may be more sensitive to the effects of caffeine at the 
psychomotor level, with these subjects showing greater improvements in attention and choice reaction 
time compared to younger participants. 
Research by Norager et al. (2005) appears to be the only study to assess the effects of caffeine 




increases in cycling endurance (25%) and arm flexion endurance (54%), coupled with a reduction in RPE in 
men and women aged over 70, following 6mg/kg-1 caffeine consumption. No significant differences were 
found in muscle strength, walking speed, and reaction time. Norager et al. (2005) recognised that the 
reported increase in endurance may be due to the effect of caffeine on psychological ability, as it was 
stated that the elderly are capable of working at higher loads for prolonged periods than that achieved in 
their study. Norager et al. (2005) further noted that the increase in arm flexion was markedly higher than 
that seen in an earlier study on younger individuals. As with young adults, Pincomb et al. (1985) and 
Conard et al. (1982) reported that caffeine supplementation elicited significant increases in blood 
pressure but with no concurrent positive inotropic effect in elderly men. Furthermore, the ergogenic 
effect of caffeine on exercise performance has not been studied in children and adolescents despite the 
high consumption of caffeinated products in this population (American Academy of Paediatrics, 2011). In 
summary the current literature indicates very little about the age related effects of caffeine on physical 
performance. Measurement of this potential effect using direct in vitro testing methods will allow a more 
accurate investigation by eliminating complications in population plasma concentrations that would occur 
in whole body studies due to the earlier highlighted changes in adipose tissue to lean body mass ratio 
(Massey, 1998). 
In vitro research has confirmed the effect of caffeine via direct potentiation of isolated skeletal muscle 
performance at high (mM) (Allen and Westerblad, 1995), and more recently, at human physiological 
concentrations (50-70µM) (James et al. 2004; Tallis et al. 2012; chapter 4). The mechanism of action for 
caffeine in this instance is attributed to its adenosine receptor antagonistic properties specifically at the 
A1 receptors on the skeletal muscle membrane and/or its ability to bind to ryanodine receptors (RYR) of 
the sarcoplasmic reticulum (SR) (Damiani et al. 1996; Fredholm 1999; Rossi et al. 2001). The net effect is 
modified excitation contraction coupling specifically through enhanced ion handling (Graham, 2001; 
Kalmar & Cafarelli, 2004). Skeletal muscle ageing is associated with a reduction in excitation contraction 




1995; Navarro et al. 2001). These age related changes may significantly affect the skeletal muscle 
response to caffeine treatment.  
The present study aims to build on the previous findings of Tallis et al. (2012; chapter 4) by being the first 
to assess the effect of the maximal physiological concentration of caffeine (70µM maximal) on the 
maximal power output of isolated mouse EDL (predominantly fast-twitch) and diaphragm muscle (mixed 
muscle fiber type) during development (3 weeks old) and at various stages post physiological maturity (30 
& 50 weeks old). As previously discussed in chapter 7, 50 weeks represents ‘middle age’ and significant 
reductions in muscle contractility were reported deeming this an appropriate age range to examine the 
age related ergogenic effect of caffeine. The research uniquely uses the work loop technique to 
approximate the cyclical length changes used by some muscles during in vivo muscle performance and is 
the first (in vivo or in vitro) to assess if the ergogenic effect of caffeine is altered by the development and 
ageing of skeletal muscle. Tallis et al. (2012; chapter 4) further demonstrated a fiber type specific 
response to caffeine, therefore the present study will also asses the age related ergogenic effect of 
caffeine on two different skeletal muscles with diverse function and different fiber type composition. In 
light of our previous findings it is suggested that the direct treatment of mouse EDL and diaphragm with 
70µM caffeine will cause an age dependant improvement in muscle power output. Furthermore the 











A more detailed account of the methods is given in the general methods section (chapter 3). 
From birth mice were housed in groups of 8 without access to running wheels and aged to 3 weeks, 10 
weeks, 30 weeks, and 50 weeks (n = 20 for each age group) before sampling.  Rational for the use of mice 
at these ages has been previously discussed in chapter 7. 3-week-old mice were used to represent muscle 
in a developmental stage; 10 week old represents physical maturity, 50 week old was used to represent 
‘middle-aged’ muscle. Mice from each age range were tested within 7 days of reaching their target age. 
Ageing was associated with significant weight gain in the mice used in the present study. 
Either whole diaphragm (approximate composition: 6.2% IIb, 34.6% IIx, 43.6% IIa, 15.6% I, Agbulut et al. 
2003) or both EDL (approximate composition: 86.8% type IIb, 9.3% IIx, 3.9% I, Agbulut et al. 2003) muscles 
were dissected from each mouse (body mass (g):  3 weeks = 15.8± 1.2; 10 weeks = 31.9±0.8; 30 weeks = 
41.6±0.8; 50 weeks 58.2±5.4; n=20 in each case). 
EDL of the left hind limb, or the right half of the diaphragm, was immediately frozen in liquid nitrogen and 
the opposing EDL muscle or section of diaphragm prepared for mechanical assessment. Muscles were 
prepared as previously described in the methods section of chapter 7. 
Once dissected the muscle was placed in the muscle bath and circulated with oxygenated Krebs solution 
at 37oC.The muscle length and stimulation amplitude (14-18V for EDL; 10-16V for diaphragm) were 
optimised to produce maximal twitch force. Following this each muscle was subjected to a 250ms burst of 
electrical stimulation in order to produce a tetanus response. Stimulation frequency was optimised in 
order to produce maximal tetanus force (usually 200Hz for EDL; 140Hz for diaphragm, and this did not 
change with age). A 5-minute rest period was imposed between each tetanus in order to allow the muscle 





The Work Loop Technique  
Each muscle was subjected to four sinusoidal length change cycles per set at a total symmetrical strain of 
0.10. A cycle frequency of 10Hz and 7Hz was used for EDL and diaphragm muscle respectively. 10Hz 
represents the cycle frequency that has previously been shown to elicit maximal power output in EDL 
(James et al. 1995). 7Hz represents the cycle frequency that elicited maximal power output in diaphragm 
in preliminary work by the authors and is similar to previous findings (Altringham and Young, 1991). These 
frequencies have been demonstrated to be optimal for maximum power generation in adult mice but may 
not be uniform across all age ranges. However, the present study allows a direct comparison across age 
ranges at the selected cycle frequencies. Usually 49ms burst duration was used for EDL which is in keeping 
with that previously used at 10Hz cycle frequency (James et al. 1995). The burst duration commonly used 
to elicit maximum power output in diaphragm muscle was 55ms. On occasions the burst duration had to 
be increased or decreased to adjust the number of stimuli given. A stimulation phase shift of -2 ms and -5 
ms were used for EDL and diaphragm respectively as they corresponded with maximal power output.  
The Effect of 70µM Caffeine Treatment 
Each muscle was subjected to a set of four work loop cycles every ten minutes over a 130-minute 
duration (James et al. 2005; Tallis et al. 2012; chapter 4). Three measurements of the muscle’s maximal 
power output were made in standard Krebs-Henseleit solution and this formed the control. Following this 
the circulating fluid was changed to Krebs containing 70µM caffeine and a further 6 measurements of 
maximal power were made. The assessment concluded with a washout period were the circulating fluid 
was changed back to standard Krebs and a further four measurements of maximal power were taken (Fig 
7.3.1). 
At the end of the experiment the muscle was detached from the rig, tendons removed, then weighed in 





Statistical Analysis of the Data 
In control conditions muscle power output will decrease over time due to the gradual development of an 
anoxic core (Barclay, 2005). Over the 130-minute duration of the protocol used in the present study, 
muscle power had decreased to 92.5±0.61% of initial power output. In order to avoid the given 
deterioration in muscle power output masking the effects of the caffeine treatment, a 1st order regression 
equation was calculated using the pre-treatment control data and post treatment washout control data to 
identify the linear relationship between muscle power output and time. This regression equation was 
then used to determine theoretical control muscle power output for each time point during caffeine 
treatment (James et al. 2005; Tallis et al. 2012; chapter 4). 
Initially for each treatment group, pre-treatment controls were compared directly against post treatment 
washout controls using a paired t-test. There was no significant difference between these measurements 
(Paired T-test p>0.7 in each individual case) therefore these results were pooled to form controls. 
Thereafter, it was assumed that any subsequent change in muscle power output was solely the effect of 
the given caffeine treatment. Consequently, controls were compared directly against caffeine treatment 
using a further paired T-test for each treatment group. To establish whether a difference in the effect of 
caffeine occurred between ages a single factor ANOVA was conducted on the caffeine data for each of 
EDL and diaphragm muscle. When the ANOVA indicated a significant difference between age groups, 
Tukey post hoc tests were used to identify where these differences occurred. An independent samples t-
test was conducted to compare the caffeine treatment results for EDL and diaphragm of the same age 
group in order to identify whether the ergogenic benefit was greater in a particular muscle each age.  








Whole Animal Body Mass 
Increasing age resulted in a significant increase in mean mouse body mass and upon visual inspection and 
dissection it was evident that this was due to an increase in adipose tissue (ANOVA p<0.001). At 50 weeks 
of age mean body mass had increased by 73% compared to that at 3 weeks. At 50 weeks individual body 
masses had either increased above 70g or appeared to stay below 50g, which is similar to the mean body 
mass at 30 weeks. This information has been previously reported in chapter 7 where it is discussed in 
greater depth. 
The Effect of 70µM Caffeine Treatment on the Maximal Power Output of Mouse EDL 
Treatment of mouse EDL with 70µM caffeine resulted in a significant increase in power output by up to 
1%, 4%, 5% and 3% for 3, 10, 30 and 50 week old mice respectively  (Fig 8.4.1; paired t-testp<0.001 
between control and caffeine power output in all cases). There was a significant effect of age on the 
caffeine-induced improvement in power output (Fig 8.4.1; ANOVA p<0.001). The caffeine induced 
increase in muscle PO was the highest at 30 weeks and was significantly greater than the response at 3 
and 50 weeks (Fig 8.4.1; Tukey p<0.001 in both cases) and had a tendency to be greater than that at 10 
weeks (Fig 8.4.1; Tukey p=0.079). The ergogenic benefit at 3 weeks was significantly lower than at all 
other ages (Fig 8.4.1; Tukey p<0.005 in all cases). The increase in muscle PO at 10 weeks did not prove to 






Figure 8.4.1 – The effect of 70µM caffeine on the mean acute maximal power output of mouse EDL 
isolated from 3, 10, 30 and 50 week old mice [Data represented as mean ± SE: n=10 in each case]. 
 
The Effect of 70µM Caffeine Treatment on the Maximal Power Output of Mouse Diaphragm 
Treatment of mouse diaphragm with 70µM caffeine resulted in a significant increase in power output by 
up to 2%, 6%, 4%, and 2% for 3, 10, 30 and 50 week old mice respectively  (Fig 8.4.2; paired t-testp<0.001 
in all cases). There was a significant effect of age on the caffeine-induced increase in power output (Fig 
8.4.2; ANOVA p<0.005). The caffeine induced increase in power output at 10 weeks was the highest and 
was significantly greater than at 3, 30 and 50 weeks (Fig 8.4.2; Tukey p<0.004 in all cases). Power output 
was also significantly higher at 30 weeks compared to at 3 weeks and 50 weeks (Fig 8.4.2; Tukey p<0.02 in 
both cases). There was no significant difference in power output between 3 weeks and 50 weeks (Fig 

































Figure 8.4.2 – The effect of 70µM caffeine on the mean acute maximal power output of mouse diaphragm 
isolated from 3, 10, 30 and 50 week old mice [Data represented as mean ± SE: n=10 in each case]. 
 
The ergogenic benefit of 70µM caffeine treatment was significantly greater in EDL muscle compared to 
diaphragm at 30 and 50 weeks (two-sample t-testp<0.005 in both cases). The caffeine-induced 
potentiation of diaphragm power output had a tendency to be greater than EDL at 10 weeks (two-sample 
t-testp=0.054). The caffeine induced increase in maximal muscle power output at 3 weeks was not 
significantly different between muscles (independent samplest-testp=0.54). The peak effect of caffeine 












































Figure 8.4.3 – The comparison of the peak effect of caffeine on muscle power output with increased age 
between EDL and diaphragm [Data represented as mean ± SE: n=10 in each case].  
In order to assess if body mass, or more specifically the potential associated increase in muscle fat 
content, affected the direct ergogenic effect of caffeine, the caffeine induced increase in net power 
output was compared between the two distinct groups highlighted at 50 weeks in Figure 7.4.1. Whole 
animal body mass of the mice where diaphragm preparations were taken displayed and equal divide (n=5 
in each case) in those below 50g (43±2g; mean±SE) and those greater than 80g (90±3g; mean±SE). 
Subsequently the caffeine response was compared between these groups and no significant difference in 













































Figure 8.4.4 – The effect of high (90g) and low (43g) whole animal body mass on the direct ergogenic 










































8.5. Discussion  
The Direct Effect of 70µM Caffeine on Post Mature Skeletal Muscle 
The direct treatment of mouse EDL and diaphragm muscle with 70µM caffeine significantly potentiated 
maximal power output independent of age. Interestingly, the present findings indicate a muscle specific 
relationship between age and level of direct ergogenic effect. The caffeine-induced potentiation of 
maximal muscle power output was greatest at 30 weeks for EDL but was significantly reduced in the 
oldest age group. The peak ergogenic benefit in diaphragm muscle occurred at 10 weeks which reduced 
with increased age. The caffeine induced increase in EDL muscle power output at 10 weeks (up to 4%) is 
consistent with the 3% reported by James et al. (2005) and Tallis et al. (2012; chapter 4) using similar 
experimental methods. This study is the first to assess the direct effect of 70µM caffeine on diaphragm 
muscle and the 6% increase in muscle power is comparable to that previously reported for mouse soleus 
(Tallis et al. 2012; chapter 4). The given age related reduction in the caffeine induced force potentiation, 
identified in the present study, is likely to correlate with the age related decline in muscle function 
(Chapter 7) suggesting that the mechanism of ageing may be accountable for this loss in the ergogenic 
effect. 
The rate of muscle activation and force production is primarily determined by effectiveness of excitation 
contraction coupling and the intramuscular Ca2+ transient time (Berchtold et al. 2000). The demonstrated 
caffeine induced increase in maximal power output is likely to occur due to the effects of caffeine as a 
modifier of excitation-contraction coupling (Graham, 2001; Kalmar & Cafarelli, 2004). Mechanistically, it is 
believed that caffeine acts as a direct agonist to adenosine receptors on the skeletal muscle membrane 
and has been demonstrated to bind to ryanodine receptors (RyR) of the sarcoplasmic reticulum (SR) (Bhat 
et al. 1997; Damiani et al. 1996; Fredholm et al. 1999; Rossi et al. 2001). It is likely that these actions then 
result in an improved opening of RyR channels promoting a greater Ca2+ release into the intracellular 
space, an increased Ca2+myofibrillar sensitivity, a decreased SR Ca2+ pump sensitivity and increased SR 




the SR is likely to occur resulting in an elevated basal and subsequently activated intracellular 
Ca2+ concentration (Allen et al. 1989; Allen & Westerblad, 1995).   
Ageing skeletal muscle is associated with a reduction in the functionality of excitation-contraction 
coupling; subsequently this will result in a reduction in contractile performance and potentially the 
sensitivity to caffeine (Navarro et al. 2001). Renganathan et al. (1997) demonstrated a significant age 
related reduction in SRCa2+ release of rat EDL and soleus muscle attributed to DHPR-RyR uncoupling. This 
was further supported by Delbono et al. (1995) who confirmed a similar effect in fast fibers of human 
quadriceps muscle.  A reduction in the voltage gated SR Ca2+ release mechanism would result in a 
decreased Ca2+ availability for the contractile proteins and consequently a reduction in contractile force. 
Consequently, in the context of the present study, caffeine may still bind to RyR in the older aged group 
muscle, but a reduction in the number of physiologically active RyR will result in a decrease in the force 
and power enhancing effects of caffeine. In addition Larsson & Salviati (1989) reported an age related 
reduction in SR Ca2+ concentration and Ca2+ pump activity of fast twitch muscle of chemically skinned rats. 
Therefore, it is likely that the reduction in the ergogenic properties of caffeine in post mature muscle arise 
from a reduced ability to increase SR Ca2+ release. Hunter et al. (1999) and Narayanan et al. (1996) provide 
further support for a significant reduction in SR Ca2+ uptake and Ca2+-ATPase activity in older muscle. A 
potential shift in the primary mechanism of caffeine acting in aged skeletal muscle may occur if this effect 
is coupled with the caffeine induced decrease in SR Ca2+ pump sensitivity as reported by Allen et al. (1989) 
and Allen and Westerblad (1995). In this instance there will be a further increase in basal and post 
contractile intracellular Ca2+ concentration eliciting a greater force. 
The Direct Effect of 70µM Caffeine on Developing Skeletal Muscle 
Despite the regular consumption of caffeine containing products by children and caffeine containing 
energy drinks marketed specifically at this age group, the effect of caffeine on exercise performance has 
not been fully validated in younger people (American Academy of Paediatrics, 2011). Turley, Bland and 




physiological responses to exercise in 7-9 year old children. Caffeine treatment had no effect on substrate 
metabolism; however, mild and moderate dose caffeine treatment resulted in a slight increase in blood 
pressure and slight decrease in heart rate. 
The present study shows that the treatment of muscle from 3-week-old mice with 70µM caffeine has only 
a small, but significant, effect on the potentiation of maximal work loop power output. The ergogenic 
benefit in this age group was not significantly different between diaphragm and EDL and the given 
response is likely to relate to the stage of postnatal muscle development. Schiaffino and Margreth (1969) 
and Luff and Atwood (1971) established that at birth, skeletal muscle SR is sparse and occurs as a loose 
network of tubes. Furthermore, Luff and Atwood (1971) demonstrated a muscle fiber type specific 
increase in mouse SR from 1.1% of fiber volume at birth to 5.5% in adult EDL (predominantly fast-twitch), 
and from 1.7% at birth to 2.9% in adult in soleus (predominantly slow-twitch). SR development occurred 
most rapidly in the initial 20 days and had reached adult values by 30 days in soleus and was still 
increasing after 60 days in EDL. Therefore, it should be considered that in the 3-week-old diaphragm and 
EDL muscle used in present study, SR is not fully developed, thereby limiting the action of caffeine on RYR 
and consequently reducing the level of caffeine induced Ca2+ release and subsequent force potentiating 
effects.   
Previous literature and the present research suggest that caffeine in a young age group has both a limited 
effect on physiological responses to exercise and a limited direct effect on skeletal muscle. However, the 
stimulant effects at the central nervous system should be fully evaluated before conclusions are made 
about the value of caffeine as an ergogenic aid in children. The effectiveness of caffeine on the cognitive 
function of children requires further investigation; Hughes and Hale (1998) reported only slight 
improvements in vigilance performance and decrease reaction time in this population. It is unlikely 
however that caffeine supplementation in a young age group will greatly enhance sporting performance 




studies by Hughes and Hale (1998) and a review by American Academy of Paediatrics (2011), potentially 
outweigh its benefit.  
The Muscle Specific Action of 70µM Caffeine Treatment 
At 10 weeks the caffeine induced potentiation of maximal skeletal muscle power output was significantly 
greater in diaphragm muscle compared to EDL. However, with a further increase in age the effect of 
caffeine was greater in more aged EDL. It has been firmly established that the force potentiating effects of 
caffeine are more greatly pronounced in muscle with a predominantly slower fiber type (Fryer & Neering, 
1989; Rossi et al. 2001; Tallis et al. 2012; chapter 4). Although of mixed muscle phenotype, diaphragm will 
consist of a significantly greater proportion of oxidative muscle fibers than EDL and subsequently the 
caffeine-induced benefit was greater in this muscle during maturity. In order to establish why this muscle 
specific action of caffeine changed, the age related alterations in phenotype should be considered. 
Despite early work suggesting that muscle fiber number decreases more rapidly in type II fibers it is now 
widely established that muscle fiber number will decrease equally across fast and slow fiber types 
(Deschenes, 2004).A key aspect of ageing phenotype appears to be a shift towards an oxidative 
metabolism as the reduction in the cross-sectional area (CSA) of type IIb fibers appears to be more 
pronounced (Aniansson et al. 1986; Coggan et al. 1991).Alnaqeeb and Goldspink (1986) showed a 
significant 22.7% reduction in the CSA of fast glycolytic (FG) fibers of rat EDL, the CSA of fast-oxidative 
glycolytic (FOG) fibers increased by 12.4% in conjunction with a relatively small increase in slow oxidative 
(SO) CSA. The ageing of mice to 30 weeks in the present study is likely to evoke this specific CSA 
phenotype shift in EDL and an increase in the CSA of SO may explain the elevated benefit of caffeine at 
this age group. Any further increase at 50 weeks is probably masked by the previously discussed 






The Direct Effect of 70µM Caffeine on Mouse Diaphragm Muscle 
Kivity et al. (1990) demonstrated that high dose caffeine significantly improved the pre and post exercise 
forced expiratory volume in one second (FEV1) in healthy human male subjects. Although this effect was 
largely attributed to the bronchodilator properties of caffeine, thought should also be given to a 
potentially increased performance of the respiratory muscle. The present study is the first to show a 
direct effect of physiological concentrations of caffeine to potentiate the maximal PO of diaphragm 
muscle. This extends the work of Brinbaum and Herbst (2004) who also suggested that caffeine may 
provide a modest ergogenic benefit by increasing respiratory efficiency. 
Practical Implications and Limitations of the Present Findings 
The present findings infer that caffeine can be used to directly improve skeletal muscle performance in 
mice across a broad age range. However, when applying these results to human performance it should be 
considered that there would be differences in caffeine metabolism between species e.g. caffeine has a 
shorter half-life in rodents (Fredholm et al. 1999). The development and ageing of skeletal muscle over 
time will differ greatly between mice and humans making it difficult to give a human equivalent of the 
ages used in the present study. That said the age-associated changes in the mechanical properties of 
mouse muscles follow the typical pattern of human ageing suggesting that the effect of caffeine 
treatment in the present study is likely to be similar. 
The mechanisms proposed in the present study are likely to significantly contribute to the varied force 
potentiating effect of caffeine treatment with age, however, further research assessing the action of 
caffeine on increased Ca2+ sensitivity of the myofibrils and decreased SR Ca2+pump sensitivity should be 
investigated over a similar age range. 
The present work further indicates that the direct effect of caffeine in post mature muscle is not 
significantly affected by whole animal body mass. The give increase in whole animal body mass, largely 




diaphragm muscle.  This subsequently indicates that increased whole animal adipose tissue, and likely 
increase in muscle fat content, has little effect on skeletal muscle calcium handling properties. The effect 
of obesity on the direct muscle mechanical properties and the response to caffeine is an area that 
requires further investigation. 
Conclusion 
The present study is the first to assess the ergogenic properties of caffeine on isolated skeletal muscle 
performance from development to post maturity. The direct treatment of mouse muscle with, 
physiologically relevant, 70µM caffeine significantly potentiated the maximal power output of mouse EDL 
and diaphragm muscle independent of age. The ergogenic benefit of caffeine was significantly reduced in 
the older age groups but the effect may still be substantial to evoke significant enhancements in muscular 
performance. Caffeine also had a reduced effect on skeletal muscle in young mice, which brings into 













9. General Conclusion 
Evidence presented in the present thesis provides an in-depth understanding of the ergogenic effects of 
physiologically relevant concentrations of caffeine when acting directly on skeletal muscle. 
A summary of the unique and key findings of this thesis: 
 
1. There was no dose dependent effect of caffeine on mouse soleus and EDL muscles at 
physiological levels; 50-70µM concentrations must be used to potentiate acute maximal force 
production. (Chapter 4) 
 
2. 70µM caffeine induced a greater ergogenic effect in mouse muscle with a predominantly slower 
fiber type (i.e. in soleus compared with EDL). (Chapter 4) 
 
3. In mouse EDL and soleus muscle, the caffeine induced force potentiation was not significantly 
affected by stimulation frequency. (Chapter 4) 
 
4. At the skeletal muscle level there were inter-individual differences in response to caffeine with a 
division between responders and non-responders that cannot be related to caffeine habituation 
as these mice did not receive caffeine in their diet. (Chapter 4) 
 
5. There was a fiber type specific effect of 70µM caffeine on mouse soleus skeletal muscle fatigue 
resistance. Maximally stimulated muscle fatigued faster with caffeine treatment in contrast to sub 





6. There was no direct ergogenic effect of physiologically relevant concentrations of taurine on 
mouse soleus muscle performance, nor did taurine combined with 70µM caffeine potentiate the 
effect of 70µMcaffeine treatment alone. (Chapter 6) 
 
7. The change in mouse skeletal muscle mechanical properties in development and ageing were 
muscle specific and are likely to depend on anatomical function and location and predominant 
fiber type. (Chapter 7) 
 
8. The age related reduction in maximal muscle force exceeds the reduction in muscle power output 
when examined using isolated mouse EDL and diaphragm preparations. (Chapter 7) 
 
9. The alterations in fatigue resistance of mouse skeletal muscle from development and with 
increasing age is likely to be more complex than first realized. Although fatigue resistance is 
muscle fiber type dependent, the present evidence identifies a four stage process whereby for 
both mouse EDL and diaphragm muscles: muscle in the development stage had the greatest 
fatigue resistance; fatigue resistance was reduced when the muscle reaches maturity; the muscle 
then became more fatigue resistant before a further secondary reduction in fatigue resistance 
within the oldest age group. (Chapter 7) 
 
10. The ergogenic effect of 70µM caffeine was reduced in developing and with increasing age in 
mouse EDL and diaphragm muscles, which is likely a result of a deterioration in the performance 





The implications of the results of this thesis suggest that the consumption of caffeine in physiological 
doses can significantly enhance skeletal muscle performance. This coupled with the potential reported 
central nervous system and metabolic effects may result in large increases in sporting performance 
(Graham et al. 2001; Magkos & Kavouras, 2005; Davis & Green, 2009). As a result, the effects of caffeine 
abuse in a sporting context should be more closely considered with particular reference to the inclusion 
of caffeine on the World Anti-Doping Agencies’ prohibited list. The present evidence suggesting an 
individualised ergogenic response to caffeine adding further weight to this debate. In essence caffeine use 
in sport may evoke a large increase in performance in some athletes’ whilst in others the benefit is 
reduced or no effect is present. Subsequently, large responding performers will receive a legal 
performance boost that cannot be equally matched among all competitors. The remaining section of the 
discussion will focus on key aims of the thesis, which were to measure the direct effects of caffeine on 
skeletal muscle performance. 
The present findings indicate that physiological doses of caffeine have a fiber type specific effect. Such 
findings have also been previously demonstrated using high concentrations of caffeine that would be 
toxic for human consumption (Fredholm et al. 1999).The present findings infer that the caffeine response 
is enhanced in muscles with a predominately slower phenotype. Subsequently this response may induce 
an amplified ergogenic effect of caffeine during prolonged submaximal activities that have a greater 
reliance on oxidative fibers. Interestingly the present results highlight that the magnitude of the caffeine 
effect is independent of muscle activation intensity. This therefore suggests that although the SR 
concentration of Ca2+ will be greater during submaximal intensity, the caffeine-induced release of Ca2+ is 
in some way limited. The mechanism limiting further calcium release needs to be elucidated to better 
understand the reasons underpinning the present study’s findings. 
The present findings also highlight the complex relationship between the ergogenic effect of caffeine and 
fatigue resistance. Findings provide further insight to the conclusions of James et al. (2005) suggesting 




stimulated maximally but prolonged when a submaximal intensity is used. This effect is attributed to the 
ability of the muscle to better handle increased intramuscular Ca2+ concentration at these lower 
stimulation intensities. I.e. when caffeine induces higher calcium release in maximally activated muscle 
the muscle is less able to handle the extra caffeine and fatigue resistance is compromised. 
In conjunction with an increased performance of locomotory muscle, the present evidence demonstrates 
that 70µM caffeine might also be used to enhance acute power output of the diaphragm.  Therefore, 
caffeine may play a role in increasing respiratory performance and subsequent interaction of the 
discussed effects may provide further explanation to the body of evidence that suggests a greater 
ergogenic effect of caffeine in prolonged endurance based actives (Graham et al. 2001; Davis & Green, 
2009). In light of the performance enhancements demonstrated in the present studies, the use of caffeine 
as a training aid should be considered. Promoting work at a higher intensity and for a prolonged duration 
would allow an amplified training stimulus. In light of this it is important to consider personal regulation 
of caffeine consumption due to the potential desensitising to its effects and the health implications of 
long-term caffeine use. Bell and McClellan (2002) demonstrated that the ergogenic benefit of caffeine 
was greater in subjects that did not regularly consume caffeine, suggesting habituation to long term 
exposure. Furthermore habitual daily use of caffeine exceeding 500-600mg (4-7 cups of coffee) is believed 
to result in a significant health risk and sustained abuse may result in ‘caffeinism’ (Newrot et al. 2003). 
This is characterised by a spectrum of clinical symptoms ranging from anxiety and irritability, insomnia, 
muscle tremors, dieresis, arrhythmia, tachycardia, elevated respiration rate, and gastrointestinal 
disturbances (Newrot et al. 2003). Contrary to common belief recent articles suggest that caffeine does 
not promote ventricular arrhythmia and myocardial infraction, suggesting the evidence examining the 
effects of caffeine on the cardiovascular system is inconclusive (Peters et al. 2001; Katan & Schouten, 
2005). A review by Newrot et al. (2003) concluded that for a healthy adult population, moderate daily 
caffeine intake at doses up to 400mg per day (equivalent to 6 mg.kg-1 per body weight in 65 kg person) is 




caffeine doses employed within the majority of whole body human research examining the ergogenic 
effects of caffeine a sample of which is outlined in Tables 1.4.1 and 1.4.1. 
Many energy drinks contain a range of compounds that their manufacturers suggest will actively improve 
human exercise performance. We have demonstrated that physiological concentrations of caffeine can 
directly enhance skeletal muscle performance. However, many energy drinks also contain high 
concentrations of taurine. Despite evidence suggesting enhanced skeletal muscle function following 
chronic supplementation, the acute effect of taurine, such as that delivered by energy drinks, has received 
very little attention. Evidence from the present work demonstrates that taurine, at a physiological 
concentration, fails to elicit a direct effect on skeletal muscle function (Chapter 6). Furthermore, in 
contrast to suggestions from past literature (Geib et al. 1994; Steele et al. 1990), using non-physiologically 
relevant concentrations of taurine and caffeine, an interaction of these ingredients does not occur and 
taurine fails to potentiate the effect of caffeine alone. 
The body of evidence that examines the effect of caffeine on performance (both in vivo and in vitro) is 
almost entirely based on subjects (both human and other mammals) that are around their age related 
physiological peak. As well as being the first to provide an in-depth examination of the mechanical 
properties of skeletal muscle from development and with increasing age, the present evidence also 
investigates the potential age related response to the ergogenic effect of caffeine. Initially the findings 
from this thesis suggest that muscle development is likely to be related to predominant phenotype and 
physiological function, as diaphragm muscle matured faster than locomotory EDL muscle. The present 
evidence also highlights the complexity of the ageing process as mechanical properties of skeletal muscle 
deteriorate at different rates and this is also muscle dependent. The question as to which muscle ages 
faster is fundamentally unanswerable as the present evidence indicates a variation between the 
mechanical properties measured. Interestingly, diaphragm muscle shows a greater loss of maximal force 
and power compared to EDL. This is of significance as previous evidence suggests that muscles with a 




due to such fibers experiencing atrophy to a larger degree. Conversely, EDL muscle demonstrated a much 
greater deterioration in fatigue resistance compared to diaphragm muscle. 
Additionally, the present evidence is the first to shed light on the equivocal findings on the effect of 
ageing on fatigue. The magnitude in this alteration varies, however a clear 4-stage pattern has been 
discovered. During the developmental stage muscle was at its most fatigue resistant, but fatigue 
resistance had decreased when maturity was reached. Following this, as the animal begins to age further, 
fatigue resistance increased before decreasing again. In the case of EDL this was significantly reduced in 
comparison to mature values but middle aged and mature fatigue resistance were similar in the 
diaphragm muscle. In contrast to previous evidence the present findings also indicate that the reduction 
in maximal muscle force exceeds the reduction in maximal muscle power output.  As the ageing response 
was correlated to a decrease in EDL muscle mass, it is suggested that the enhanced reduction in power in 
human research is a consequence of the further interaction of atrophy and deterioration in 
neuromuscular innervation. 
Having a greater understanding of the ageing response is important in the potential development of 
innovations to improve human health and quality of life. Ageing diaphragm muscle is likely to significantly 
affect cardiorespiratory function and may contribute to COPD or related symptoms in the elderly. 
Furthermore with falls relating to greater rates of morbidity and mortality in elderly citizens, the 
importance of understanding ageing effects on peripheral muscle performance is of equal importance 
(Aschkenasy & Rothenhaus, 2006). 
The result of this age and muscle dependent alteration in mechanical properties greatly affects the direct 
force potentiating properties of 70µM caffeine. Caffeine evoked the greatest potentiation of maximal 
force when muscle was in the range of peak maturity. During stages of development and later stages of 
ageing, in the context of the present study, the ergogenic effect of caffeine was greatly reduced. 
Alterations in the magnitude of the effect of caffeine infer age related changes in excitation contraction 




ergogenic effect may still provide a significant enhancement in the physical performance of elderly 
citizens and subsequently may have a role to play in increasing quality of life and rehabilitation program 
performance. A more senior population may be long term habitual caffeine users and as such the 
potential reduction in caffeine sensitivity should be considered here. Furthermore, as with all individuals 



















10. Future Work 
The group of studies in the present thesis assess a number of questions regarding the effects of 
physiological concentrations of caffeine on isolated mouse skeletal muscle performance and the changes 
in mechanical properties that occur with age. In light of these findings a number of further questions have 
been raised which could structure the future direction of caffeine and ageing research. 
 
• Is the ageing effect and subsequent change in the ergogenic effects of caffeine different in ageing 
male mice? The speed of ageing in male mice is likely to be different to that in female mice due to 
differences in gender related hormone secretion. Subsequently it would be interesting to repeat 
the studies outlined in chapters 4 and 5 in male mice to make a direct comparison to the results in 
female mice. 
 
• How much can increased physical activity offset the ageing response and potentially improve the 
ergogenic effect of caffeine? Training ‘middle aged’ mice and comparing the mechanical 
properties of their skeletal muscle with an untrained group would enable us to assess if the direct 
effect of training on skeletal muscle performance can counteract the ageing response. 
Maintaining muscle properties might also affect the direct ergogenic effect of caffeine in aged 
muscle, therefore examining the caffeine response in trained post mature muscle would allow us 
to quantify if the ergogenic effect is trainable and as such is it possible to enhance the individual 
caffeine benefit. 
 
• How much is the effect of ageing on skeletal muscle affected by apparent differences in the 
quantity of body fat? A further area of interest would be to examine how much of the age related 




in the loss of muscle function.  Analysis of the results from the present work suggest that middle 
aged mice with a lower body mass-produced significantly higher diaphragm PO per g body mass 
compared to those with a higher body mass (Fig 10.1; TTest p<0.001).There was no significant 
difference in mean diaphragm work loop PO per kg muscle mass between mice with a high body 
mass compared to those with a lower body mass (Fig 10.1; TTest p=0.17).However the trend for 
decreased muscle PO is evident and is an area that needs further analysis. Increased body weight 
could affect the amount of exercise the mouse performs in each cage further increasing the age 
related deterioration in muscle performance. Changes in daily activity could be monitored in each 









Figure 10.1 – A comparison of mean maximal work loop power output of diaphragm muscle of middle 
aged mice between those with a high body mass and those with a low body mass. [Data represented as 
mean ± SE: n=5 in each case). 
• The effect of caffeine on exercise performance in elderly humans. Presently there are a limited 
number human studies that assess the ergogenic effect of caffeine in elderly whole body 








































































likely to be greater if the direct skeletal muscle effects are combined with the potential CNS 
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